<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Amyotrophic lateral sclerosis - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"33e01070-d49f-48ec-bb98-e724a816b222","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Amyotrophic_lateral_sclerosis","wgTitle":"Amyotrophic lateral sclerosis","wgCurRevisionId":1016485537,"wgRevisionId":1016485537,"wgArticleId":19375577,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1: long volume value","Articles with short description","Short description is different from Wikidata","Use dmy dates from September 2020","Articles containing potentially dated statements from 2016","All articles containing potentially dated statements",
"All articles with unsourced statements","Articles with unsourced statements from October 2020","Articles containing potentially dated statements from 2017","Articles containing potentially dated statements from July 2015","Articles containing potentially dated statements from 2013","Commons category link is on Wikidata","Articles with Curlie links","Wikipedia articles with BNF identifiers","Wikipedia articles with LCCN identifiers","Wikipedia articles with LNB identifiers","Wikipedia articles with NDL identifiers","Wikipedia medicine articles ready to translate","RTTNEURO","Amyotrophic lateral sclerosis","Motor neuron diseases","Rare diseases","Unsolved problems in neuroscience","Systemic atrophies primarily affecting the central nervous system","Cytoskeletal defects","Neuromuscular disorders"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Amyotrophic_lateral_sclerosis","wgRelevantArticleId":19375577,"wgIsProbablyEditable":!0,
"wgRelevantPageIsProbablyEditable":!0,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":!0,"wgMediaViewerEnabledByDefault":!0,"wgPopupsFlags":10,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":!0,"nearby":!0,"watchlist":!0,"tagline":!1},"wgWMESchemaEditAttemptStepOversample":!1,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgCentralAuthMobileDomain":!1,"wgEditSubmitButtonLabelPublish":!0,"wgULSPosition":"interlanguage","wgWikibaseItemId":"Q206901"};RLSTATE={"ext.globalCssJs.user.styles":"ready","site.styles":"ready","noscript":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","ext.tmh.thumbnail.styles":"ready","skins.vector.styles.legacy":"ready","jquery.makeCollapsible.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready",
"ext.uls.interlanguage":"ready","ext.wikimediaBadges":"ready","wikibase.client.init":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","mw.MediaWikiPlayer.loader","mw.PopUpMediaTransform","mw.TMHGalleryHook.js","site","mediawiki.page.ready","jquery.makeCollapsible","mediawiki.toc","skins.vector.legacy.js","ext.gadget.ReferenceTooltips","ext.gadget.charinsert","ext.gadget.extra-toolbar-buttons","ext.gadget.refToolbar","ext.gadget.switcher","ext.centralauth.centralautologin","mmv.head","mmv.bootstrap.autostart","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.compactlinks","ext.uls.interface","ext.cx.eventlogging.campaigns","ext.centralNotice.geoIP","ext.centralNotice.startUp"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.tmh.thumbnail.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cskins.vector.styles.legacy%7Cwikibase.client.init&amp;only=styles&amp;skin=vector"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector"></script>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector"/>
<meta name="generator" content="MediaWiki 1.36.0-wmf.38"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/7/75/ALS_Coronal.jpg"/>
<meta property="og:title" content="Amyotrophic lateral sclerosis - Wikipedia"/>
<meta property="og:type" content="website"/>
<link rel="preconnect" href="//upload.wikimedia.org"/>
<link rel="alternate" media="only screen and (max-width: 720px)" href="//en.m.wikipedia.org/wiki/Amyotrophic_lateral_sclerosis"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Amyotrophic_lateral_sclerosis"/>
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Amyotrophic_lateral_sclerosis rootpage-Amyotrophic_lateral_sclerosis skin-vector action-view skin-vector-legacy"><div id="mw-page-base" class="noprint"></div>
<div id="mw-head-base" class="noprint"></div>
<div id="content" class="mw-body" role="main">
	<a id="top"></a>
	<div id="siteNotice" class="mw-body-content"><!-- CentralNotice --></div>
	<div class="mw-indicators mw-body-content">
	</div>
	<h1 id="firstHeading" class="firstHeading" >Amyotrophic lateral sclerosis</h1>
	<div id="bodyContent" class="mw-body-content">
		<div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div>
		<div id="contentSub"></div>
		<div id="contentSub2"></div>
		
		<div id="jump-to-nav"></div>
		<a class="mw-jump-link" href="#mw-head">Jump to navigation</a>
		<a class="mw-jump-link" href="#searchInput">Jump to search</a>
		<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div role="note" class="hatnote navigation-not-searchable">This article is about the neurodegenerative disease. For other uses, see <a href="/wiki/ALS_(disambiguation)" class="mw-disambig" title="ALS (disambiguation)">ALS (disambiguation)</a>.</div>
<div role="note" class="hatnote navigation-not-searchable">"Motor neurone disease" redirects here. For a group of muscle-wasting disorders, see <a href="/wiki/Motor_neuron_disease" title="Motor neuron disease">Motor neuron disease</a>.</div>
<div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Neurodegenerative disease</div>
<p class="mw-empty-elt">
</p>
<table class="infobox"><tbody><tr><th colspan="2" class="infobox-above" style="background:#ccc">Amyotrophic lateral sclerosis<br />(ALS)</th></tr><tr><th scope="row" class="infobox-label">Other names</th><td class="infobox-data">Lou Gehrig's disease;<br />Charcot's disease;<br />motor neurone disease (MND)<sup id="cite_ref-Orphanet2009_1-0" class="reference"><a href="#cite_note-Orphanet2009-1">&#91;1&#93;</a></sup></td></tr><tr><td colspan="2" class="infobox-full-data"><a href="/wiki/File:ALS_Coronal.jpg" class="image"><img alt="ALS Coronal.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/75/ALS_Coronal.jpg/300px-ALS_Coronal.jpg" decoding="async" width="300" height="306" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/75/ALS_Coronal.jpg/450px-ALS_Coronal.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/75/ALS_Coronal.jpg/600px-ALS_Coronal.jpg 2x" data-file-width="920" data-file-height="938" /></a></td></tr><tr><td colspan="2" class="infobox-full-data">An <a href="/wiki/MRI_of_the_brain" class="mw-redirect" title="MRI of the brain">MRI of the brain</a> with <a href="/wiki/T2-weighted" class="mw-redirect" title="T2-weighted">increased T2 signal</a> in the posterior part of the <a href="/wiki/Internal_capsule" title="Internal capsule">internal capsule</a> that can be tracked to the <a href="/wiki/Motor_cortex" title="Motor cortex">motor cortex</a>, consistent with the diagnosis of ALS</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_specialty" title="Medical specialty">Specialty</a></th><td class="infobox-data"><a href="/wiki/Neurology" title="Neurology">Neurology</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Signs_and_symptoms" title="Signs and symptoms">Symptoms</a></th><td class="infobox-data"><b>Early</b>: <a href="/wiki/Spasticity" title="Spasticity">Stiff muscles</a>, <a href="/wiki/Fasciculation" title="Fasciculation">muscle twitches</a>, gradual increasing weakness<sup id="cite_ref-NINDS2020_2-0" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup> <br /> <b>Later</b>: Difficulty in <a href="/wiki/Dysarthria" title="Dysarthria">speaking</a>, <a href="/wiki/Dysphagia" title="Dysphagia">swallowing</a>, and  <a href="/wiki/Shortness_of_breath" title="Shortness of breath">breathing</a>; <a href="/wiki/Respiratory_failure" title="Respiratory failure">respiratory failure</a><sup id="cite_ref-NINDS2020_2-1" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Usual onset</th><td class="infobox-data">50s–60s<sup id="cite_ref-Lancet2011_3-0" class="reference"><a href="#cite_note-Lancet2011-3">&#91;3&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Causes</th><td class="infobox-data">Unknown (most), inherited (few)</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_diagnosis" title="Medical diagnosis">Diagnostic method</a></th><td class="infobox-data">Suspected as based on symptoms and supported by <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">MRI</a><sup id="cite_ref-NINDS2020_2-2" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Treatment</th><td class="infobox-data"><a href="/wiki/Non-invasive_ventilation" title="Non-invasive ventilation">Non-invasive ventilation</a><sup id="cite_ref-Support2016_4-0" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medication" title="Medication">Medication</a></th><td class="infobox-data"><a href="/wiki/Riluzole" title="Riluzole">Riluzole</a>, <a href="/wiki/Edaravone" title="Edaravone">edaravone</a><sup id="cite_ref-CD001447_5-0" class="reference"><a href="#cite_note-CD001447-5">&#91;5&#93;</a></sup><sup id="cite_ref-FDA2017_6-0" class="reference"><a href="#cite_note-FDA2017-6">&#91;6&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Prognosis" title="Prognosis">Prognosis</a></th><td class="infobox-data">Life expectancy 2–4 years<sup id="cite_ref-Support2016_4-1" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Frequency</th><td class="infobox-data">2.6/100,000 per year (Europe)<sup id="cite_ref-Har2017_7-0" class="reference"><a href="#cite_note-Har2017-7">&#91;7&#93;</a></sup></td></tr></tbody></table>
<p><b>Amyotrophic lateral sclerosis</b> (<b>ALS</b>; also known as <b>Lou Gehrig's disease</b> in <a href="/wiki/Canada" title="Canada">Canada</a> and the <a href="/wiki/United_States" title="United States">United States</a>, as <b>motor neurone disease</b> (<b>MND</b>) in <a href="/wiki/Australia" title="Australia">Australia</a>, <a href="/wiki/Republic_of_Ireland" title="Republic of Ireland">Ireland</a>, <a href="/wiki/New_Zealand" title="New Zealand">New Zealand</a>, <a href="/wiki/South_Africa" title="South Africa">South Africa</a>, and the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a>, and <b>Charcot disease</b> in <a href="/wiki/Geographical_distribution_of_French_speakers" title="Geographical distribution of French speakers">francophone countries</a>) is a <a href="/wiki/Neurodegenerative" class="mw-redirect" title="Neurodegenerative">neurodegenerative</a> <a href="/wiki/Neuromuscular_disease" title="Neuromuscular disease">neuromuscular disease</a> that results in the progressive loss of <a href="/wiki/Motor_neuron" title="Motor neuron">motor neurons</a> that control <a href="/wiki/Skeletal_muscle" title="Skeletal muscle">voluntary muscles</a>.<sup id="cite_ref-NINDS2020_2-3" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup><sup id="cite_ref-NHS_8-0" class="reference"><a href="#cite_note-NHS-8">&#91;8&#93;</a></sup><sup id="cite_ref-healthdirectAU_9-0" class="reference"><a href="#cite_note-healthdirectAU-9">&#91;9&#93;</a></sup> ALS is the most common type of <a href="/wiki/Motor_neuron_disease" title="Motor neuron disease">motor neuron disease</a>.<sup id="cite_ref-Zucchi_10-0" class="reference"><a href="#cite_note-Zucchi-10">&#91;10&#93;</a></sup><sup id="cite_ref-NIH2020_11-0" class="reference"><a href="#cite_note-NIH2020-11">&#91;11&#93;</a></sup> Early symptoms of ALS include <a href="/wiki/Spasticity" title="Spasticity">stiff muscles</a>, <a href="/wiki/Fasciculation" title="Fasciculation">muscle twitches</a>, and gradual increasing weakness and <a href="/wiki/Muscle_atrophy" title="Muscle atrophy">muscle wasting</a>.<sup id="cite_ref-NINDS2020_2-4" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup>
</p><p>It may begin with weakness in the arms or legs, when it is known as <i>limb-onset</i>, or with difficulty in <a href="/wiki/Dysarthria" title="Dysarthria">speaking</a> or <a href="/wiki/Dysphagia" title="Dysphagia">swallowing</a>, when it is known as <i>bulbar-onset</i>.<sup id="cite_ref-NINDS2020_2-5" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup><sup id="cite_ref-Nature2017_12-0" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> About half of the people affected develop at least mild difficulties with <a href="/wiki/Cognitive_disorder" title="Cognitive disorder">thinking</a> and behavior and most people experience <a href="/wiki/Pain" title="Pain">pain</a>.<sup id="cite_ref-Lancet2017_13-0" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup><sup id="cite_ref-Pain2017_14-0" class="reference"><a href="#cite_note-Pain2017-14">&#91;14&#93;</a></sup> The affected muscles are responsible for chewing food, speaking, and walking.<sup id="cite_ref-NINDS2020_2-6" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup> Motor neuron loss continues until the ability to eat, speak, move, and finally breathe is lost.<sup id="cite_ref-NINDS2020_2-7" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup> ALS eventually causes <a href="/wiki/Paralysis" title="Paralysis">paralysis</a> and early death, usually from <a href="/wiki/Respiratory_failure" title="Respiratory failure">respiratory failure</a>.<sup id="cite_ref-Hilton_15-0" class="reference"><a href="#cite_note-Hilton-15">&#91;15&#93;</a></sup>
</p><p>Most cases of ALS (about 90% to 95%) have no known cause, and are known as <i>sporadic ALS</i>.<sup id="cite_ref-NINDS2020_2-8" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup><sup id="cite_ref-alsa_16-0" class="reference"><a href="#cite_note-alsa-16">&#91;16&#93;</a></sup> However both <a href="/wiki/Genetics" title="Genetics">genetic</a> and <a href="/wiki/Environmental_factors" class="mw-redirect" title="Environmental factors">environmental factors</a> are believed to be involved.<sup id="cite_ref-Wingo2011_17-0" class="reference"><a href="#cite_note-Wingo2011-17">&#91;17&#93;</a></sup> The remaining 5% to 10% of cases have a genetic cause linked to a <a href="/wiki/Family_history_(medicine)" title="Family history (medicine)">history of the disease in the family</a>, and these are known as <i>familial ALS</i>.<sup id="cite_ref-alsa_16-1" class="reference"><a href="#cite_note-alsa-16">&#91;16&#93;</a></sup><sup id="cite_ref-Lancet2011_3-1" class="reference"><a href="#cite_note-Lancet2011-3">&#91;3&#93;</a></sup> About half of these genetic cases are due to one of two specific <a href="/wiki/Gene" title="Gene">genes</a>.<sup id="cite_ref-NINDS2020_2-9" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup> The underlying mechanism involves damage to both <a href="/wiki/Upper_motor_neuron" title="Upper motor neuron">upper</a> and <a href="/wiki/Lower_motor_neuron" title="Lower motor neuron">lower motor neurons</a>.<sup id="cite_ref-NINDS2020_2-10" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup> The <a href="/wiki/Diagnosis" title="Diagnosis">diagnosis</a> is based on a person's signs and <a href="/wiki/Symptoms" class="mw-redirect" title="Symptoms">symptoms</a>, with testing done to rule out other potential causes.<sup id="cite_ref-NINDS2020_2-11" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup>
</p><p>There is no cure for ALS yet, and treatment is targeted at improving the symptoms.<sup id="cite_ref-NHS_8-1" class="reference"><a href="#cite_note-NHS-8">&#91;8&#93;</a></sup> A medication called <a href="/wiki/Riluzole" title="Riluzole">riluzole</a> may extend life by about two to three months.<sup id="cite_ref-CD001447_5-1" class="reference"><a href="#cite_note-CD001447-5">&#91;5&#93;</a></sup> <a href="/wiki/Non-invasive_ventilation" title="Non-invasive ventilation">Non-invasive ventilation</a> may result in both improved quality and length of life.<sup id="cite_ref-Support2016_4-2" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> <a href="/wiki/Mechanical_ventilation" title="Mechanical ventilation">Mechanical ventilation</a> can prolong survival but does not stop disease progression.<sup id="cite_ref-Care2017_18-0" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup> A <a href="/wiki/Feeding_tube" title="Feeding tube">feeding tube</a> may help.<sup id="cite_ref-Conn2015_19-0" class="reference"><a href="#cite_note-Conn2015-19">&#91;19&#93;</a></sup> The disease can affect people of any age, but usually starts around the age of 60 and in inherited cases around the age of 50.<sup id="cite_ref-Lancet2011_3-2" class="reference"><a href="#cite_note-Lancet2011-3">&#91;3&#93;</a></sup> The average survival from onset to death is two to four years, though this can vary, and about 10% survive longer than 10 years,<sup id="cite_ref-Support2016_4-3" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup><sup id="cite_ref-Nature2014_20-0" class="reference"><a href="#cite_note-Nature2014-20">&#91;20&#93;</a></sup><sup id="cite_ref-NINDS2020_2-12" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup> and death is usually due to respiratory failure.<sup id="cite_ref-Lancet2011_3-3" class="reference"><a href="#cite_note-Lancet2011-3">&#91;3&#93;</a></sup> In Europe, the disease affects about two to three people per 100,000 per year.<sup id="cite_ref-Har2017_7-1" class="reference"><a href="#cite_note-Har2017-7">&#91;7&#93;</a></sup> Rates in much of the world are unclear.<sup id="cite_ref-Conspiracy_21-0" class="reference"><a href="#cite_note-Conspiracy-21">&#91;21&#93;</a></sup> In the United States, it is more common in <a href="/wiki/White_people" title="White people">white people</a> than <a href="/wiki/Black_people" title="Black people">black people</a>.<sup id="cite_ref-MMWR_2015_22-0" class="reference"><a href="#cite_note-MMWR_2015-22">&#91;22&#93;</a></sup>
</p><p>Descriptions of the disease date back to at least 1824 by <a href="/wiki/Charles_Bell" title="Charles Bell">Charles Bell</a>.<sup id="cite_ref-Rowland2001_23-0" class="reference"><a href="#cite_note-Rowland2001-23">&#91;23&#93;</a></sup> In 1869, the connection between the symptoms and the underlying neurological problems was first described by <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a>, who in 1874 began using the term <i>amyotrophic lateral sclerosis</i>.<sup id="cite_ref-Rowland2001_23-1" class="reference"><a href="#cite_note-Rowland2001-23">&#91;23&#93;</a></sup> It became well known in the United States in the 20th century when in 1939 it affected baseball player <a href="/wiki/Lou_Gehrig" title="Lou Gehrig">Lou Gehrig</a> and later worldwide following the 1963 diagnosis of <a href="/wiki/Astrophysics" title="Astrophysics">cosmologist</a> <a href="/wiki/Stephen_Hawking" title="Stephen Hawking">Stephen Hawking</a>.<sup id="cite_ref-Kel2013_24-0" class="reference"><a href="#cite_note-Kel2013-24">&#91;24&#93;</a></sup><sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup> The first ALS gene was discovered in 1993 while the first <a href="/wiki/Animal_model" class="mw-redirect" title="Animal model">animal model</a> was developed in 1994.<sup id="cite_ref-Neuroscience2014_26-0" class="reference"><a href="#cite_note-Neuroscience2014-26">&#91;26&#93;</a></sup><sup id="cite_ref-MouseModels2018_27-0" class="reference"><a href="#cite_note-MouseModels2018-27">&#91;27&#93;</a></sup> In 2014, videos of the <a href="/wiki/Ice_Bucket_Challenge" title="Ice Bucket Challenge">Ice Bucket Challenge</a> went viral on the Internet and increased public awareness of the condition.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup>
</p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Classification"><span class="tocnumber">1</span> <span class="toctext">Classification</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Classical_ALS,_PLS,_and_PMA"><span class="tocnumber">1.1</span> <span class="toctext">Classical ALS, PLS, and PMA</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Regional_variants"><span class="tocnumber">1.2</span> <span class="toctext">Regional variants</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Age_of_onset"><span class="tocnumber">1.3</span> <span class="toctext">Age of onset</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-5"><a href="#Signs_and_symptoms"><span class="tocnumber">2</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#Initial_symptoms"><span class="tocnumber">2.1</span> <span class="toctext">Initial symptoms</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Progression"><span class="tocnumber">2.2</span> <span class="toctext">Progression</span></a></li>
<li class="toclevel-2 tocsection-8"><a href="#Late_stages"><span class="tocnumber">2.3</span> <span class="toctext">Late stages</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-9"><a href="#Cause"><span class="tocnumber">3</span> <span class="toctext">Cause</span></a>
<ul>
<li class="toclevel-2 tocsection-10"><a href="#Genetics"><span class="tocnumber">3.1</span> <span class="toctext">Genetics</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Environmental_factors"><span class="tocnumber">3.2</span> <span class="toctext">Environmental factors</span></a>
<ul>
<li class="toclevel-3 tocsection-12"><a href="#Head_injury"><span class="tocnumber">3.2.1</span> <span class="toctext">Head injury</span></a></li>
<li class="toclevel-3 tocsection-13"><a href="#Physical_activity"><span class="tocnumber">3.2.2</span> <span class="toctext">Physical activity</span></a></li>
<li class="toclevel-3 tocsection-14"><a href="#Sports"><span class="tocnumber">3.2.3</span> <span class="toctext">Sports</span></a></li>
<li class="toclevel-3 tocsection-15"><a href="#Smoking"><span class="tocnumber">3.2.4</span> <span class="toctext">Smoking</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-16"><a href="#Pathophysiology"><span class="tocnumber">4</span> <span class="toctext">Pathophysiology</span></a>
<ul>
<li class="toclevel-2 tocsection-17"><a href="#Neuropathology"><span class="tocnumber">4.1</span> <span class="toctext">Neuropathology</span></a></li>
<li class="toclevel-2 tocsection-18"><a href="#Biochemistry"><span class="tocnumber">4.2</span> <span class="toctext">Biochemistry</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-19"><a href="#Diagnosis"><span class="tocnumber">5</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-20"><a href="#Diagnostic_criteria"><span class="tocnumber">5.1</span> <span class="toctext">Diagnostic criteria</span></a></li>
<li class="toclevel-2 tocsection-21"><a href="#Differential_diagnosis"><span class="tocnumber">5.2</span> <span class="toctext">Differential diagnosis</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-22"><a href="#Management"><span class="tocnumber">6</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-23"><a href="#Medications"><span class="tocnumber">6.1</span> <span class="toctext">Medications</span></a></li>
<li class="toclevel-2 tocsection-24"><a href="#Breathing_support"><span class="tocnumber">6.2</span> <span class="toctext">Breathing support</span></a>
<ul>
<li class="toclevel-3 tocsection-25"><a href="#Non-invasive_ventilation"><span class="tocnumber">6.2.1</span> <span class="toctext">Non-invasive ventilation</span></a></li>
<li class="toclevel-3 tocsection-26"><a href="#Invasive_ventilation"><span class="tocnumber">6.2.2</span> <span class="toctext">Invasive ventilation</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-27"><a href="#Therapy"><span class="tocnumber">6.3</span> <span class="toctext">Therapy</span></a></li>
<li class="toclevel-2 tocsection-28"><a href="#Nutrition"><span class="tocnumber">6.4</span> <span class="toctext">Nutrition</span></a></li>
<li class="toclevel-2 tocsection-29"><a href="#End-of-life_care"><span class="tocnumber">6.5</span> <span class="toctext">End-of-life care</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-30"><a href="#Epidemiology"><span class="tocnumber">7</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-31"><a href="#History"><span class="tocnumber">8</span> <span class="toctext">History</span></a>
<ul>
<li class="toclevel-2 tocsection-32"><a href="#Diagnostic_criteria_2"><span class="tocnumber">8.1</span> <span class="toctext">Diagnostic criteria</span></a></li>
<li class="toclevel-2 tocsection-33"><a href="#Name"><span class="tocnumber">8.2</span> <span class="toctext">Name</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-34"><a href="#Society_and_culture"><span class="tocnumber">9</span> <span class="toctext">Society and culture</span></a></li>
<li class="toclevel-1 tocsection-35"><a href="#Research"><span class="tocnumber">10</span> <span class="toctext">Research</span></a>
<ul>
<li class="toclevel-2 tocsection-36"><a href="#Model_organisms"><span class="tocnumber">10.1</span> <span class="toctext">Model organisms</span></a></li>
<li class="toclevel-2 tocsection-37"><a href="#Treatments"><span class="tocnumber">10.2</span> <span class="toctext">Treatments</span></a></li>
<li class="toclevel-2 tocsection-38"><a href="#Cause_2"><span class="tocnumber">10.3</span> <span class="toctext">Cause</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-39"><a href="#See_also"><span class="tocnumber">11</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-40"><a href="#Notes"><span class="tocnumber">12</span> <span class="toctext">Notes</span></a></li>
<li class="toclevel-1 tocsection-41"><a href="#References"><span class="tocnumber">13</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-42"><a href="#External_links"><span class="tocnumber">14</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
</div>
<h2><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=1" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>ALS is a <a href="/wiki/Motor_neuron_disease" title="Motor neuron disease">motor neuron disease</a>, also spelled "motor neurone disease", which is a group of <a href="/wiki/Neurological_disorder" title="Neurological disorder">neurological disorders</a> that selectively affect <a href="/wiki/Motor_neuron" title="Motor neuron">motor neurons</a>, the cells that control <a href="/wiki/Skeletal_muscle" title="Skeletal muscle">voluntary muscles</a> of the body.<sup id="cite_ref-NINDS2020_2-13" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup> Other motor neuron diseases include <a href="/wiki/Primary_lateral_sclerosis" title="Primary lateral sclerosis">primary lateral sclerosis</a> (PLS), <a href="/wiki/Progressive_muscular_atrophy" title="Progressive muscular atrophy">progressive muscular atrophy</a> (PMA), <a href="/wiki/Progressive_bulbar_palsy" title="Progressive bulbar palsy">progressive bulbar palsy</a>, <a href="/wiki/Pseudobulbar_palsy" title="Pseudobulbar palsy">pseudobulbar palsy</a>, and <a href="/wiki/Monomelic_amyotrophy" title="Monomelic amyotrophy">monomelic amyotrophy</a> (MMA).<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup>
</p><p>ALS itself can be classified in a few different ways: by how fast the disease progresses which is related to the age of onset; by whether it is familial or sporadic, and by the region first affected.<sup id="cite_ref-NINDS2020_2-14" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup> In about 25% of cases, muscles in the face, mouth, and throat are affected first because motor neurons in the part of the <a href="/wiki/Brainstem" title="Brainstem">brainstem</a> called the <a href="/wiki/Medulla_oblongata" title="Medulla oblongata">medulla oblongata</a> (formerly called the "bulb") start to die first along with lower motor neurons. This form is called "<a href="/wiki/Bulbar" class="mw-redirect" title="Bulbar">bulbar</a>-onset ALS". In about 5% of cases, muscles in the trunk of the body are affected first.<sup id="cite_ref-Lancet2011_3-4" class="reference"><a href="#cite_note-Lancet2011-3">&#91;3&#93;</a></sup> In most cases the disease spreads and affects other spinal cord regions. A few people with ALS have symptoms that are limited to one spinal cord region for at least 12 to 24 months before spreading to a second region; these regional variants of ALS are associated with a better prognosis.<sup id="cite_ref-Regional_ALS_Variants_30-0" class="reference"><a href="#cite_note-Regional_ALS_Variants-30">&#91;30&#93;</a></sup>
</p>
<h3><span id="Classical_ALS.2C_PLS.2C_and_PMA"></span><span class="mw-headline" id="Classical_ALS,_PLS,_and_PMA">Classical ALS, PLS, and PMA</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=2" title="Edit section: Classical ALS, PLS, and PMA">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:UMN_vs_LMN.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e9/UMN_vs_LMN.png/290px-UMN_vs_LMN.png" decoding="async" width="290" height="294" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e9/UMN_vs_LMN.png/435px-UMN_vs_LMN.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e9/UMN_vs_LMN.png/580px-UMN_vs_LMN.png 2x" data-file-width="1477" data-file-height="1496" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:UMN_vs_LMN.png" class="internal" title="Enlarge"></a></div>Typical or "classical" ALS involves neurons in the brain (<a href="/wiki/Upper_motor_neuron" title="Upper motor neuron">upper motor neurons</a>) and in the spinal cord (<a href="/wiki/Lower_motor_neuron" title="Lower motor neuron">lower motor neurons</a>).<sup id="cite_ref-Cold_Spring_Harbor_2017_31-0" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-31">&#91;31&#93;</a></sup></div></div></div>
<p>ALS can be classified by the types of motor neurons that are affected. Typical or "classical" ALS involves <a href="/wiki/Upper_motor_neuron" title="Upper motor neuron">upper motor neurons</a> in the brain, and <a href="/wiki/Lower_motor_neuron" title="Lower motor neuron">lower motor neurons</a> in the spinal cord.<sup id="cite_ref-Cold_Spring_Harbor_2017_31-1" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-31">&#91;31&#93;</a></sup> <a href="/wiki/Primary_lateral_sclerosis" title="Primary lateral sclerosis">Primary lateral sclerosis</a> (PLS) involves only upper motor neurons, and <a href="/wiki/Progressive_muscular_atrophy" title="Progressive muscular atrophy">progressive muscular atrophy</a> (PMA) involves only lower motor neurons. There is debate over whether PLS and PMA are separate diseases or simply variants of ALS.<sup id="cite_ref-Lancet2017_13-1" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup>
</p><p>Classic ALS accounts for about 70% of all cases of ALS and can be subdivided into <b>limb-onset ALS</b> (also known as spinal-onset) and <b>bulbar-onset ALS</b>.<sup id="cite_ref-Lancet2017_13-2" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> Limb-onset ALS, begins with weakness in the arms and legs<sup id="cite_ref-Nature2017_12-1" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> and accounts for about two-thirds of all classic ALS cases.<sup id="cite_ref-Lancet2017_13-3" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> Bulbar-onset ALS begins with weakness in the muscles of speech, chewing, and swallowing<sup id="cite_ref-Cold_Spring_Harbor_2017_31-2" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-31">&#91;31&#93;</a></sup> and accounts for the other one-third of cases.<sup id="cite_ref-Lancet2017_13-4" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> Bulbar onset is associated with a worse prognosis than limb-onset ALS; a population-based study found that bulbar-onset ALS has a median survival of 2.0 years and a 10-year survival rate of 3%, while limb-onset ALS has a median survival of 2.6 years and a 10-year survival rate of 13%.<sup id="cite_ref-JNNP_July_2011_32-0" class="reference"><a href="#cite_note-JNNP_July_2011-32">&#91;32&#93;</a></sup> A rare variant is respiratory-onset ALS that accounts for about 3% of all cases of ALS,<sup id="cite_ref-Lancet2017_13-5" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> in which the initial symptoms are difficulty breathing (<a href="/wiki/Dyspnea" class="mw-redirect" title="Dyspnea">dyspnea</a>) with exertion, at rest, or while lying down (<a href="/wiki/Orthopnea" title="Orthopnea">orthopnea</a>).<sup id="cite_ref-33" class="reference"><a href="#cite_note-33">&#91;33&#93;</a></sup> Spinal and bulbar symptoms tend to be mild or absent at the beginning. It is more common in males.<sup id="cite_ref-Nature2014_20-1" class="reference"><a href="#cite_note-Nature2014-20">&#91;20&#93;</a></sup> Respiratory-onset ALS has the worst prognosis of any ALS variant; in a population-based study, those with respiratory-onset had a median survival of 1.4 years and 0% survival at 10 years.<sup id="cite_ref-JNNP_July_2011_32-1" class="reference"><a href="#cite_note-JNNP_July_2011-32">&#91;32&#93;</a></sup>
</p><p>Primary lateral sclerosis (PLS) accounts for about 5% of all cases of ALS and affects upper motor neurons in the arms and legs.<sup id="cite_ref-Nature2014_20-2" class="reference"><a href="#cite_note-Nature2014-20">&#91;20&#93;</a></sup> However, more than 75% of people with apparent PLS develop lower motor neuron signs within four years of symptom onset, meaning that a definite diagnosis of PLS cannot be made until then.<sup id="cite_ref-Classification2016_34-0" class="reference"><a href="#cite_note-Classification2016-34">&#91;34&#93;</a></sup> PLS has a better prognosis than classic ALS, as it progresses slower, results in less functional decline, does not affect the ability to breathe, and causes less severe weight loss.<sup id="cite_ref-Nature2014_20-3" class="reference"><a href="#cite_note-Nature2014-20">&#91;20&#93;</a></sup>
</p><p>Progressive muscular atrophy (PMA) accounts for about 5% of all cases of ALS and affects lower motor neurons in the arms and legs.<sup id="cite_ref-Nature2014_20-4" class="reference"><a href="#cite_note-Nature2014-20">&#91;20&#93;</a></sup> While PMA is associated with longer survival on average than classic ALS, it still progresses to other spinal cord regions over time, eventually leading to respiratory failure and death.<sup id="cite_ref-Lancet2017_13-6" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> Upper motor neuron signs can develop late in the course of PMA, in which case the diagnosis might be changed to classic ALS.<sup id="cite_ref-Classification2016_34-1" class="reference"><a href="#cite_note-Classification2016-34">&#91;34&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Regional_variants">Regional variants</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=3" title="Edit section: Regional variants">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Regional variants of ALS have symptoms that are limited to a single spinal cord region for at least a year; they progress more slowly than classic ALS and are associated with longer survival. Examples include flail arm syndrome, flail leg syndrome, and isolated bulbar ALS. Flail arm syndrome and flail leg syndrome are often considered to be regional variants of PMA because they only involve lower motor neurons. Isolated bulbar ALS can involve upper or lower motor neurons. These regional variants of ALS cannot be diagnosed at the onset of symptoms; a failure of the disease to spread to other spinal cord regions for an extended period of time (at least 12 months) must be observed.<sup id="cite_ref-Regional_ALS_Variants_30-1" class="reference"><a href="#cite_note-Regional_ALS_Variants-30">&#91;30&#93;</a></sup>
</p><p>Flail arm syndrome, also called brachial amyotrophic diplegia,<sup id="cite_ref-35" class="reference"><a href="#cite_note-35">&#91;a&#93;</a></sup> is characterized by lower motor neuron damage in the cervical spinal cord only, leading to gradual onset of weakness in the proximal arm muscles and decreased or absent reflexes. Flail leg syndrome, also called leg amyotrophic diplegia,<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">&#91;b&#93;</a></sup> is characterized by lower motor neuron damage in the lumbosacral spinal cord only, leading to gradual onset of weakness in the legs and decreased or absent reflexes. Isolated bulbar ALS is characterized by upper or lower motor neuron damage in the bulbar region only, leading to gradual onset of difficulty with speech (<a href="/wiki/Dysarthria" title="Dysarthria">dysarthria</a>) and swallowing (<a href="/wiki/Dysphagia" title="Dysphagia">dysphagia</a>); <a href="/wiki/Breathing" title="Breathing">breathing</a> (respiration) is generally preserved, at least initially. Two small studies have shown that people with isolated bulbar ALS may live longer than people with bulbar-onset ALS.<sup id="cite_ref-Regional_ALS_Variants_30-2" class="reference"><a href="#cite_note-Regional_ALS_Variants-30">&#91;30&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Age_of_onset">Age of onset</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=4" title="Edit section: Age of onset">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>ALS can also be classified based on the age of onset. While the peak age of onset is 58 to 63 for sporadic ALS and 47 to 52 for familial ALS,<sup id="cite_ref-Lancet2011_3-5" class="reference"><a href="#cite_note-Lancet2011-3">&#91;3&#93;</a></sup> about 10% of all cases of ALS begin before age 45 ("young-onset" ALS), and about 1% of all cases begin before age 25 (juvenile ALS).<sup id="cite_ref-Cold_Spring_Harbor_2017_31-3" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-31">&#91;31&#93;</a></sup> People who develop young-onset ALS are more likely to be male, less likely to have bulbar onset of symptoms, and more likely to have a slower progression of disease.<sup id="cite_ref-Classification2016_34-2" class="reference"><a href="#cite_note-Classification2016-34">&#91;34&#93;</a></sup> Juvenile ALS is more likely to be familial than adult-onset ALS; genes known to be associated with juvenile ALS include <i><a href="/wiki/ALS2" title="ALS2">ALS2</a></i>, <i><a href="/wiki/SETX" title="SETX">SETX</a></i>, <i><a href="/wiki/SPG11" title="SPG11">SPG11</a></i>, <i><a href="/wiki/FUS_(gene)" class="mw-redirect" title="FUS (gene)">FUS</a></i>, and <i><a href="/wiki/SIGMAR1" class="mw-redirect" title="SIGMAR1">SIGMAR1</a></i>. Although most people with juvenile ALS live longer than those with adult-onset ALS, some of them have specific mutations in <i>FUS</i> and <i>SOD1</i> that are associated with a poor prognosis.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">&#91;35&#93;</a></sup> Late onset (after age 65) is associated with a more rapid functional decline and shorter survival.<sup id="cite_ref-Clinical_Features_of_ALS_38-0" class="reference"><a href="#cite_note-Clinical_Features_of_ALS-38">&#91;36&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=5" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The disorder causes muscle weakness, <a href="/wiki/Atrophy" title="Atrophy">atrophy</a>, and <a href="/wiki/Spasticity" title="Spasticity">muscle spasms</a> throughout the body due to the degeneration of the upper motor and lower motor neurons. Individuals affected by the disorder may ultimately lose the ability to initiate and control all voluntary movement,<sup id="cite_ref-Support2016_4-4" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> although bladder and bowel function and the <a href="/wiki/Extraocular_muscles" title="Extraocular muscles">extraocular muscles</a> (the muscles responsible for eye movement) are usually spared<sup id="cite_ref-39" class="reference"><a href="#cite_note-39">&#91;37&#93;</a></sup><sup id="cite_ref-41" class="reference"><a href="#cite_note-41">&#91;c&#93;</a></sup> until the final stages of the disease.<sup id="cite_ref-NEJM_2017_42-0" class="reference"><a href="#cite_note-NEJM_2017-42">&#91;39&#93;</a></sup>
</p><p><a href="/wiki/Cognitive_disorder" title="Cognitive disorder">Cognitive</a> or behavioral dysfunction is present in 30–50% of individuals with ALS.<sup id="cite_ref-Martin2017_43-0" class="reference"><a href="#cite_note-Martin2017-43">&#91;40&#93;</a></sup> Around half of people with ALS will experience mild changes in cognition and behavior, and 10–15% will show signs of <a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">frontotemporal dementia</a> (FTD).<sup id="cite_ref-Support2016_4-5" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> <a href="/wiki/Perseveration" title="Perseveration">Repeating phrases or gestures</a>, apathy, and <a href="/wiki/Disinhibition" title="Disinhibition">loss of inhibition</a> are frequently reported behavioral features of ALS.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44">&#91;41&#93;</a></sup> <a href="/wiki/Language_disorder" title="Language disorder">Language dysfunction</a>, <a href="/wiki/Executive_dysfunction" title="Executive dysfunction">executive dysfunction</a>, and troubles with <a href="/wiki/Social_cognition" title="Social cognition">social cognition</a> and <a href="/wiki/Verbal_memory" title="Verbal memory">verbal memory</a> are the most commonly reported cognitive symptoms in ALS; a meta-analysis found no relationship between dysfunction and disease severity.<sup id="cite_ref-2016cog_45-0" class="reference"><a href="#cite_note-2016cog-45">&#91;42&#93;</a></sup> However, cognitive and behavioral dysfunctions have been found to correlate with reduced survival in people with ALS and increased caregiver burden; this may be due in part to deficits in social cognition.<sup id="cite_ref-2016cog_45-1" class="reference"><a href="#cite_note-2016cog-45">&#91;42&#93;</a></sup> About half the people who have ALS experience <a href="/wiki/Emotional_lability" title="Emotional lability">emotional lability</a>, in which they cry or laugh for no reason; it is more common in those with bulbar-onset ALS.<sup id="cite_ref-Support2016_4-6" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup>
</p><p>Pain is a symptom experienced by most people with ALS and can take the form of <a href="/wiki/Neuropathic_pain" title="Neuropathic pain">neuropathic pain</a> (pain caused by nerve damage), spasticity, muscle cramps, and <a href="/wiki/Nociceptive_pain" class="mw-redirect" title="Nociceptive pain">nociceptive pain</a> caused by reduced mobility and muscle weakness; examples of nociceptive pain in ALS include <a href="/wiki/Contracture" title="Contracture">contractures</a> (permanent shortening of a muscle or joint), neck pain, back pain, shoulder pain, and pressure ulcers.<sup id="cite_ref-Pain2017_14-1" class="reference"><a href="#cite_note-Pain2017-14">&#91;14&#93;</a></sup>
</p><p><a href="/wiki/Sensory_neuron" title="Sensory neuron">Sensory nerves</a> and the <a href="/wiki/Autonomic_nervous_system" title="Autonomic nervous system">autonomic nervous system</a> are generally unaffected, meaning the majority of people with ALS maintain <a href="/wiki/Hearing" title="Hearing">hearing</a>, <a href="/wiki/Visual_perception" title="Visual perception">sight</a>, <a href="/wiki/Somatosensory_system" title="Somatosensory system">touch</a>, <a href="/wiki/Olfaction" title="Olfaction">smell</a>, and <a href="/wiki/Taste" title="Taste">taste</a>.<sup id="cite_ref-NINDS2020_2-15" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Initial_symptoms">Initial symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=6" title="Edit section: Initial symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The start of ALS may be so subtle that the symptoms are overlooked.<sup id="cite_ref-NINDS2020_2-16" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup> The earliest symptoms of ALS are muscle weakness or muscle atrophy. Other presenting symptoms include trouble swallowing or breathing, cramping, or stiffness of affected muscles; muscle weakness affecting an arm or a leg; or slurred and nasal speech. The parts of the body affected by early symptoms of ALS depend on which motor neurons in the body are damaged first.<sup id="cite_ref-NHS_8-2" class="reference"><a href="#cite_note-NHS-8">&#91;8&#93;</a></sup>
</p><p>In limb-onset ALS, the first symptoms are in the arms or the legs. If the legs are affected first, people may experience awkwardness, tripping, or stumbling when walking or running; this is often marked by walking with a "<a href="/wiki/Foot_drop" title="Foot drop">dropped foot</a>" that drags gently on the ground. If the arms are affected first, they may experience difficulty with tasks requiring manual dexterity, such as buttoning a shirt, writing, or turning a key in a lock.<sup id="cite_ref-NHS_8-3" class="reference"><a href="#cite_note-NHS-8">&#91;8&#93;</a></sup>
</p><p>In bulbar-onset ALS, the first symptoms are difficulty speaking or swallowing. Speech may become slurred, nasal in character, or quieter. There may be difficulty with swallowing and loss of tongue mobility. A smaller proportion of people experience "respiratory-onset" ALS, where the <a href="/wiki/Intercostal_muscle" title="Intercostal muscle">intercostal muscles</a> that support breathing are affected first.<sup id="cite_ref-Lancet2011_3-6" class="reference"><a href="#cite_note-Lancet2011-3">&#91;3&#93;</a></sup>
</p><p>Over time, people experience increasing difficulty moving, swallowing (<a href="/wiki/Dysphagia" title="Dysphagia">dysphagia</a>), and speaking or forming words (<a href="/wiki/Dysarthria" title="Dysarthria">dysarthria</a>). Symptoms of upper motor neuron involvement include tight and stiff muscles (<a href="/wiki/Spasticity" title="Spasticity">spasticity</a>) and exaggerated reflexes (<a href="/wiki/Hyperreflexia" title="Hyperreflexia">hyperreflexia</a>), including an overactive gag reflex. An abnormal reflex commonly called <a href="/wiki/Plantar_reflex" title="Plantar reflex">Babinski's sign</a> also indicates upper motor neuron damage. Symptoms of lower motor neuron degeneration include muscle weakness and atrophy, muscle cramps, and fleeting twitches of muscles that can be seen under the skin (<a href="/wiki/Fasciculation" title="Fasciculation">fasciculations</a>). However, twitching is more of a side effect than a diagnostic symptom; it either occurs after or accompanies weakness and atrophy.<sup id="cite_ref-NINDS2020_2-17" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Progression">Progression</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=7" title="Edit section: Progression">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Although the initial symptoms and rate of progression vary from person to person, the disease eventually spreads to unaffected regions and the affected regions become more affected. Most people eventually are not able to walk or use their hands and arms, lose the ability to speak and swallow food and their own saliva, and begin to lose the ability to cough and to breathe on their own.<sup id="cite_ref-Support2016_4-7" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup>
</p><p>The rate of progression can be measured using the <a href="/wiki/ALS_Functional_Rating_Scale_-_Revised" title="ALS Functional Rating Scale - Revised">ALS Functional Rating Scale - Revised</a> (ALSFRS-R), a 12-item instrument survey administered as a clinical interview or self-reported questionnaire that produces a score between 48 (normal function) and 0 (severe disability);<sup id="cite_ref-46" class="reference"><a href="#cite_note-46">&#91;43&#93;</a></sup> it is the most commonly used outcome measure in clinical trials and is used by doctors to track disease progression.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47">&#91;44&#93;</a></sup> Though the degree of variability is high and a small percentage of people have a much slower disorder, on average, people with ALS lose about 0.9 FRS points per month. A survey-based study among clinicians showed that they rated a 20% change in the slope of the ALSFRS-R as being clinically meaningful.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48">&#91;45&#93;</a></sup>
</p><p>Disease progression tends to be slower in people who are younger than 40 at onset,<sup id="cite_ref-49" class="reference"><a href="#cite_note-49">&#91;46&#93;</a></sup> are mildly obese,<sup id="cite_ref-50" class="reference"><a href="#cite_note-50">&#91;47&#93;</a></sup> have symptoms restricted primarily to one limb, and those with primarily upper motor neuron symptoms.<sup id="cite_ref-JNNP_July_2011_32-2" class="reference"><a href="#cite_note-JNNP_July_2011-32">&#91;32&#93;</a></sup> Conversely, progression is faster and prognosis poorer in people with bulbar-onset ALS, respiratory-onset ALS and frontotemporal dementia.<sup id="cite_ref-JNNP_July_2011_32-3" class="reference"><a href="#cite_note-JNNP_July_2011-32">&#91;32&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Late_stages">Late stages</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=8" title="Edit section: Late stages">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Difficulties with chewing and swallowing make eating very difficult and increase the risk of choking or of aspirating food into the lungs. In later stages of the disorder, <a href="/wiki/Aspiration_pneumonia" title="Aspiration pneumonia">aspiration pneumonia</a> can develop, and maintaining a healthy weight can become a significant problem that may require the insertion of a feeding tube. As the diaphragm and <a href="/wiki/Intercostal_muscle" title="Intercostal muscle">intercostal muscles</a> of the <a href="/wiki/Rib_cage" title="Rib cage">rib cage</a> that support breathing weaken, measures of <a href="/wiki/Spirometry" title="Spirometry">lung function</a> such as <a href="/wiki/Vital_capacity" title="Vital capacity">vital capacity</a> and inspiratory pressure diminish. In respiratory-onset ALS, this may occur before significant limb weakness is apparent. The most common cause of death among people with ALS are <a href="/wiki/Respiratory_failure" title="Respiratory failure">respiratory failure</a> or <a href="/wiki/Pneumonia" title="Pneumonia">pneumonia</a><sup id="cite_ref-Lancet2011_3-7" class="reference"><a href="#cite_note-Lancet2011-3">&#91;3&#93;</a></sup> and most people with ALS die in their own home from the former cause, with their breath stopping while they sleep.<sup id="cite_ref-NHS_8-4" class="reference"><a href="#cite_note-NHS-8">&#91;8&#93;</a></sup>
</p><p>Although respiratory support can ease problems with breathing and prolong survival, it does not affect the progression of ALS. Most people with ALS die between two and four years after the diagnosis.<sup id="cite_ref-Support2016_4-8" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> Around half of people with ALS die within 30 months of their symptoms beginning, and about 20% of people with ALS live between five and ten years after symptoms begin.<sup id="cite_ref-Lancet2011_3-8" class="reference"><a href="#cite_note-Lancet2011-3">&#91;3&#93;</a></sup> Guitarist <a href="/wiki/Jason_Becker" title="Jason Becker">Jason Becker</a> has lived since 1989 with the disorder, while <a href="/wiki/Astrophysics" title="Astrophysics">cosmologist</a> <a href="/wiki/Stephen_Hawking" title="Stephen Hawking">Stephen Hawking</a> lived for 55 more years following his diagnosis, but they are considered unusual cases.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51">&#91;48&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Cause">Cause</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=9" title="Edit section: Cause">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Though the exact cause of ALS is unknown, genetic and environmental factors are thought to be of roughly equal importance.<sup id="cite_ref-Wingo2011_17-1" class="reference"><a href="#cite_note-Wingo2011-17">&#91;17&#93;</a></sup> The genetic factors are better understood than the environmental factors; no specific environmental factor has been definitively shown to cause ALS. A <a href="/wiki/Liability_threshold_model" class="mw-redirect" title="Liability threshold model">liability threshold model</a> for ALS proposes that cellular damage accumulates over time due to genetic factors present at birth and exposure to environmental risks throughout life.<sup id="cite_ref-Conspiracy_21-1" class="reference"><a href="#cite_note-Conspiracy-21">&#91;21&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Genetics">Genetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=10" title="Edit section: Genetics">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Genetics_of_amyotrophic_lateral_sclerosis" title="Genetics of amyotrophic lateral sclerosis">Genetics of amyotrophic lateral sclerosis</a></div>
<p>ALS can be classified as familial or sporadic, depending on whether or not there is a family history of the disease.<sup id="cite_ref-Nature2014_20-7" class="reference"><a href="#cite_note-Nature2014-20">&#91;20&#93;</a></sup><sup id="cite_ref-fALS_52-0" class="reference"><a href="#cite_note-fALS-52">&#91;49&#93;</a></sup> There is no consensus among neurologists on the exact definition of familial ALS. The strictest definition is that a person with ALS must have two or more <a href="/wiki/First-degree_relatives" class="mw-redirect" title="First-degree relatives">first-degree relatives</a> (children, siblings, or parents) who also have ALS. A less strict definition is that a person with ALS must have at least one first-degree or <a href="/wiki/Second-degree_relative" title="Second-degree relative">second-degree relative</a> (grandparents, grandchildren, aunts, uncles, nephews, nieces or half-siblings) who also has ALS.<sup id="cite_ref-Neurology_2017_53-0" class="reference"><a href="#cite_note-Neurology_2017-53">&#91;50&#93;</a></sup> Familial ALS is usually said to account for 10% of all cases of ALS, though estimates range from 5%<sup id="cite_ref-54" class="reference"><a href="#cite_note-54">&#91;51&#93;</a></sup> to 20%.<sup id="cite_ref-The_Neuroscientist_2015_55-0" class="reference"><a href="#cite_note-The_Neuroscientist_2015-55">&#91;52&#93;</a></sup> Higher estimates use a broader definition of familial ALS and examine the family history of people with ALS more thoroughly.<sup id="cite_ref-Neurology_2017_53-1" class="reference"><a href="#cite_note-Neurology_2017-53">&#91;50&#93;</a></sup>
</p><p>In sporadic ALS, there is no family history of the disease.<sup id="cite_ref-NEJM_2017_42-1" class="reference"><a href="#cite_note-NEJM_2017-42">&#91;39&#93;</a></sup> Sporadic ALS and familial ALS appear identical clinically and pathologically and are similar genetically;<sup id="cite_ref-The_Neuroscientist_2015_55-1" class="reference"><a href="#cite_note-The_Neuroscientist_2015-55">&#91;52&#93;</a></sup> about 10% of people with sporadic ALS have mutations in genes that are known to cause familial ALS.<sup id="cite_ref-Lancet2017_13-7" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> In light of these parallels, the term "sporadic ALS" has been criticized as misleading because it implies that cases of sporadic ALS are only caused by environmental factors; the term "isolated ALS" has been suggested as a more accurate alternative.<sup id="cite_ref-The_Neuroscientist_2015_55-2" class="reference"><a href="#cite_note-The_Neuroscientist_2015-55">&#91;52&#93;</a></sup>
</p><p>More than 20 genes have been associated with familial ALS, of which four account for the majority of familial cases:<sup id="cite_ref-Revue_Neurologique_56-0" class="reference"><a href="#cite_note-Revue_Neurologique-56">&#91;53&#93;</a></sup> <i><a href="/wiki/C9orf72" title="C9orf72">C9orf72</a></i> (40%), <i><a href="/wiki/SOD1" title="SOD1">SOD1</a></i> (20%), <i><a href="/wiki/FUS_(gene)" class="mw-redirect" title="FUS (gene)">FUS</a></i> (1–5%), and <i><a href="/wiki/TARDBP" class="mw-redirect" title="TARDBP">TARDBP</a></i> (1–5%).<sup id="cite_ref-Lancet2017_13-8" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> The genetics of familial ALS are better understood than the genetics of sporadic ALS;<sup id="cite_ref-Lancet2017_13-9" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> as of 2016<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit">&#91;update&#93;</a></sup>, the known ALS genes explained about 70% of familial ALS and about 15% of sporadic ALS.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57">&#91;54&#93;</a></sup><sup id="cite_ref-58" class="reference"><a href="#cite_note-58">&#91;55&#93;</a></sup> Overall, first-degree relatives of an individual with ALS have a 1% risk of developing ALS.<sup id="cite_ref-Wingo2011_17-2" class="reference"><a href="#cite_note-Wingo2011-17">&#91;17&#93;</a></sup><sup id="cite_ref-59" class="reference"><a href="#cite_note-59">&#91;56&#93;</a></sup> ALS has an <a href="/wiki/Oligogenic_inheritance" title="Oligogenic inheritance">oligogenic mode of inheritance</a>, meaning that mutations in two or more genes are required to cause disease.<sup id="cite_ref-Neuroscience2014_26-1" class="reference"><a href="#cite_note-Neuroscience2014-26">&#91;26&#93;</a></sup>
</p><p>ALS and <a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">frontotemporal dementia</a> (FTD) are now considered to be part of a common disease spectrum (FTD–ALS) because of genetic, clinical, and pathological similarities.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60">&#91;57&#93;</a></sup> Genetically, <i>C9orf72</i> repeat expansions account for about 40% of familial ALS and 25% of familial FTD.<sup id="cite_ref-Neuroscience2014_26-2" class="reference"><a href="#cite_note-Neuroscience2014-26">&#91;26&#93;</a></sup> Clinically, 50% of people with ALS have some cognitive or behavioral impairments and 5–15% have FTD, while 40% of people with FTD have some motor neuron symptoms and 12.5% have ALS.<sup id="cite_ref-Lancet2017_13-10" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> Pathologically, abnormal aggregations of TDP-43 protein are seen in up to 97% of ALS patients and up to 50% of FTD patients.<sup id="cite_ref-Trends_in_Genetics_2018_61-0" class="reference"><a href="#cite_note-Trends_in_Genetics_2018-61">&#91;58&#93;</a></sup> Other genes known to cause FTD-ALS include <i><a href="/wiki/CHCHD10" title="CHCHD10">CHCHD10</a></i>, <i><a href="/wiki/SQSTM1" class="mw-redirect" title="SQSTM1">SQSTM1</a></i>, and <i><a href="/wiki/TANK-binding_kinase_1" title="TANK-binding kinase 1">TBK1</a></i>.<sup id="cite_ref-Revue_Neurologique_56-1" class="reference"><a href="#cite_note-Revue_Neurologique-56">&#91;53&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Environmental_factors">Environmental factors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=11" title="Edit section: Environmental factors">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Where no family history of the disease is present&#160;— around 90% of cases&#160;— no cause is known. Possible associations for which evidence is inconclusive include military service and smoking.<sup id="cite_ref-Martin2017_43-1" class="reference"><a href="#cite_note-Martin2017-43">&#91;40&#93;</a></sup> Although studies on military history and ALS frequency are inconsistent, there is weak evidence for a <a href="/wiki/Correlation_and_dependence" title="Correlation and dependence">positive correlation</a>.<sup id="cite_ref-beard_62-0" class="reference"><a href="#cite_note-beard-62">&#91;59&#93;</a></sup> Various proposed factors include exposure to <a href="/wiki/Toxin" title="Toxin">environmental toxins</a> (inferred from geographical deployment studies), as well as alcohol and tobacco use during military service.<sup id="cite_ref-beard_62-1" class="reference"><a href="#cite_note-beard-62">&#91;59&#93;</a></sup>
</p><p>A 2016 review of 16 meta-analyses concluded that there was convincing evidence for an association with chronic occupational exposure to <a href="/wiki/Lead" title="Lead">lead</a>; suggestive evidence for farming, exposure to heavy metals other than lead, beta-carotene intake, and head injury; and weak evidence for omega-three fatty acid intake, exposure to extremely low frequency electromagnetic fields, pesticides, and serum uric acid.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63">&#91;60&#93;</a></sup>
</p><p>In a 2017 study by the United States <a href="/wiki/Centers_for_Disease_Control_and_Prevention" title="Centers for Disease Control and Prevention">Centers for Disease Control and Prevention</a> analyzing U.S. deaths from 1985 to 2011, occupations correlated with ALS deaths were <a href="/wiki/White-collar_worker" title="White-collar worker">white collar</a>, such as in management, financial, architectural, computing, legal, and education jobs.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64">&#91;61&#93;</a></sup> Other potential risk factors remain unconfirmed, including chemical exposure, electromagnetic field exposure, occupation, physical trauma, and electric shock.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65">&#91;62&#93;</a></sup><sup id="cite_ref-Ingre_2015_66-0" class="reference"><a href="#cite_note-Ingre_2015-66">&#91;63&#93;</a></sup> There is a tentative association with exposure to various <a href="/wiki/Pesticide" title="Pesticide">pesticides</a>, including the <a href="/wiki/Insecticide#Organochlorine_compounds" title="Insecticide">organochlorine insecticides</a> <a href="/wiki/Aldrin" title="Aldrin">aldrin</a>, <a href="/wiki/Dieldrin" title="Dieldrin">dieldrin</a>, <a href="/wiki/DDT" title="DDT">DDT</a>, and <a href="/wiki/Toxaphene" title="Toxaphene">toxaphene</a>.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67">&#91;64&#93;</a></sup><sup id="cite_ref-68" class="reference"><a href="#cite_note-68">&#91;65&#93;</a></sup><sup id="cite_ref-69" class="reference"><a href="#cite_note-69">&#91;66&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Head_injury">Head injury</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=12" title="Edit section: Head injury">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>A 2015 review found that moderate to severe <a href="/wiki/Traumatic_brain_injury" title="Traumatic brain injury">traumatic brain injury</a> is a risk factor for ALS, but whether mild traumatic brain injury increases rates was unclear.<sup id="cite_ref-Gard2015_70-0" class="reference"><a href="#cite_note-Gard2015-70">&#91;67&#93;</a></sup> A 2017 meta-analysis found an association between head injuries and ALS; however, this association disappeared when the authors considered the possibility of reverse causation, which is the idea that head injuries are an early symptom of undiagnosed ALS, rather than the cause of ALS.<sup id="cite_ref-71" class="reference"><a href="#cite_note-71">&#91;68&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Physical_activity">Physical activity</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=13" title="Edit section: Physical activity">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>A number of reviews have found no relationship between the amount of physical activity and the risk of developing ALS.<sup id="cite_ref-72" class="reference"><a href="#cite_note-72">&#91;69&#93;</a></sup><sup id="cite_ref-73" class="reference"><a href="#cite_note-73">&#91;70&#93;</a></sup><sup id="cite_ref-Armon_2007_74-0" class="reference"><a href="#cite_note-Armon_2007-74">&#91;71&#93;</a></sup> A 2009 review found that the evidence for physical activity as a risk factor for ALS was limited, conflicting, and of insufficient quality to come to a firm conclusion.<sup id="cite_ref-Physical_Activity_as_a_Risk_Factor_75-0" class="reference"><a href="#cite_note-Physical_Activity_as_a_Risk_Factor-75">&#91;72&#93;</a></sup> A 2014 review concluded that physical activity in general is not a risk factor for ALS, that soccer and American football are possibly associated with ALS, and that there was not enough evidence to say whether or not physically demanding occupations are associated with ALS.<sup id="cite_ref-76" class="reference"><a href="#cite_note-76">&#91;73&#93;</a></sup> A 2016 review found the evidence inconclusive and noted that differences in study design make it difficult to compare studies, as they do not use the same measures of physical activity or the same diagnostic criteria for ALS.<sup id="cite_ref-77" class="reference"><a href="#cite_note-77">&#91;74&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Sports">Sports</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=14" title="Edit section: Sports">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Both soccer and American football have been identified as risk factors for ALS in several studies, although this association is based on small numbers of ALS cases.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78">&#91;75&#93;</a></sup> A 2012 retrospective cohort study of 3,439 former <a href="/wiki/NFL" class="mw-redirect" title="NFL">NFL</a> players found that their risk of dying from neurodegenerative causes was three times higher than the general US population, and their risk of dying from ALS or Alzheimer's disease was four times higher.<sup id="cite_ref-79" class="reference"><a href="#cite_note-79">&#91;76&#93;</a></sup> However, this increased risk was calculated on the basis of two deaths from Alzheimer's disease and six deaths from ALS out of 334 deaths total in this cohort, meaning that this study does not definitively prove that playing American football is a risk factor for ALS.<sup id="cite_ref-80" class="reference"><a href="#cite_note-80">&#91;77&#93;</a></sup> Some NFL players thought to have died from ALS may have actually had <a href="/wiki/Chronic_traumatic_encephalopathy" title="Chronic traumatic encephalopathy">chronic traumatic encephalopathy</a> (CTE), a neurodegenerative disorder associated with multiple head injuries that can present with symptoms that are very similar to ALS.<sup id="cite_ref-Gard2015_70-1" class="reference"><a href="#cite_note-Gard2015-70">&#91;67&#93;</a></sup><sup id="cite_ref-83" class="reference"><a href="#cite_note-83">&#91;d&#93;</a></sup>
</p><p>Soccer was identified as a possible risk factor for ALS in a retrospective cohort study of 24,000 Italian soccer players who played between 1960 and 1996. There were 375 deaths in this group, including eight from ALS. Based on this information and the incidence of ALS, it was calculated that the soccer players were 11 times more likely to die from ALS than the general Italian population.<sup id="cite_ref-Conspiracy_21-2" class="reference"><a href="#cite_note-Conspiracy-21">&#91;21&#93;</a></sup> However, this calculation has been criticized for relying on an inappropriately low number of expected cases of ALS in the cohort.<sup id="cite_ref-Physical_Activity_as_a_Risk_Factor_75-1" class="reference"><a href="#cite_note-Physical_Activity_as_a_Risk_Factor-75">&#91;72&#93;</a></sup> When the lifetime risk of developing ALS was used to predict the number of expected cases, soccer players were no more likely to die of ALS than the general population.<sup id="cite_ref-Conspiracy_21-3" class="reference"><a href="#cite_note-Conspiracy-21">&#91;21&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Smoking">Smoking</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=15" title="Edit section: Smoking">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Smoking is possibly associated with ALS. A 2009 review concluded that smoking was an established risk factor for ALS.<sup id="cite_ref-84" class="reference"><a href="#cite_note-84">&#91;80&#93;</a></sup> A 2010 systematic review and meta-analysis concluded that there was not a strong association between smoking and ALS, but that smoking might be associated with a higher risk of ALS in women.<sup id="cite_ref-85" class="reference"><a href="#cite_note-85">&#91;81&#93;</a></sup> A 2011 meta-analysis concluded that smoking increases the risk of ALS versus never smoking. Among smokers, the younger they started smoking, the more likely they were to get ALS; however, neither the number of years smoked nor the number of cigarettes smoked per day affected their risk of developing ALS.<sup id="cite_ref-86" class="reference"><a href="#cite_note-86">&#91;82&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=16" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Neuropathology">Neuropathology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=17" title="Edit section: Neuropathology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The defining feature of ALS is the death of both upper motor neurons (located in the <a href="/wiki/Motor_cortex" title="Motor cortex">motor cortex</a> of the brain) and lower motor neurons (located in the brainstem and spinal cord).<sup id="cite_ref-87" class="reference"><a href="#cite_note-87">&#91;83&#93;</a></sup> In ALS with frontotemporal dementia, neurons throughout the frontal and temporal lobes of the brain die as well.<sup id="cite_ref-NEJM_2017_42-2" class="reference"><a href="#cite_note-NEJM_2017-42">&#91;39&#93;</a></sup> The pathological hallmark of ALS is the presence of <a href="/wiki/Inclusion_bodies" title="Inclusion bodies">inclusion bodies</a> (abnormal aggregations of protein) known as <i>Bunina bodies</i> in the cytoplasm of motor neurons. In about 97% of people with ALS, the main component of the inclusion bodies is <a href="/wiki/TDP-43" class="mw-redirect" title="TDP-43">TDP-43</a> protein;<sup id="cite_ref-Nature2017_12-2" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> however, in those with <i>SOD1</i> or <i>FUS</i> mutations, the main component of the inclusion bodies<sup id="cite_ref-Okamoto_88-0" class="reference"><a href="#cite_note-Okamoto-88">&#91;84&#93;</a></sup><sup id="cite_ref-White_89-0" class="reference"><a href="#cite_note-White-89">&#91;85&#93;</a></sup> is SOD1 protein or FUS protein, respectively.<sup id="cite_ref-Cold_Spring_Harbor_2017_31-4" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-31">&#91;31&#93;</a></sup> The <a href="/wiki/Gross_pathology" title="Gross pathology">gross pathology</a> of ALS, which are features of the disease that can be seen with the naked eye, include skeletal muscle atrophy, motor cortex atrophy, sclerosis of the <a href="/wiki/Corticospinal_tract" title="Corticospinal tract">corticospinal</a> and <a href="/wiki/Corticobulbar_tract" title="Corticobulbar tract">corticobulbar tracts</a>, thinning of the <a href="/wiki/Hypoglossal_nerve" title="Hypoglossal nerve">hypoglossal nerves</a> (which control the tongue), and thinning of the anterior roots of the spinal cord.<sup id="cite_ref-Nature2017_12-3" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> Aside from the death of motor neurons, two other characteristics common to most ALS variants are focal initial pathology, meaning that symptoms start in a single spinal cord region, and progressive continuous spread, meaning that symptoms spread to additional regions over time. <a href="/wiki/Prion" title="Prion">Prion</a>-like propagation of misfolded proteins from cell to cell may explain why ALS starts in one area and spreads to others.<sup id="cite_ref-Cold_Spring_Harbor_2017_31-5" class="reference"><a href="#cite_note-Cold_Spring_Harbor_2017-31">&#91;31&#93;</a></sup> The <a href="/wiki/Glymphatic_system" title="Glymphatic system">glymphatic system</a> may also be involved in the <a href="/wiki/Pathogenesis" title="Pathogenesis">pathogenesis</a> of ALS.<sup id="cite_ref-90" class="reference"><a href="#cite_note-90">&#91;86&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Biochemistry">Biochemistry</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=18" title="Edit section: Biochemistry">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/76/ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg/290px-ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg" decoding="async" width="290" height="353" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/76/ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg/435px-ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/76/ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg/580px-ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg 2x" data-file-width="1052" data-file-height="1280" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:ALS_Disease_Pathology_and_Proposed_Disease_Mechanisms.jpg" class="internal" title="Enlarge"></a></div>This figure shows ten proposed disease mechanisms for ALS and the genes associated with them.<sup id="cite_ref-Modelling_ALS_91-0" class="reference"><a href="#cite_note-Modelling_ALS-91">&#91;87&#93;</a></sup></div></div></div>
<p>It is still not fully understood why neurons die in ALS, but this <a href="/wiki/Neurodegeneration" title="Neurodegeneration">neurodegeneration</a> is thought to involve many different cellular and molecular processes.<sup id="cite_ref-Lancet2017_13-11" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> The genes known to be involved in ALS can be grouped into three general categories based on their normal function: protein degradation, the <a href="/wiki/Cytoskeleton" title="Cytoskeleton">cytoskeleton</a>, and RNA processing. Mutant SOD1 protein forms intracellular aggregations that inhibit protein degradation. Cytoplasmic aggregations of <a href="/wiki/Wild-type" class="mw-redirect" title="Wild-type">wild-type</a> (normal) SOD1 protein are common in sporadic ALS.<sup id="cite_ref-NEJM_2017_42-3" class="reference"><a href="#cite_note-NEJM_2017-42">&#91;39&#93;</a></sup> It is thought that misfolded mutant SOD1 can cause misfolding and aggregation of wild-type SOD1 in neighboring neurons in a prion-like manner.<sup id="cite_ref-Nature2017_12-4" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> Other protein degradation genes that can cause ALS when mutated include <i><a href="/wiki/Valosin-containing_protein" title="Valosin-containing protein">VCP</a></i>, <i><a href="/wiki/Optineurin" title="Optineurin">OPTN</a></i>, <i>TBK1</i>, and <i>SQSTM1</i>. Three genes implicated in ALS that are important for maintaining the cytoskeleton<sup id="cite_ref-NEJM_2017_42-4" class="reference"><a href="#cite_note-NEJM_2017-42">&#91;39&#93;</a></sup> and for axonal transport<sup id="cite_ref-Nature2017_12-5" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> include <i><a href="/wiki/DCTN1" title="DCTN1">DCTN1</a></i>, <i><a href="/wiki/PFN1" class="mw-redirect" title="PFN1">PFN1</a></i>, and <i><a href="/wiki/TUBA4A" title="TUBA4A">TUBA4A</a></i>.<sup id="cite_ref-NEJM_2017_42-5" class="reference"><a href="#cite_note-NEJM_2017-42">&#91;39&#93;</a></sup>
</p><p>There are a number of ALS genes that encode for RNA-binding proteins. The first to be discovered was TDP-43 protein,<sup id="cite_ref-NEJM_2017_42-6" class="reference"><a href="#cite_note-NEJM_2017-42">&#91;39&#93;</a></sup> a nuclear protein that aggregates in the cytoplasm of motor neurons in almost all cases of ALS; however, mutations in <i>TARDBP</i>, the gene that codes for TDP-43, are a rare cause of ALS.<sup id="cite_ref-Nature2017_12-6" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> <i>FUS</i> codes for FUS, another RNA-binding protein with a similar function to TDP-43, which can cause ALS when mutated.<sup id="cite_ref-Neuroscience2014_26-3" class="reference"><a href="#cite_note-Neuroscience2014-26">&#91;26&#93;</a></sup> It is thought that mutations in <i>TARDBP</i> and <i>FUS</i> increase the binding affinity of the low-complexity domain, causing their respective proteins to aggregate in the cytoplasm. Once these mutant RNA-binding proteins are misfolded and aggregated, they may be able to misfold normal protein both within and between cells in a prion-like manner.<sup id="cite_ref-NEJM_2017_42-7" class="reference"><a href="#cite_note-NEJM_2017-42">&#91;39&#93;</a></sup> This also leads to decreased levels of RNA-binding protein in the nucleus, which may mean that their target RNA transcripts do not undergo the normal processing. Other RNA metabolism genes associated with ALS include <i><a href="/wiki/Angiogenin" title="Angiogenin">ANG</a></i>, <i><a href="/wiki/SETX" title="SETX">SETX</a></i>, and <i><a href="/wiki/MATR3" title="MATR3">MATR3</a></i>.<sup id="cite_ref-Nature2017_12-7" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup>
</p><p><i>C9orf72</i> is the most commonly mutated gene in ALS and causes motor neuron death through a number of mechanisms.<sup id="cite_ref-NEJM_2017_42-8" class="reference"><a href="#cite_note-NEJM_2017-42">&#91;39&#93;</a></sup> The pathogenic mutation is a hexanucleotide repeat expansion (a series of six nucleotides repeated over and over);<sup id="cite_ref-Trends_in_Genetics_2018_61-1" class="reference"><a href="#cite_note-Trends_in_Genetics_2018-61">&#91;58&#93;</a></sup> people with 30 repeats are normal, while people with hundreds or thousands of repeats can have familial ALS, frontotemporal dementia, or sometimes sporadic ALS. The three mechanisms of disease associated with these <i>C9orf72</i> repeats are deposition of RNA transcripts in the nucleus, translation of the RNA into toxic dipeptide repeat proteins in the cytoplasm, and decreased levels of the normal C9orf72 protein.<sup id="cite_ref-NEJM_2017_42-9" class="reference"><a href="#cite_note-NEJM_2017-42">&#91;39&#93;</a></sup>  Mitochondrial bioenergetic dysfunction leading to dysfunctional motor neuron axonal homeostasis (reduced axonal length and fast axonal transport of mitochondrial cargo) has been shown to occur in <i>C9orf72</i>-ALS using human <a href="/wiki/Induced_pluripotent_stem_cells" class="mw-redirect" title="Induced pluripotent stem cells">induced pluripotent stem cell</a> (iPSC) technologies coupled with <a href="/wiki/CRISPR/Cas9-mediated_genome_editing" class="mw-redirect" title="CRISPR/Cas9-mediated genome editing">CRSIPR/Cas9</a> gene-editing, and human post-mortem spinal cord tissue examination.<sup id="cite_ref-link.springer.com_92-0" class="reference"><a href="#cite_note-link.springer.com-92">&#91;88&#93;</a></sup>
</p><p><a href="/wiki/Excitotoxicity" title="Excitotoxicity">Excitotoxicity</a>, or nerve cell death caused by high levels of intracellular calcium due to excessive stimulation by the excitatory neurotransmitter <a href="/wiki/Glutamate" class="mw-redirect" title="Glutamate">glutamate</a>, is a mechanism thought to be common to all forms of ALS. Motor neurons are more sensitive to excitotoxicity than other types of neurons because they have a lower calcium-buffering capacity and a type of glutamate receptor (the <a href="/wiki/AMPA_receptor" title="AMPA receptor">AMPA receptor</a>) that is more permeable to calcium. In ALS, there are decreased levels of excitatory amino acid transporter 2 (<a href="/wiki/EAAT2" class="mw-redirect" title="EAAT2">EAAT2</a>), which is the main transporter that removes glutamate from the synapse; this leads to increased synaptic glutamate levels and excitotoxicity. Riluzole, a drug that modestly prolongs survival in ALS, inhibits glutamate release from pre-synaptic neurons; however, it is unclear if this mechanism is responsible for its therapeutic effect.<sup id="cite_ref-Nature2017_12-8" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=19" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:ALS_cross.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/6d/ALS_cross.jpg/290px-ALS_cross.jpg" decoding="async" width="290" height="382" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/6d/ALS_cross.jpg/435px-ALS_cross.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6d/ALS_cross.jpg/580px-ALS_cross.jpg 2x" data-file-width="713" data-file-height="938" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:ALS_cross.jpg" class="internal" title="Enlarge"></a></div>MRI (axial <a href="/wiki/Fluid-attenuated_inversion_recovery" title="Fluid-attenuated inversion recovery">FLAIR</a>) demonstrates increased <a href="/wiki/Spin-spin_relaxation" class="mw-redirect" title="Spin-spin relaxation"><i>T<sub>2</sub></i></a> signal within the <a href="/wiki/Internal_capsule#Posterior_limb" title="Internal capsule">posterior part of the internal capsule</a>, consistent with the diagnosis of ALS.</div></div></div>
<p>No test can provide a definite diagnosis of ALS, although the presence of upper and lower motor neuron signs in a single limb is strongly suggestive.<sup id="cite_ref-NINDS2020_2-18" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup> Instead, the diagnosis of ALS is primarily based on the symptoms and signs the <a href="/wiki/Physician" title="Physician">physician</a> observes in the person and a series of tests to rule out other diseases.<sup id="cite_ref-NINDS2020_2-19" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup> Physicians obtain the person's full <a href="/wiki/Medical_history" title="Medical history">medical history</a> and usually conduct a neurologic examination at regular intervals to assess whether symptoms such as muscle weakness, atrophy of muscles, <a href="/wiki/Hyperreflexia" title="Hyperreflexia">hyperreflexia</a>, and spasticity are worsening.<sup id="cite_ref-NINDS2020_2-20" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup> A number of biomarkers are being studied for the condition, but so far are not in general medical use.<sup id="cite_ref-93" class="reference"><a href="#cite_note-93">&#91;89&#93;</a></sup><sup id="cite_ref-94" class="reference"><a href="#cite_note-94">&#91;90&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Diagnostic_criteria">Diagnostic criteria</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=20" title="Edit section: Diagnostic criteria">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The diagnosis of ALS is based on the El Escorial Revised criteria and the Awaji criteria.<sup id="cite_ref-Nature2017_12-9" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> The original El Escorial criteria had four levels of diagnostic certainty, based on how many of the four spinal cord regions were involved: bulbar, cervical, thoracic, and lumbar. Definite ALS was defined as upper motor neuron (UMN) and lower motor neuron (LMN) signs in three spinal cord regions, probable ALS as UMN and LMN signs in two regions, possible ALS as UMN and LMN signs in only one region, and suspected ALS as LMN signs only. The El Escorial Revised criteria, also known as the Airlie House criteria, dropped the "suspected ALS" category and added a "laboratory-supported probable ALS" category. The Awaji criteria give abnormal EMG tests the same weight as clinical signs of LMN dysfunction in making the diagnosis of ALS,<sup id="cite_ref-Classification2016_34-3" class="reference"><a href="#cite_note-Classification2016-34">&#91;34&#93;</a></sup> thus making the "laboratory-supported probable ALS" category unnecessary. The only three categories in the Awaji criteria are definite ALS, probable ALS, and possible ALS.<sup id="cite_ref-Awaji_Criteria_2008_95-0" class="reference"><a href="#cite_note-Awaji_Criteria_2008-95">&#91;91&#93;</a></sup>
</p><p>The El Escorial Revised criteria are specific for ALS, which means that someone who meets the criteria is very likely to have ALS; however, they are not especially sensitive for ALS, which means that someone who does not meet the criteria can still have ALS. Their sensitivity is particularly poor in the early stages of ALS. The Awaji criteria have better sensitivity than the El Escorial Revised criteria, especially for bulbar-onset ALS.<sup id="cite_ref-Classification2016_34-4" class="reference"><a href="#cite_note-Classification2016-34">&#91;34&#93;</a></sup> A 2012 meta-analysis found that the El Escorial Revised criteria had a sensitivity of 62.2%, while the Awaji criteria had a sensitivity of 81.1%; both sets of criteria had a specificity of about 98%.<sup id="cite_ref-96" class="reference"><a href="#cite_note-96">&#91;92&#93;</a></sup> The El Escorial criteria were designed to standardize patient groups for clinical trials<sup id="cite_ref-97" class="reference"><a href="#cite_note-97">&#91;93&#93;</a></sup> but are not as useful in clinical practice; possible ALS as described by the El Escorial criteria is almost always clinically ALS.<sup id="cite_ref-Nature2017_12-10" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Differential_diagnosis">Differential diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=21" title="Edit section: Differential diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Because symptoms of ALS can be similar to those of a wide variety of other, more treatable diseases or disorders, appropriate tests must be conducted to exclude the possibility of other conditions. One of these tests is <a href="/wiki/Electromyography" title="Electromyography">electromyography</a> (EMG), a special recording technique that detects electrical activity in muscles. Certain EMG findings can support the diagnosis of ALS. Another common test measures <a href="/wiki/Nerve_conduction_velocity" title="Nerve conduction velocity">nerve conduction velocity</a> (NCV).Specific abnormalities in the NCV results may suggest, for example, that the person has a form of <a href="/wiki/Peripheral_neuropathy" title="Peripheral neuropathy">peripheral neuropathy</a> (damage to peripheral nerves) or <a href="/wiki/Myopathy" title="Myopathy">myopathy</a> (muscle disease) rather than ALS. While a <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">magnetic resonance imaging</a> (MRI) is often normal in people with early stage ALS, it can reveal evidence of other problems that may be causing the symptoms, such as a spinal cord tumor, <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a>, a <a href="/wiki/Herniated_disc" class="mw-redirect" title="Herniated disc">herniated disc</a> in the neck, <a href="/wiki/Syringomyelia" title="Syringomyelia">syringomyelia</a>, or cervical <a href="/wiki/Spondylosis" title="Spondylosis">spondylosis</a>.<sup id="cite_ref-NINDS2020_2-21" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup>
</p><p>Based on the person's symptoms and findings from the examination and from these tests, the physician may order tests on blood and <a href="/wiki/Urine" title="Urine">urine</a> samples to eliminate the possibility of other diseases, as well as routine laboratory tests. In some cases, for example, if a physician suspects the person may have a myopathy rather than ALS, a muscle biopsy may be performed.<sup id="cite_ref-NINDS2020_2-22" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup>
</p><p>A number of infectious diseases can sometimes cause ALS-like symptoms,<sup id="cite_ref-NINDS2020_2-23" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup> including human immunodeficiency virus (<a href="/wiki/HIV" title="HIV">HIV</a>), <a href="/wiki/Human_T-lymphotropic_virus" title="Human T-lymphotropic virus">human T-lymphotropic virus</a> (HTLV), <a href="/wiki/Lyme_disease" title="Lyme disease">Lyme disease</a>, and <a href="/wiki/Syphilis" title="Syphilis">syphilis</a>.<sup id="cite_ref-Lancet2017_13-12" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> Neurological disorders such as multiple sclerosis, <a href="/wiki/Post-polio_syndrome" title="Post-polio syndrome">post-polio syndrome</a>, <a href="/wiki/Multifocal_motor_neuropathy" title="Multifocal motor neuropathy">multifocal motor neuropathy</a>, <a href="/wiki/Chronic_inflammatory_demyelinating_polyneuropathy" title="Chronic inflammatory demyelinating polyneuropathy">CIDP</a>, <a href="/wiki/Spinal_muscular_atrophy" title="Spinal muscular atrophy">spinal muscular atrophy</a>, and <a href="/wiki/Spinal_and_bulbar_muscular_atrophy" title="Spinal and bulbar muscular atrophy">spinal and bulbar muscular atrophy</a> can also mimic certain aspects of the disease and should be considered.<sup id="cite_ref-NINDS2020_2-24" class="reference"><a href="#cite_note-NINDS2020-2">&#91;2&#93;</a></sup>
</p><p>ALS must be differentiated from the "ALS mimic syndromes", which are unrelated disorders that may have a similar presentation and clinical features to ALS or its variants.<sup id="cite_ref-98" class="reference"><a href="#cite_note-98">&#91;94&#93;</a></sup> Because of the prognosis carried by this diagnosis and the variety of diseases or disorders that can resemble ALS in the early stages of the disease, people with ALS symptoms should always obtain a specialist neurological opinion in order to rule out alternative diagnoses. <a href="/wiki/Lambert%E2%80%93Eaton_myasthenic_syndrome" title="Lambert–Eaton myasthenic syndrome">Myasthenic syndrome</a>, also known as Lambert–Eaton syndrome, can mimic ALS, and its initial presentation can be similar to that of <a href="/wiki/Myasthenia_gravis" title="Myasthenia gravis">myasthenia gravis</a> (MG), a treatable autoimmune disease sometimes mistaken for ALS.<sup id="cite_ref-99" class="reference"><a href="#cite_note-99">&#91;95&#93;</a></sup><sup id="cite_ref-100" class="reference"><a href="#cite_note-100">&#91;96&#93;</a></sup> <a href="/wiki/Benign_fasciculation_syndrome" title="Benign fasciculation syndrome">Benign fasciculation syndrome</a> and <a href="/wiki/Cramp_fasciculation_syndrome" title="Cramp fasciculation syndrome">Cramp fasciculation syndrome</a> are other conditions that mimic some of the early symptoms of ALS, but are accompanied by normal EMG readings and no major disablement.<sup id="cite_ref-101" class="reference"><a href="#cite_note-101">&#91;97&#93;</a></sup>
</p><p>Most cases of ALS, however, are correctly diagnosed, with the error rate of diagnosis in large ALS clinics being less than 10%.<sup id="cite_ref-102" class="reference"><a href="#cite_note-102">&#91;98&#93;</a></sup><sup id="cite_ref-pmid8708642_103-0" class="reference"><a href="#cite_note-pmid8708642-103">&#91;99&#93;</a></sup> One study examined 190 people who met the MND/ALS diagnostic criteria, complemented with laboratory research in compliance with both research protocols and regular monitoring. Thirty of these people (16%) had their diagnosis completely changed during the clinical observation development period.<sup id="cite_ref-104" class="reference"><a href="#cite_note-104">&#91;100&#93;</a></sup> In the same study, three people had a false negative diagnosis of MG, which can mimic ALS and other neurological disorders, leading to a delay in diagnosis and treatment. MG is eminently treatable; ALS is not.<sup id="cite_ref-105" class="reference"><a href="#cite_note-105">&#91;101&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=22" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There is no cure for ALS. Management focuses on treating symptoms and providing supportive care, with the goal of improving quality of life and prolonging survival.<sup id="cite_ref-Lancet2017_13-13" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> This care is best provided by multidisciplinary teams of healthcare professionals; attending a multidisciplinary ALS clinic is associated with longer survival, fewer hospitalizations, and improved quality of life.<sup id="cite_ref-Support2016_4-9" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> <a href="/wiki/Riluzole" title="Riluzole">Riluzole</a> prolongs survival by about 2–3 months.<sup id="cite_ref-CD001447_5-2" class="reference"><a href="#cite_note-CD001447-5">&#91;5&#93;</a></sup> <a href="/wiki/Edaravone" title="Edaravone">Edaravone</a> slows functional decline slightly in a small number of people with ALS;<sup id="cite_ref-Edaravone_Trial_106-0" class="reference"><a href="#cite_note-Edaravone_Trial-106">&#91;102&#93;</a></sup> it is expensive and must be administered by daily IV infusions that may decrease quality of life.<sup id="cite_ref-Eda2018_107-0" class="reference"><a href="#cite_note-Eda2018-107">&#91;103&#93;</a></sup> Other medications may be used to manage other symptoms.<sup id="cite_ref-British_Medical_Bulletin_108-0" class="reference"><a href="#cite_note-British_Medical_Bulletin-108">&#91;104&#93;</a></sup>
</p><p><a href="/wiki/Non-invasive_ventilation" title="Non-invasive ventilation">Non-invasive ventilation</a> (NIV) is the main treatment for respiratory failure in ALS.<sup id="cite_ref-Nature2017_12-11" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> In people with normal bulbar function, it prolongs survival by about seven months and improves quality of life. One study found that NIV is ineffective for people with poor bulbar function<sup id="cite_ref-Cochrane_NIV_109-0" class="reference"><a href="#cite_note-Cochrane_NIV-109">&#91;105&#93;</a></sup> while another suggested that it may provide a modest survival benefit.<sup id="cite_ref-Lancet2017_13-14" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> Many people with ALS have difficulty tolerating NIV.<sup id="cite_ref-Sleep_Disorders_and_Respiratory_Function_110-0" class="reference"><a href="#cite_note-Sleep_Disorders_and_Respiratory_Function-110">&#91;106&#93;</a></sup> Invasive ventilation is an option for people with advanced ALS when NIV is not enough to manage their symptoms.<sup id="cite_ref-Support2016_4-10" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> While invasive ventilation prolongs survival, disease progression and functional decline continue.<sup id="cite_ref-Care2017_18-1" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup> It may decrease the quality of life of people with ALS or their caregivers.<sup id="cite_ref-Conn2015_19-1" class="reference"><a href="#cite_note-Conn2015-19">&#91;19&#93;</a></sup><sup id="cite_ref-Care2017_18-2" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup> Invasive ventilation is more commonly used in Japan than North America or Europe.<sup id="cite_ref-ALS_Ethics_111-0" class="reference"><a href="#cite_note-ALS_Ethics-111">&#91;107&#93;</a></sup>
</p><p>Physical therapy can promote functional independence<sup id="cite_ref-Lewis_&amp;_Rushanan_112-0" class="reference"><a href="#cite_note-Lewis_&amp;_Rushanan-112">&#91;108&#93;</a></sup><sup id="cite_ref-asha_113-0" class="reference"><a href="#cite_note-asha-113">&#91;109&#93;</a></sup> through aerobic, range of motion, and stretching exercises.<sup id="cite_ref-British_Medical_Bulletin_108-1" class="reference"><a href="#cite_note-British_Medical_Bulletin-108">&#91;104&#93;</a></sup> Occupational therapy can assist with activities of daily living through adaptive equipment.<sup id="cite_ref-ajop_114-0" class="reference"><a href="#cite_note-ajop-114">&#91;110&#93;</a></sup> Speech therapy can assist people with ALS who have difficulty speaking.<sup id="cite_ref-asha_113-1" class="reference"><a href="#cite_note-asha-113">&#91;109&#93;</a></sup> Preventing weight loss and malnutrition in people with ALS improves both survival and quality of life.<sup id="cite_ref-Lancet2017_13-15" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> Initially, difficulty swallowing (dysphagia) can be managed by dietary changes and swallowing techniques. A <a href="/wiki/Feeding_tube" title="Feeding tube">feeding tube</a> should be considered if someone with ALS loses 5% or more of their body weight or if they cannot safely swallow food and water.<sup id="cite_ref-Nature2017_12-12" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> The feeding tube is usually inserted by <a href="/wiki/Percutaneous_endoscopic_gastrostomy" title="Percutaneous endoscopic gastrostomy">percutaneous endoscopic gastrostomy</a> (PEG). There is weak evidence that PEG tubes improve survival.<sup id="cite_ref-Cochrane_Tube_Feeding_115-0" class="reference"><a href="#cite_note-Cochrane_Tube_Feeding-115">&#91;111&#93;</a></sup> PEG insertion is usually performed with the intent of improving quality of life.<sup id="cite_ref-Conn2015_19-2" class="reference"><a href="#cite_note-Conn2015-19">&#91;19&#93;</a></sup>
</p><p>Palliative care should begin shortly after someone is diagnosed with ALS.<sup id="cite_ref-EFNS_2012_116-0" class="reference"><a href="#cite_note-EFNS_2012-116">&#91;112&#93;</a></sup> Discussion of end-of-life issues gives people with ALS time to reflect on their preferences for end-of-life care and can help avoid unwanted interventions or procedures. Hospice care can improve symptom management at the end of life and increases the likelihood of a peaceful death.<sup id="cite_ref-Conn2015_19-3" class="reference"><a href="#cite_note-Conn2015-19">&#91;19&#93;</a></sup> In the final days of life, opioids can be used to treat pain and dyspnea, while benzodiazepines can be used to treat anxiety.<sup id="cite_ref-Care2017_18-3" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Medications">Medications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=23" title="Edit section: Medications">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:Riluzole2DACS.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4a/Riluzole2DACS.svg/290px-Riluzole2DACS.svg.png" decoding="async" width="290" height="109" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4a/Riluzole2DACS.svg/435px-Riluzole2DACS.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4a/Riluzole2DACS.svg/580px-Riluzole2DACS.svg.png 2x" data-file-width="728" data-file-height="274" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Riluzole2DACS.svg" class="internal" title="Enlarge"></a></div>Chemical structure of <a href="/wiki/Riluzole" title="Riluzole">riluzole</a>, a medication that prolongs survival by 2–3 months<sup id="cite_ref-CD001447_5-3" class="reference"><a href="#cite_note-CD001447-5">&#91;5&#93;</a></sup></div></div></div>
<p><a href="/wiki/Riluzole" title="Riluzole">Riluzole</a> has been found to modestly prolong survival by about 2–3 months.<sup id="cite_ref-117" class="reference"><a href="#cite_note-117">&#91;113&#93;</a></sup><sup id="cite_ref-CD001447_5-4" class="reference"><a href="#cite_note-CD001447-5">&#91;5&#93;</a></sup> It may have a greater survival benefit for those with <a href="/wiki/Bulbar-onset_ALS" class="mw-redirect" title="Bulbar-onset ALS">bulbar-onset ALS</a>.<sup id="cite_ref-CD001447_5-5" class="reference"><a href="#cite_note-CD001447-5">&#91;5&#93;</a></sup> It may work by decreasing release of the excitatory neurotransmitter <a href="/wiki/Glutamate_(neurotransmitter)" title="Glutamate (neurotransmitter)">glutamate</a> from pre-synaptic neurons.<sup id="cite_ref-Nature2017_12-13" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> The most common side effects are nausea and a lack of energy (<a href="/wiki/Asthenia" class="mw-redirect" title="Asthenia">asthenia</a>).<sup id="cite_ref-CD001447_5-6" class="reference"><a href="#cite_note-CD001447-5">&#91;5&#93;</a></sup> People with ALS should begin treatment with riluzole as soon as possible following their diagnosis.<sup id="cite_ref-EFNS_2012_116-1" class="reference"><a href="#cite_note-EFNS_2012-116">&#91;112&#93;</a></sup>
</p><p><a href="/wiki/Edaravone" title="Edaravone">Edaravone</a> has been shown to modestly slow the decline in function in a small group of people with early-stage ALS.<sup id="cite_ref-118" class="reference"><a href="#cite_note-118">&#91;e&#93;</a></sup><sup id="cite_ref-120" class="reference"><a href="#cite_note-120">&#91;f&#93;</a></sup><sup id="cite_ref-Edaravone_Trial_106-2" class="reference"><a href="#cite_note-Edaravone_Trial-106">&#91;102&#93;</a></sup><sup id="cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-0" class="reference"><a href="#cite_note-Therapeutic_Advances_in_Neurological_Disorders-121">&#91;115&#93;</a></sup> It may work by protecting motor neurons from <a href="/wiki/Oxidative_stress" title="Oxidative stress">oxidative stress</a>.<sup id="cite_ref-Edaravone&#39;s_Clinical_Development_122-0" class="reference"><a href="#cite_note-Edaravone&#39;s_Clinical_Development-122">&#91;116&#93;</a></sup> The most common side effects are bruising and gait disturbance.<sup id="cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-1" class="reference"><a href="#cite_note-Therapeutic_Advances_in_Neurological_Disorders-121">&#91;115&#93;</a></sup> Treatment with edaravone is expensive and requires daily hour-long IV infusions for 10 days in a two-week period.<sup id="cite_ref-Eda2018_107-1" class="reference"><a href="#cite_note-Eda2018-107">&#91;103&#93;</a></sup>
</p><p>Other medications may be used to help reduce fatigue, ease muscle cramps, control spasticity, and reduce excess saliva and <a href="/wiki/Phlegm" title="Phlegm">phlegm</a>.<sup id="cite_ref-British_Medical_Bulletin_108-2" class="reference"><a href="#cite_note-British_Medical_Bulletin-108">&#91;104&#93;</a></sup> <a href="/wiki/Gabapentin" title="Gabapentin">Gabapentin</a>, <a href="/wiki/Pregabalin" title="Pregabalin">pregabalin</a>, and <a href="/wiki/Tricyclic_antidepressants" class="mw-redirect" title="Tricyclic antidepressants">tricyclic antidepressants</a> (e.g., <a href="/wiki/Amitriptyline" title="Amitriptyline">amitriptyline</a>) can be used for neuropathic pain, while nonsteroidal anti-inflammatory drugs (<a href="/wiki/NSAIDs" class="mw-redirect" title="NSAIDs">NSAIDs</a>), <a href="/wiki/Acetaminophen" class="mw-redirect" title="Acetaminophen">acetaminophen</a>, and <a href="/wiki/Opioid" title="Opioid">opioids</a> can be used for nociceptive pain.<sup id="cite_ref-Pain2017_14-2" class="reference"><a href="#cite_note-Pain2017-14">&#91;14&#93;</a></sup>
</p><p>Depression can be treated with <a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">selective serotonin reuptake inhibitors</a> (SSRIs) or tricyclic antidepressants,<sup id="cite_ref-Nature2017_12-14" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> while <a href="/wiki/Benzodiazepines" class="mw-redirect" title="Benzodiazepines">benzodiazepines</a> can be used for anxiety.<sup id="cite_ref-Support2016_4-11" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> There are no medications to treat cognitive impairment/frontotemporal dementia (FTD); however, SSRIs and antipsychotics can help treat some of the symptoms of FTD.<sup id="cite_ref-Nature2017_12-15" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> <a href="/wiki/Baclofen" title="Baclofen">Baclofen</a> and <a href="/wiki/Tizanidine" title="Tizanidine">tizanidine</a> are the most commonly used oral drugs for treating spasticity; an <a href="/wiki/Intrathecal" class="mw-redirect" title="Intrathecal">intrathecal</a> baclofen pump can be used for severe spasticity.<sup id="cite_ref-Nature2017_12-16" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> <a href="/wiki/Atropine" title="Atropine">Atropine</a>, <a href="/wiki/Scopolamine" title="Scopolamine">scopolamine</a>, amitriptyline or <a href="/wiki/Glycopyrrolate" class="mw-redirect" title="Glycopyrrolate">glycopyrrolate</a> may be prescribed when people with ALS begin having trouble swallowing their saliva (<a href="/wiki/Sialorrhea" class="mw-redirect" title="Sialorrhea">sialorrhea</a>).<sup id="cite_ref-Nature2017_12-17" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup>
</p><p>A 2017 review concluded that <a href="/wiki/Mexiletine" title="Mexiletine">mexiletine</a> was safe and effective for treating cramps in ALS based on a randomized controlled trial from 2016.<sup id="cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-2" class="reference"><a href="#cite_note-Therapeutic_Advances_in_Neurological_Disorders-121">&#91;115&#93;</a></sup> In a study from 2020, AMX0035, a combination of <a href="/wiki/Sodium_phenylbutyrate" title="Sodium phenylbutyrate">sodium phenylbutyrate</a> and <a href="/wiki/Tauroursodeoxycholic_acid" title="Tauroursodeoxycholic acid">taurursodiol</a>, was shown to prolong the survival of patients by several months.<sup id="cite_ref-123" class="reference"><a href="#cite_note-123">&#91;117&#93;</a></sup><sup id="cite_ref-124" class="reference"><a href="#cite_note-124">&#91;118&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Breathing_support">Breathing support</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=24" title="Edit section: Breathing support">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<h4><span class="mw-headline" id="Non-invasive_ventilation">Non-invasive ventilation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=25" title="Edit section: Non-invasive ventilation">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:BIPAP.JPG" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/04/BIPAP.JPG/290px-BIPAP.JPG" decoding="async" width="290" height="226" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/04/BIPAP.JPG/435px-BIPAP.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/04/BIPAP.JPG/580px-BIPAP.JPG 2x" data-file-width="3840" data-file-height="2994" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:BIPAP.JPG" class="internal" title="Enlarge"></a></div><a href="/wiki/Non-invasive_ventilation" title="Non-invasive ventilation">Non-invasive ventilation</a> supports breathing with a face or nasal mask connected to a ventilator.</div></div></div>
<p><a href="/wiki/Non-invasive_ventilation" title="Non-invasive ventilation">Non-invasive ventilation</a> (NIV) is the primary treatment for respiratory failure in ALS<sup id="cite_ref-Nature2017_12-18" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> and was the first treatment shown to improve both survival and quality of life.<sup id="cite_ref-Support2016_4-12" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> NIV uses a face or nasal mask connected to a ventilator that provides intermittent positive pressure to support breathing. Continuous positive pressure is not recommended for people with ALS because it makes breathing more difficult.<sup id="cite_ref-Care2017_18-4" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup> Initially, NIV is used only at night<sup id="cite_ref-Support2016_4-13" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> because the first sign of respiratory failure is decreased gas exchange (<a href="/wiki/Hypoventilation" title="Hypoventilation">hypoventilation</a>) during sleep; symptoms associated with this nocturnal hypoventilation include interrupted sleep, anxiety, morning headaches, and daytime fatigue. As the disease progresses, people with ALS develop shortness of breath when lying down, during physical activity or talking, and eventually at rest.<sup id="cite_ref-NeuroRehabilitation_2015_125-0" class="reference"><a href="#cite_note-NeuroRehabilitation_2015-125">&#91;119&#93;</a></sup> Other symptoms include poor concentration, poor memory, confusion, respiratory tract infections, and a weak cough. Respiratory failure is the most common cause of death in ALS.<sup id="cite_ref-Support2016_4-14" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup>
</p><p>It is important to monitor the respiratory function of people with ALS every three months, because beginning NIV soon after the start of respiratory symptoms is associated with increased survival. This involves asking the person with ALS if they have any respiratory symptoms and measuring their respiratory function.<sup id="cite_ref-Support2016_4-15" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> The most commonly used measurement is upright <a href="/wiki/Forced_vital_capacity" class="mw-redirect" title="Forced vital capacity">forced vital capacity</a> (FVC), but it is a poor detector of early respiratory failure and is not a good choice for those with bulbar symptoms, as they have difficulty maintaining a tight seal around the mouthpiece. Measuring FVC while the person is lying on their back (supine FVC) is a more accurate measure of diaphragm weakness than upright FVC.<sup id="cite_ref-Sleep_Disorders_and_Respiratory_Function_110-1" class="reference"><a href="#cite_note-Sleep_Disorders_and_Respiratory_Function-110">&#91;106&#93;</a></sup> Sniff nasal inspiratory pressure (SNIP) is a rapid, convenient test of diaphragm strength that is not affected by bulbar muscle weakness.<sup id="cite_ref-Care2017_18-5" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup> If someone with ALS has signs and symptoms of respiratory failure, they should undergo daytime <a href="/wiki/Blood_gas_analysis" class="mw-redirect" title="Blood gas analysis">blood gas analysis</a><sup id="cite_ref-Support2016_4-16" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> to look for <a href="/wiki/Hypoxemia" title="Hypoxemia">hypoxemia</a> (low oxygen in the blood) and <a href="/wiki/Hypercapnia" title="Hypercapnia">hypercapnia</a> (too much carbon dioxide in the blood).<sup id="cite_ref-Care2017_18-6" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup> If their daytime blood gas analysis is normal, they should then have nocturnal <a href="/wiki/Pulse_oximetry" title="Pulse oximetry">pulse oximetry</a> to look for hypoxemia during sleep.<sup id="cite_ref-Support2016_4-17" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup>
</p><p>Non-invasive ventilation prolongs survival longer than riluzole. A 2006 randomized controlled trial found that NIV prolongs survival by about 48 days and improves quality of life; however, it also found that some people with ALS benefit more from this intervention than others. For those with normal or only moderately impaired bulbar function, NIV prolongs survival by about seven months and significantly improves quality of life. For those with poor bulbar function, NIV neither prolongs survival nor improves quality of life, though it does improve some sleep-related symptoms.<sup id="cite_ref-Cochrane_NIV_109-1" class="reference"><a href="#cite_note-Cochrane_NIV-109">&#91;105&#93;</a></sup> Despite the clear benefits of NIV, about 25–30% of all people with ALS are unable to tolerate it, especially those with cognitive impairment or bulbar dysfunction.<sup id="cite_ref-Sleep_Disorders_and_Respiratory_Function_110-2" class="reference"><a href="#cite_note-Sleep_Disorders_and_Respiratory_Function-110">&#91;106&#93;</a></sup> Results from a large 2015 cohort study suggest that NIV may prolong survival in those with bulbar weakness, and so NIV should be offered to all people with ALS, even if it is likely that they will have difficulty tolerating it.<sup id="cite_ref-Lancet2017_13-16" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Invasive_ventilation">Invasive ventilation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=26" title="Edit section: Invasive ventilation">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Invasive ventilation bypasses the nose and mouth (the upper airways) by making a cut in the trachea (<a href="/wiki/Tracheostomy" class="mw-redirect" title="Tracheostomy">tracheostomy</a>) and inserting a <a href="/wiki/Tracheal_tube" title="Tracheal tube">tube</a> connected to a ventilator.<sup id="cite_ref-Care2017_18-7" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup> It is an option for people with advanced ALS whose respiratory symptoms are poorly managed despite continuous NIV use.<sup id="cite_ref-Support2016_4-18" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> While invasive ventilation prolongs survival, especially for those younger than 60, it does not treat the underlying neurodegenerative process. The person with ALS will continue to lose motor function, making communication increasingly difficult and sometimes leading to <a href="/wiki/Locked-in_syndrome" title="Locked-in syndrome">locked-in syndrome</a>, in which they are completely paralyzed except for their eye muscles.<sup id="cite_ref-Care2017_18-8" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup> About half of the people with ALS who choose to undergo invasive ventilation report a decrease in their quality of life<sup id="cite_ref-Conn2015_19-4" class="reference"><a href="#cite_note-Conn2015-19">&#91;19&#93;</a></sup> but most still consider it to be satisfactory. However, invasive ventilation imposes a heavy burden on caregivers and may decrease their quality of life.<sup id="cite_ref-Care2017_18-9" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup> Attitudes toward invasive ventilation vary from country to country; about 30% of people with ALS in Japan choose invasive ventilation, versus less than 5% in North America and Europe.<sup id="cite_ref-ALS_Ethics_111-1" class="reference"><a href="#cite_note-ALS_Ethics-111">&#91;107&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Therapy">Therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=27" title="Edit section: Therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg" class="image"><img alt="A man with ALS communicates with his wife by pointing to letters and words with a head mounted laser pointer." src="//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg/290px-Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg" decoding="async" width="290" height="229" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg/435px-Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/36/Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg/580px-Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg 2x" data-file-width="609" data-file-height="480" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Using_a_head_mounted_laser_to_point_to_a_communication_board.jpg" class="internal" title="Enlarge"></a></div>A man with ALS communicates by pointing to letters and words using a head-mounted laser pointer.</div></div></div>
<p><a href="/wiki/Physical_therapy" title="Physical therapy">Physical therapy</a> plays a large role in rehabilitation for individuals with ALS. Specifically, physical, occupational, and speech therapists can set goals and promote benefits for individuals with ALS by delaying loss of strength, maintaining endurance, limiting pain, improving speech and swallowing, preventing complications, and promoting functional independence.<sup id="cite_ref-Lewis_&amp;_Rushanan_112-1" class="reference"><a href="#cite_note-Lewis_&amp;_Rushanan-112">&#91;108&#93;</a></sup><sup id="cite_ref-asha_113-2" class="reference"><a href="#cite_note-asha-113">&#91;109&#93;</a></sup>
</p><p>Occupational therapy and special equipment such as <a href="/wiki/Assistive_technology" title="Assistive technology">assistive technology</a> can also enhance people's independence and safety throughout the course of ALS.<sup id="cite_ref-ajop_114-1" class="reference"><a href="#cite_note-ajop-114">&#91;110&#93;</a></sup> Gentle, low-impact <a href="/wiki/Aerobic_exercise" title="Aerobic exercise">aerobic exercise</a> such as performing activities of daily living, walking, swimming, and <a href="/wiki/Stationary_bicycle" title="Stationary bicycle">stationary bicycling</a> can strengthen unaffected muscles, improve cardiovascular health, and help people fight fatigue and depression. Range of motion and stretching exercises can help prevent painful <a href="/wiki/Spasticity" title="Spasticity">spasticity</a> and shortening (contracture) of muscles. Physical and occupational therapists can recommend exercises that provide these benefits without overworking muscles, because muscle exhaustion can lead to worsening of symptoms associated with ALS, rather than providing help to people with ALS.<sup id="cite_ref-British_Medical_Bulletin_108-3" class="reference"><a href="#cite_note-British_Medical_Bulletin-108">&#91;104&#93;</a></sup> They can suggest devices such as ramps, braces, walkers, bathroom equipment (shower chairs, toilet risers, etc.), and wheelchairs that help people remain mobile. Occupational therapists can provide or recommend equipment and adaptations to enable ALS people to retain as much safety and independence in activities of daily living as possible.<sup id="cite_ref-ajop_114-2" class="reference"><a href="#cite_note-ajop-114">&#91;110&#93;</a></sup> Since respiratory insufficiency is the primary cause of mortality, physical therapists can help improve respiratory outcomes in people with ALS by implementing pulmonary physical therapy. This includes inspiratory muscle training, lung volume recruitment training, and manual assisted cough therapy aimed at increasing respiratory muscle strength as well as increasing survival rates.<sup id="cite_ref-126" class="reference"><a href="#cite_note-126">&#91;120&#93;</a></sup>
</p><p>People with ALS who have difficulty speaking or swallowing may benefit from working with a <a href="/wiki/Speech-language_pathology" class="mw-redirect" title="Speech-language pathology">speech-language pathologist</a>.<sup id="cite_ref-asha_113-3" class="reference"><a href="#cite_note-asha-113">&#91;109&#93;</a></sup> These health professionals can teach people adaptive strategies such as techniques to help them speak louder and more clearly. As ALS progresses, speech-language pathologists can recommend the use of <a href="/wiki/Augmentative_and_alternative_communication" title="Augmentative and alternative communication">augmentative and alternative communication</a> such as voice amplifiers, speech-generating devices (or voice output communication devices) or low-tech communication techniques such as head mounted laser pointers, <a href="/wiki/Letter_board#Aid_tool" title="Letter board">alphabet boards</a> or yes/no signals.<sup id="cite_ref-asha_113-4" class="reference"><a href="#cite_note-asha-113">&#91;109&#93;</a></sup> Speech-language pathologists may also help people diagnosed with ALS with their swallowing impairment (dysphagia) which may include modified diet, swallowing exercises, compensatory strategies. People with ALS might require tracheostomy placement, which SLPs will help to manage.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2020)">citation needed</span></a></i>&#93;</sup>
</p>
<h3><span class="mw-headline" id="Nutrition">Nutrition</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=28" title="Edit section: Nutrition">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Percutaneous_endoscopic_gastrostomy-tube.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/62/Percutaneous_endoscopic_gastrostomy-tube.jpg/220px-Percutaneous_endoscopic_gastrostomy-tube.jpg" decoding="async" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/62/Percutaneous_endoscopic_gastrostomy-tube.jpg/330px-Percutaneous_endoscopic_gastrostomy-tube.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/62/Percutaneous_endoscopic_gastrostomy-tube.jpg/440px-Percutaneous_endoscopic_gastrostomy-tube.jpg 2x" data-file-width="1000" data-file-height="750" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Percutaneous_endoscopic_gastrostomy-tube.jpg" class="internal" title="Enlarge"></a></div>A <a href="/wiki/Gastrostomy" title="Gastrostomy">gastrostomy</a> tube is placed through the wall of the abdomen into the stomach.</div></div></div>
<p>Preventing weight loss and malnutrition in people with ALS improves both survival and quality of life.<sup id="cite_ref-Lancet2017_13-17" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> Weight loss in ALS is caused by muscle wasting due to motor neuron death, increased resting energy expenditure, and decreased food intake. Difficulty swallowing (<a href="/wiki/Dysphagia" title="Dysphagia">dysphagia</a>) develops in about 85% of people with ALS at some point over the course of their disease and is a major cause of decreased food intake, leading to malnutrition and weight loss.<sup id="cite_ref-Care2017_18-10" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup> It is important to regularly assess the weight and swallowing ability of people with ALS.<sup id="cite_ref-Support2016_4-19" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> Initially, dysphagia may be managed by dietary changes and modified swallowing techniques.<sup id="cite_ref-Nature2017_12-19" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> Difficulty swallowing liquids usually develops first and can be managed by switching to thicker liquids like fruit nectar or smoothies, or by adding fluid thickeners to thin fluids like water and coffee. People with ALS should eat soft, moist foods, which tend to be easier to swallow than dry, crumbly, or chewy foods.<sup id="cite_ref-NeuroRehabilitation_2015_125-1" class="reference"><a href="#cite_note-NeuroRehabilitation_2015-125">&#91;119&#93;</a></sup> They should also be instructed on proper head posture during swallowing, which can make swallowing easier.<sup id="cite_ref-Nature2017_12-20" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> There is tentative evidence that high-calorie diets may prevent further weight loss and improve survival.<sup id="cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-3" class="reference"><a href="#cite_note-Therapeutic_Advances_in_Neurological_Disorders-121">&#91;115&#93;</a></sup> Patients will receive speech therapy to address their dysphagia and to continuously assess for the most least restrictive, and safe diet consistency.
</p><p>A <a href="/wiki/Feeding_tube" title="Feeding tube">feeding tube</a> should be considered if someone with ALS loses 5% or more of their body weight or if they cannot safely swallow food and water.<sup id="cite_ref-Nature2017_12-21" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> This can take the form of a <a href="/wiki/Gastrostomy" title="Gastrostomy">gastrostomy</a> tube, in which a tube is placed through the wall of the abdomen into the stomach, or a <a href="/wiki/Nasogastric_tube" class="mw-redirect" title="Nasogastric tube">nasogastric tube</a>, in which a tube is placed through the nose and down the esophagus into the stomach.<sup id="cite_ref-Care2017_18-11" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup> A gastrostomy tube is more appropriate for long-term use<sup id="cite_ref-Support2016_4-20" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> than a nasogastric tube, which is uncomfortable and can cause esophageal ulcers.<sup id="cite_ref-Care2017_18-12" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup> The feeding tube is usually inserted by <a href="/wiki/Percutaneous_endoscopic_gastrostomy" title="Percutaneous endoscopic gastrostomy">percutaneous endoscopic gastrostomy</a> (PEG). There is some evidence that a PEG tube should be inserted before vital capacity drops below 50% of expected, as a low vital capacity may be associated with a higher risk of complications. However, a large 2015 study showed that PEG insertion is safe in people with advanced ALS and low vital capacities, as long as they are on NIV during the procedure.<sup id="cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-4" class="reference"><a href="#cite_note-Therapeutic_Advances_in_Neurological_Disorders-121">&#91;115&#93;</a></sup>
</p><p>There is weak evidence that PEG tubes improve survival.<sup id="cite_ref-Cochrane_Tube_Feeding_115-1" class="reference"><a href="#cite_note-Cochrane_Tube_Feeding-115">&#91;111&#93;</a></sup> PEG insertion is usually performed with the intent of improving quality of life<sup id="cite_ref-Conn2015_19-5" class="reference"><a href="#cite_note-Conn2015-19">&#91;19&#93;</a></sup> by sustaining nutrition and medication intake.<sup id="cite_ref-Support2016_4-21" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup> This reduces the risk of weight loss and dehydration, and can decrease anxiety from extended mealtimes<sup id="cite_ref-Conn2015_19-6" class="reference"><a href="#cite_note-Conn2015-19">&#91;19&#93;</a></sup> and decreased oral food intake.<sup id="cite_ref-Support2016_4-22" class="reference"><a href="#cite_note-Support2016-4">&#91;4&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="End-of-life_care">End-of-life care</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=29" title="Edit section: End-of-life care">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Palliative_care" title="Palliative care">Palliative care</a>, which relieves symptoms and improves quality of life without treating the underlying disease, should begin shortly after someone is diagnosed with ALS.<sup id="cite_ref-EFNS_2012_116-2" class="reference"><a href="#cite_note-EFNS_2012-116">&#91;112&#93;</a></sup> Early discussion of end-of-life issues gives people with ALS time to reflect on their preferences for end-of-life care and can help avoid unwanted interventions or procedures.<sup id="cite_ref-Conn2015_19-7" class="reference"><a href="#cite_note-Conn2015-19">&#91;19&#93;</a></sup> Once they have been fully informed about all aspects of various life-prolonging measures, they can fill out <a href="/wiki/Advance_directive" class="mw-redirect" title="Advance directive">advance directives</a> indicating their attitude toward noninvasive ventilation, invasive ventilation, and feeding tubes.<sup id="cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-5" class="reference"><a href="#cite_note-Therapeutic_Advances_in_Neurological_Disorders-121">&#91;115&#93;</a></sup> Late in the disease course, difficulty speaking due to muscle weakness (<a href="/wiki/Dysarthria" title="Dysarthria">dysarthria</a>) and cognitive dysfunction may impair their ability to communicate their wishes regarding care.<sup id="cite_ref-Nature2017_12-22" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> Continued failure to solicit the preferences of the person with ALS may lead to unplanned and potentially unwanted emergency interventions, such as invasive ventilation. If people with ALS or their family members are reluctant to discuss end-of-life issues, it may be useful to use the introduction of gastrostomy or noninvasive ventilation as an opportunity to bring up the subject.<sup id="cite_ref-Conn2015_19-8" class="reference"><a href="#cite_note-Conn2015-19">&#91;19&#93;</a></sup>
</p><p><a href="/wiki/Hospice_care" class="mw-redirect" title="Hospice care">Hospice care</a>, or palliative care at the end of life, is especially important in ALS because it helps to optimize the management of symptoms and increases the likelihood of a peaceful death.<sup id="cite_ref-Conn2015_19-9" class="reference"><a href="#cite_note-Conn2015-19">&#91;19&#93;</a></sup> It is unclear exactly when the end-of-life phase begins in ALS, but it is associated with significant difficulty moving, communicating, and, in some cases, thinking.<sup id="cite_ref-Nature2017_12-23" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> Although many people with ALS fear choking to death (suffocating),<sup id="cite_ref-Conn2015_19-10" class="reference"><a href="#cite_note-Conn2015-19">&#91;19&#93;</a></sup> they can be reassured that this occurs rarely, about 0–3% of the time. About 90% of people with ALS die peacefully.<sup id="cite_ref-127" class="reference"><a href="#cite_note-127">&#91;121&#93;</a></sup> In the final days of life, opioids can be used to treat pain and <a href="/wiki/Dyspnea" class="mw-redirect" title="Dyspnea">dyspnea</a>, while <a href="/wiki/Benzodiazepine" title="Benzodiazepine">benzodiazepines</a> can be used to treat anxiety.<sup id="cite_ref-Care2017_18-13" class="reference"><a href="#cite_note-Care2017-18">&#91;18&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=30" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>ALS is the most common motor neuron disease in adults and the third most common neurodegenerative disease<sup id="cite_ref-Neuroscience2014_26-4" class="reference"><a href="#cite_note-Neuroscience2014-26">&#91;26&#93;</a></sup> after <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer&#39;s disease">Alzheimer's disease</a> and <a href="/wiki/Parkinson%27s_disease" title="Parkinson&#39;s disease">Parkinson's disease</a>.<sup id="cite_ref-128" class="reference"><a href="#cite_note-128">&#91;122&#93;</a></sup> Worldwide the number of people who develop ALS yearly is estimated to be 1.9 people per 100,000 per year, while the number of people who have ALS at any given time is estimated to be about 4.5 people per 100,000.<sup id="cite_ref-Global_Epidemiology_129-0" class="reference"><a href="#cite_note-Global_Epidemiology-129">&#91;123&#93;</a></sup> In Europe, the number of new cases a year is about 2.6 people per 100,000, while the number affected is 7–9 people per 100,000.<sup id="cite_ref-Har2017_7-2" class="reference"><a href="#cite_note-Har2017-7">&#91;7&#93;</a></sup> The lifetime risk of developing ALS is 1:350 for European men and 1:400 for European women. Men have a higher risk mainly because spinal-onset ALS is more common in men than women.<sup id="cite_ref-Conspiracy_21-4" class="reference"><a href="#cite_note-Conspiracy-21">&#91;21&#93;</a></sup> The number of those with ALS in the United States in 2015 was 5.2 people per 100,000, and was higher in whites, males, and people over 60 years old.<sup id="cite_ref-MMWR_2015_22-1" class="reference"><a href="#cite_note-MMWR_2015-22">&#91;22&#93;</a></sup> The number of new cases is about 0.8 people per 100,000 per year in east Asia and about 0.7 people per 100,000 per year in south Asia. About 80% of ALS epidemiology studies have been conducted in Europe and the United States, mostly in people of northern European descent.<sup id="cite_ref-Nature2017_12-24" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> There is not enough information to determine the rates of ALS in much of the world, including Africa, parts of Asia, India, Russia, and South America.<sup id="cite_ref-Conspiracy_21-5" class="reference"><a href="#cite_note-Conspiracy-21">&#91;21&#93;</a></sup> There are several geographic clusters in the Western Pacific where the prevalence of ALS was reported to be 50–100 times higher than the rest of the world, including Guam, the <a href="/wiki/Kii_Peninsula" title="Kii Peninsula">Kii Peninsula</a> of Japan, and <a href="/wiki/Western_New_Guinea" title="Western New Guinea">Western New Guinea</a>. The incidence in these areas has decreased since the 1960s;<sup id="cite_ref-Orphanet2009_1-1" class="reference"><a href="#cite_note-Orphanet2009-1">&#91;1&#93;</a></sup> the cause remains unknown.<sup id="cite_ref-Conspiracy_21-6" class="reference"><a href="#cite_note-Conspiracy-21">&#91;21&#93;</a></sup>
</p><p>People of all races and ethnic backgrounds may be affected by ALS,<sup id="cite_ref-MMWR_2015_22-2" class="reference"><a href="#cite_note-MMWR_2015-22">&#91;22&#93;</a></sup> but it is more common in whites than in Africans, Asians, or Hispanics.<sup id="cite_ref-Projected2016_130-0" class="reference"><a href="#cite_note-Projected2016-130">&#91;124&#93;</a></sup> In the United States in 2015, the prevalence of ALS in whites was 5.4 people per 100,000, while the prevalence in blacks was 2.3 people per 100,000. The Midwest had the highest prevalence of the four US Census regions with 5.5 people per 100,000, followed by the Northeast (5.1), the South (4.7), and the West (4.4). The Midwest and Northeast likely had a higher prevalence of ALS because they have a higher proportion of whites than the South and West.<sup id="cite_ref-MMWR_2015_22-3" class="reference"><a href="#cite_note-MMWR_2015-22">&#91;22&#93;</a></sup> Ethnically mixed populations may be at a lower risk of developing ALS; a study in Cuba found that people of mixed ancestry were less likely to die from ALS than whites or blacks.<sup id="cite_ref-Current_Issues_in_ALS_Epidemiology_131-0" class="reference"><a href="#cite_note-Current_Issues_in_ALS_Epidemiology-131">&#91;125&#93;</a></sup> There are also differences in the genetics of ALS between different ethnic groups; the most common ALS gene in Europe is <i>C9orf72</i>, followed by <i>SOD1</i>, <i>TARDBP</i>, and <i>FUS</i>, while the most common ALS gene in Asia is <i>SOD1</i>, followed by <i>FUS</i>, <i>C9orf72</i>, and <i>TARDBP</i>.<sup id="cite_ref-132" class="reference"><a href="#cite_note-132">&#91;126&#93;</a></sup>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:332px;"><a href="/wiki/File:Prevalence_of_ALS_in_the_United_States_by_age_group,_2012-2015.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/c/ca/Prevalence_of_ALS_in_the_United_States_by_age_group%2C_2012-2015.jpg/330px-Prevalence_of_ALS_in_the_United_States_by_age_group%2C_2012-2015.jpg" decoding="async" width="330" height="215" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/c/ca/Prevalence_of_ALS_in_the_United_States_by_age_group%2C_2012-2015.jpg/495px-Prevalence_of_ALS_in_the_United_States_by_age_group%2C_2012-2015.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/ca/Prevalence_of_ALS_in_the_United_States_by_age_group%2C_2012-2015.jpg/660px-Prevalence_of_ALS_in_the_United_States_by_age_group%2C_2012-2015.jpg 2x" data-file-width="1191" data-file-height="777" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Prevalence_of_ALS_in_the_United_States_by_age_group,_2012-2015.jpg" class="internal" title="Enlarge"></a></div>Estimated prevalence of ALS in the United States by age group, 2012–2015<sup id="cite_ref-MMWR_2015_22-4" class="reference"><a href="#cite_note-MMWR_2015-22">&#91;22&#93;</a></sup></div></div></div>
<p>ALS can affect people at any age,<sup id="cite_ref-Martin2017_43-2" class="reference"><a href="#cite_note-Martin2017-43">&#91;40&#93;</a></sup> but the peak incidence is between 50 and 75 years<sup id="cite_ref-Lancet2017_13-18" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> and decreases dramatically after 80 years.<sup id="cite_ref-Lancet2011_3-9" class="reference"><a href="#cite_note-Lancet2011-3">&#91;3&#93;</a></sup> The reason for the decreased incidence in the elderly is unclear. One thought is that people who survive into their 80s may not be genetically susceptible to developing ALS; alternatively, ALS in the elderly might go undiagnosed because of <a href="/wiki/Comorbidities" class="mw-redirect" title="Comorbidities">comorbidities</a> (other diseases they have), difficulty seeing a neurologist, or dying quickly from an aggressive form of ALS.<sup id="cite_ref-Current_Issues_in_ALS_Epidemiology_131-1" class="reference"><a href="#cite_note-Current_Issues_in_ALS_Epidemiology-131">&#91;125&#93;</a></sup> In the United States in 2015, the lowest prevalence was in the 18–39 age group, while the highest prevalence was in the 70–79 age group.<sup id="cite_ref-MMWR_2015_22-5" class="reference"><a href="#cite_note-MMWR_2015-22">&#91;22&#93;</a></sup> Sporadic ALS usually starts around the ages of 58 to 63 years, while familial ALS starts earlier, usually around 47 to 52 years.<sup id="cite_ref-Lancet2011_3-10" class="reference"><a href="#cite_note-Lancet2011-3">&#91;3&#93;</a></sup> The number of ALS cases worldwide is projected to increase from 222,801 in 2015 to 376,674 in 2040, an increase of 69%. This will largely be due to the aging of the world's population, especially in developing countries.<sup id="cite_ref-Projected2016_130-1" class="reference"><a href="#cite_note-Projected2016-130">&#91;124&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=31" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:Jean-Martin_Charcot.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/6a/Jean-Martin_Charcot.jpg/170px-Jean-Martin_Charcot.jpg" decoding="async" width="170" height="225" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/6a/Jean-Martin_Charcot.jpg/255px-Jean-Martin_Charcot.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6a/Jean-Martin_Charcot.jpg/340px-Jean-Martin_Charcot.jpg 2x" data-file-width="457" data-file-height="604" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Jean-Martin_Charcot.jpg" class="internal" title="Enlarge"></a></div>The French neurologist <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a> coined the term <i>amyotrophic lateral sclerosis</i> in 1874.<sup id="cite_ref-Rowland2001_23-2" class="reference"><a href="#cite_note-Rowland2001-23">&#91;23&#93;</a></sup></div></div></div>
<p>Descriptions of the disease date back to at least 1824 by <a href="/wiki/Charles_Bell" title="Charles Bell">Charles Bell</a>.<sup id="cite_ref-Rowland2001_23-3" class="reference"><a href="#cite_note-Rowland2001-23">&#91;23&#93;</a></sup> In 1850, <a href="/wiki/Fran%C3%A7ois-Amilcar_Aran" title="François-Amilcar Aran">François-Amilcar Aran</a> was the first to describe a disorder he named "progressive muscular atrophy", a form of ALS in which only the lower motor neurons are affected.<sup id="cite_ref-133" class="reference"><a href="#cite_note-133">&#91;127&#93;</a></sup> In 1869, the connection between the symptoms and the underlying neurological problems were first described by <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a>, who initially introduced the term <i>amyotrophic lateral sclerosis</i> in his 1874 paper.<sup id="cite_ref-Rowland2001_23-4" class="reference"><a href="#cite_note-Rowland2001-23">&#91;23&#93;</a></sup> Flail arm syndrome, a regional variant of ALS, was first described by <a href="/wiki/Alfred_Vulpian" title="Alfred Vulpian">Alfred Vulpian</a> in 1886. Flail leg syndrome, another regional variant of ALS, was first described by <a href="/wiki/Pierre_Marie" title="Pierre Marie">Pierre Marie</a> and his student Patrikios in 1918.<sup id="cite_ref-134" class="reference"><a href="#cite_note-134">&#91;128&#93;</a></sup>
</p><p>In 1945, American naval doctors reported that ALS was 100 times more prevalent among the <a href="/wiki/Chamorro_people" title="Chamorro people">Chamorro people</a> of <a href="/wiki/Guam" title="Guam">Guam</a> than in the rest of the world. In 1956 the variant of ALS endemic to Guam was named "amyotrophic lateral sclerosis/parkinsonism dementia complex" (ALS/PDC), as it had the typical symptoms of ALS accompanied by <a href="/wiki/Parkinsonism" title="Parkinsonism">parkinsonism</a>-like symptoms; the name in the local language is <a href="/wiki/Lytico-bodig_disease" title="Lytico-bodig disease">lytico-bodig disease</a>. Despite a number of genetic and environmental studies, the cause of ALS/PDC remains unknown. Rates peaked in the early 1950s and steadily declined thereafter, and by 1985 the incidence of ALS/PDC in Guam was about the same as the rest of the world.<sup id="cite_ref-135" class="reference"><a href="#cite_note-135">&#91;129&#93;</a></sup>
</p><p>The first gene to be associated with ALS was <i><a href="/wiki/SOD1" title="SOD1">SOD1</a></i>, which was identified in 1993.<sup id="cite_ref-Neuroscience2014_26-5" class="reference"><a href="#cite_note-Neuroscience2014-26">&#91;26&#93;</a></sup> This led to the development of the first <a href="/wiki/Animal_model" class="mw-redirect" title="Animal model">animal model</a> of ALS, the <a href="/wiki/Transgenic" class="mw-redirect" title="Transgenic">transgenic</a> <i>SOD1</i> mouse, in 1994.<sup id="cite_ref-MouseModels2018_27-1" class="reference"><a href="#cite_note-MouseModels2018-27">&#91;27&#93;</a></sup> In December 1995, riluzole became the first FDA-approved drug for ALS. It was then approved in Europe in 1996 and in Japan in 1998.<sup id="cite_ref-Eda2018_107-2" class="reference"><a href="#cite_note-Eda2018-107">&#91;103&#93;</a></sup> In 1996, the ALS Functional Rating Scale (ALSFRS) was first published; it was a 10-item questionnaire that measured the ability of people with ALS to perform <a href="/wiki/Activities_of_daily_living" title="Activities of daily living">activities of daily living</a>.<sup id="cite_ref-136" class="reference"><a href="#cite_note-136">&#91;130&#93;</a></sup> In 1999, the scale was changed to give more weight to respiratory symptoms. The resulting <a href="/wiki/ALS_Functional_Rating_Scale_-_Revised" title="ALS Functional Rating Scale - Revised">ALS Functional Rating Scale - Revised</a> (ALSFRS-R) is a 12-item questionnaire that replaces the single question about breathing with a question each about dyspnea, orthopnea, and respiratory insufficiency.<sup id="cite_ref-137" class="reference"><a href="#cite_note-137">&#91;131&#93;</a></sup>
</p><p>In 2006, it was discovered that the protein TDP-43 is a major component of the inclusion bodies seen in both ALS and frontotemporal dementia (FTD), which provided evidence that ALS and FTD are part of a common disease spectrum. This led to the discovery in 2008 that mutations in <i>TARDBP</i>, the gene that codes for TDP-43, are a cause of familial ALS.<sup id="cite_ref-Neuroscience2014_26-6" class="reference"><a href="#cite_note-Neuroscience2014-26">&#91;26&#93;</a></sup> In 2011, noncoding repeat expansions in <i>C9orf72</i> were found to be a major cause of ALS and FTD.<sup id="cite_ref-Nature2017_12-25" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup> Edaravone was approved to treat ALS in Japan and South Korea in 2015 and in the United States in 2017.<sup id="cite_ref-Edaravone&#39;s_Clinical_Development_122-1" class="reference"><a href="#cite_note-Edaravone&#39;s_Clinical_Development-122">&#91;116&#93;</a></sup> As of 2017<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit">&#91;update&#93;</a></sup>, it has not been approved to treat ALS in Europe.<sup id="cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-6" class="reference"><a href="#cite_note-Therapeutic_Advances_in_Neurological_Disorders-121">&#91;115&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Diagnostic_criteria_2">Diagnostic criteria</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=32" title="Edit section: Diagnostic criteria">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In the 1950s, <a href="/wiki/Electrodiagnostic_testing" class="mw-redirect" title="Electrodiagnostic testing">electrodiagnostic testing</a> (EMG and NCV) began to be used to evaluate clinically suspected ALS. In 1969 <a href="/wiki/Electromyography#History" title="Electromyography">Edward H. Lambert</a> published the first EMG/NCS diagnostic criteria for ALS, consisting of four findings he considered to strongly support the diagnosis.<sup id="cite_ref-138" class="reference"><a href="#cite_note-138">&#91;132&#93;</a></sup> In 1990, the <a href="/wiki/World_Federation_of_Neurology" title="World Federation of Neurology">World Federation of Neurology</a> (WFN) held a meeting at <a href="/wiki/El_Escorial" title="El Escorial">El Escorial</a>, Spain, to come up with precise diagnostic criteria for ALS to help standardize clinical trials; the resulting "El Escorial" criteria were published in 1994.<sup id="cite_ref-139" class="reference"><a href="#cite_note-139">&#91;133&#93;</a></sup> In 1998, the WFN held another meeting to revise the criteria at Airlie House in <a href="/wiki/Warrenton,_Virginia" title="Warrenton, Virginia">Warrenton, Virginia</a>; the resulting "Airlie House" or "El Escorial Revised" criteria were published in 2000.<sup id="cite_ref-140" class="reference"><a href="#cite_note-140">&#91;134&#93;</a></sup> In 2006, a meeting was held on <a href="/wiki/Awaji_Island" title="Awaji Island">Awaji Island</a> in Japan to discuss how to use EMG and NCV tests to help diagnose ALS earlier; the resulting "Awaji" criteria were published in 2008.<sup id="cite_ref-Awaji_Criteria_2008_95-1" class="reference"><a href="#cite_note-Awaji_Criteria_2008-95">&#91;91&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Name">Name</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=33" title="Edit section: Name">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:1923_Lou_Gehrig.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fb/1923_Lou_Gehrig.png/170px-1923_Lou_Gehrig.png" decoding="async" width="170" height="226" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fb/1923_Lou_Gehrig.png/255px-1923_Lou_Gehrig.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fb/1923_Lou_Gehrig.png/340px-1923_Lou_Gehrig.png 2x" data-file-width="719" data-file-height="957" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:1923_Lou_Gehrig.png" class="internal" title="Enlarge"></a></div>In some countries, especially the United States, ALS is called "<a href="/wiki/Lou_Gehrig" title="Lou Gehrig">Lou Gehrig</a>'s disease".<sup id="cite_ref-What’s_in_a_name?_141-0" class="reference"><a href="#cite_note-What’s_in_a_name?-141">&#91;135&#93;</a></sup></div></div></div>
<p>Other names for ALS include Charcot's disease, Lou Gehrig's disease, and motor neurone disease.<sup id="cite_ref-Orphanet2009_1-2" class="reference"><a href="#cite_note-Orphanet2009-1">&#91;1&#93;</a></sup> <i>Amyotrophic</i> comes from the <a href="/wiki/Greek_language" title="Greek language">Greek</a> word <i><a href="/wiki/Amyotrophy" title="Amyotrophy">amyotrophia</a></i>: <i>a-</i> means "no", <i>myo</i> refers to "muscle", and <i>trophia</i> means "nourishment". Therefore, <i>amyotrophia</i> means "no muscle nourishment,"<sup id="cite_ref-What_is_ALS?_142-0" class="reference"><a href="#cite_note-What_is_ALS?-142">&#91;136&#93;</a></sup> which describes the loss of signals motor neurons usually send to muscle cells;<sup id="cite_ref-143" class="reference"><a href="#cite_note-143">&#91;137&#93;</a></sup> this leads to the characteristic muscle <a href="/wiki/Atrophy" title="Atrophy">atrophy</a> seen in people with ALS. <i>Lateral</i> identifies the areas in a person's spinal cord where the affected motor neurons that control muscle are located. <i><a href="/wiki/Sclerosis_(medicine)" title="Sclerosis (medicine)">Sclerosis</a></i> means "scarring" or "hardening" and refers to the death of the motor neurons in the spinal cord.<sup id="cite_ref-What_is_ALS?_142-1" class="reference"><a href="#cite_note-What_is_ALS?-142">&#91;136&#93;</a></sup>
</p><p>ALS is sometimes referred to as "Charcot's disease" because Jean-Martin Charcot was the first to connect the clinical symptoms with the pathology seen at autopsy. The term is ambiguous and can also refer to <a href="/wiki/Charcot%E2%80%93Marie%E2%80%93Tooth_disease" title="Charcot–Marie–Tooth disease">Charcot–Marie–Tooth disease</a> and <a href="/wiki/Charcot_joint_disease" class="mw-redirect" title="Charcot joint disease">Charcot joint disease</a>.<sup id="cite_ref-144" class="reference"><a href="#cite_note-144">&#91;138&#93;</a></sup> The British neurologist <a href="/wiki/Russell_Brain" class="mw-redirect" title="Russell Brain">Russell Brain</a> coined the term "motor neurone disease" in 1933 to reflect his belief that ALS, progressive bulbar palsy, and progressive muscular atrophy were all different forms of the same disease,<sup id="cite_ref-145" class="reference"><a href="#cite_note-145">&#91;139&#93;</a></sup> although "neurone" should be spelt "neuron".<sup id="cite_ref-146" class="reference"><a href="#cite_note-146">&#91;140&#93;</a></sup> In some countries, especially the United States, ALS is called "Lou Gehrig's disease",<sup id="cite_ref-What’s_in_a_name?_141-1" class="reference"><a href="#cite_note-What’s_in_a_name?-141">&#91;135&#93;</a></sup> after American baseball player <a href="/wiki/Lou_Gehrig" title="Lou Gehrig">Lou Gehrig</a>, who developed ALS in 1938, had to stop playing baseball in 1939, and died from it in 1941.<sup id="cite_ref-147" class="reference"><a href="#cite_note-147">&#91;141&#93;</a></sup>
</p><p>In the United States and continental Europe, the terms "ALS" or "Lou Gehrig's disease" refer to all forms of the disease, including classical ALS, progressive bulbar palsy, progressive muscular atrophy, and primary lateral sclerosis.<sup id="cite_ref-UMN_Assessment_148-0" class="reference"><a href="#cite_note-UMN_Assessment-148">&#91;142&#93;</a></sup><sup id="cite_ref-Clinical_Features_of_ALS_38-1" class="reference"><a href="#cite_note-Clinical_Features_of_ALS-38">&#91;36&#93;</a></sup> In the United Kingdom and Australia, the term "motor neurone disease" is the name used for ALS; and other diseases that affect the motor neurons are separately treated motor neuron diseases.<sup id="cite_ref-UCLH_149-0" class="reference"><a href="#cite_note-UCLH-149">&#91;143&#93;</a></sup><sup id="cite_ref-UMN_Assessment_148-1" class="reference"><a href="#cite_note-UMN_Assessment-148">&#91;142&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Society_and_culture">Society and culture</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=34" title="Edit section: Society and culture">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/List_of_people_with_amyotrophic_lateral_sclerosis" title="List of people with amyotrophic lateral sclerosis">List of people with amyotrophic lateral sclerosis</a></div>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><div id="mwe_player_0" class="PopUpMediaTransform" style="width:290px;" videopayload="&lt;div class=&quot;mediaContainer&quot; style=&quot;width:854px&quot;&gt;&lt;video id=&quot;mwe_player_1&quot; poster=&quot;//upload.wikimedia.org/wikipedia/commons/thumb/d/d2/ALS_Ice_Bucket_Challenge.ogv/854px--ALS_Ice_Bucket_Challenge.ogv.jpg&quot; controls=&quot;&quot; preload=&quot;none&quot; autoplay=&quot;&quot; style=&quot;width:854px;height:480px&quot; class=&quot;kskin&quot; data-durationhint=&quot;22.459180273242&quot; data-startoffset=&quot;0&quot; data-mwtitle=&quot;ALS_Ice_Bucket_Challenge.ogv&quot; data-mwprovider=&quot;wikimediacommons&quot;&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.480p.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp8, vorbis&amp;quot;&quot; data-title=&quot;SD WebM (480P)&quot; data-shorttitle=&quot;WebM 480P&quot; data-transcodekey=&quot;480p.webm&quot; data-width=&quot;854&quot; data-height=&quot;480&quot; data-bandwidth=&quot;1093040&quot; data-framerate=&quot;15.005&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.480p.vp9.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp9, opus&amp;quot;&quot; data-title=&quot;SD VP9 (480P)&quot; data-shorttitle=&quot;VP9 480P&quot; data-transcodekey=&quot;480p.vp9.webm&quot; data-width=&quot;854&quot; data-height=&quot;480&quot; data-bandwidth=&quot;1372200&quot; data-framerate=&quot;15.005&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.720p.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp8, vorbis&amp;quot;&quot; data-title=&quot;HD WebM (720P)&quot; data-shorttitle=&quot;WebM 720P&quot; data-transcodekey=&quot;720p.webm&quot; data-width=&quot;1280&quot; data-height=&quot;720&quot; data-bandwidth=&quot;2265496&quot; data-framerate=&quot;15.005&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.720p.vp9.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp9, opus&amp;quot;&quot; data-title=&quot;HD VP9 (720P)&quot; data-shorttitle=&quot;VP9 720P&quot; data-transcodekey=&quot;720p.vp9.webm&quot; data-width=&quot;1280&quot; data-height=&quot;720&quot; data-bandwidth=&quot;2651952&quot; data-framerate=&quot;15.005&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/d/d2/ALS_Ice_Bucket_Challenge.ogv&quot; type=&quot;video/ogg; codecs=&amp;quot;theora, vorbis&amp;quot;&quot; data-title=&quot;Original Ogg file, 1,280 × 720 (6.53 Mbps)&quot; data-shorttitle=&quot;Ogg source&quot; data-width=&quot;1280&quot; data-height=&quot;720&quot; data-bandwidth=&quot;6534883&quot; data-framerate=&quot;15.005&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.120p.vp9.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp9, opus&amp;quot;&quot; data-title=&quot;Lowest bandwidth VP9 (120P)&quot; data-shorttitle=&quot;VP9 120P&quot; data-transcodekey=&quot;120p.vp9.webm&quot; data-width=&quot;214&quot; data-height=&quot;120&quot; data-bandwidth=&quot;189576&quot; data-framerate=&quot;15.005&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.160p.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp8, vorbis&amp;quot;&quot; data-title=&quot;Low bandwidth WebM (160P)&quot; data-shorttitle=&quot;WebM 160P&quot; data-transcodekey=&quot;160p.webm&quot; data-width=&quot;284&quot; data-height=&quot;160&quot; data-bandwidth=&quot;227960&quot; data-framerate=&quot;15.005&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.180p.vp9.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp9, opus&amp;quot;&quot; data-title=&quot;Low bandwidth VP9 (180P)&quot; data-shorttitle=&quot;VP9 180P&quot; data-transcodekey=&quot;180p.vp9.webm&quot; data-width=&quot;320&quot; data-height=&quot;180&quot; data-bandwidth=&quot;287000&quot; data-framerate=&quot;15.005&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.240p.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp8, vorbis&amp;quot;&quot; data-title=&quot;Small WebM (240P)&quot; data-shorttitle=&quot;WebM 240P&quot; data-transcodekey=&quot;240p.webm&quot; data-width=&quot;426&quot; data-height=&quot;240&quot; data-bandwidth=&quot;328720&quot; data-framerate=&quot;15.005&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.240p.vp9.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp9, opus&amp;quot;&quot; data-title=&quot;Small VP9 (240P)&quot; data-shorttitle=&quot;VP9 240P&quot; data-transcodekey=&quot;240p.vp9.webm&quot; data-width=&quot;426&quot; data-height=&quot;240&quot; data-bandwidth=&quot;410728&quot; data-framerate=&quot;15.005&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.360p.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp8, vorbis&amp;quot;&quot; data-title=&quot;WebM (360P)&quot; data-shorttitle=&quot;WebM 360P&quot; data-transcodekey=&quot;360p.webm&quot; data-width=&quot;640&quot; data-height=&quot;360&quot; data-bandwidth=&quot;577104&quot; data-framerate=&quot;15.005&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/d/d2/ALS_Ice_Bucket_Challenge.ogv/ALS_Ice_Bucket_Challenge.ogv.360p.vp9.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp9, opus&amp;quot;&quot; data-title=&quot;VP9 (360P)&quot; data-shorttitle=&quot;VP9 360P&quot; data-transcodekey=&quot;360p.vp9.webm&quot; data-width=&quot;640&quot; data-height=&quot;360&quot; data-bandwidth=&quot;734680&quot; data-framerate=&quot;15.005&quot;/&gt;&lt;/video&gt;&lt;/div&gt;"><img alt="File:ALS Ice Bucket Challenge.ogv" style="width:290px;height:163px" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d2/ALS_Ice_Bucket_Challenge.ogv/290px--ALS_Ice_Bucket_Challenge.ogv.jpg" /><a href="//upload.wikimedia.org/wikipedia/commons/d/d2/ALS_Ice_Bucket_Challenge.ogv" title="Play media" target="new"><span class="play-btn-large"><span class="mw-tmh-playtext">Play media</span></span></a></div>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:ALS_Ice_Bucket_Challenge.ogv" class="internal" title="Enlarge"></a></div>A student demonstrating the ice bucket challenge</div></div></div>
<p>In August 2014, a challenge went <a href="/wiki/Viral_phenomenon" title="Viral phenomenon">viral</a> online, commonly known as the "<a href="/wiki/Ice_Bucket_Challenge" title="Ice Bucket Challenge">ALS Ice Bucket Challenge</a>".<sup id="cite_ref-bush_150-0" class="reference"><a href="#cite_note-bush-150">&#91;144&#93;</a></sup> Contestants fill a bucket full of ice and water, then state who nominated them to do the challenge, and nominate three other individuals of their choice to take part in it. The contestants then dump the buckets of ice and water onto themselves. However, it can be done in a different order. The contestants then donate at least <a href="/wiki/United_States_dollar" title="United States dollar">US$</a>10 (or a similar amount in their local currency) to ALS research at the <a href="/wiki/ALS_Association" title="ALS Association">ALS Association</a>, the <a href="/wiki/ALS_Therapy_Development_Institute" title="ALS Therapy Development Institute">ALS Therapy Development Institute</a>, <a href="/wiki/ALS_Society_of_Canada" title="ALS Society of Canada">ALS Society of Canada</a> or <a href="/wiki/Motor_Neurone_Disease_Association" title="Motor Neurone Disease Association">Motor Neurone Disease Association</a> in the UK. Any contestants who refuse to have the ice and water dumped on them are expected to donate at least US$100 to ALS research. As of July 2015<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit">&#91;update&#93;</a></sup>, the Ice Bucket Challenge had raised $115 million for the ALS Association.<sup id="cite_ref-151" class="reference"><a href="#cite_note-151">&#91;145&#93;</a></sup>  Many celebrities have taken part in the challenge.<sup id="cite_ref-152" class="reference"><a href="#cite_note-152">&#91;146&#93;</a></sup> The Ice Bucket Challenge was credited with helping to raise funds that contributed to the discovery that the gene <i><a href="/wiki/NIMA-related_kinase_1" title="NIMA-related kinase 1">NEK1</a></i> may potentially contribute to the development for ALS.<sup id="cite_ref-153" class="reference"><a href="#cite_note-153">&#91;147&#93;</a></sup><sup id="cite_ref-154" class="reference"><a href="#cite_note-154">&#91;148&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=35" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Amyotrophic_lateral_sclerosis_research" title="Amyotrophic lateral sclerosis research">Amyotrophic lateral sclerosis research</a></div>
<h3><span class="mw-headline" id="Model_organisms">Model organisms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=36" title="Edit section: Model organisms">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:442px;"><a href="/wiki/File:ALS_animal_models,_photos_only.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f0/ALS_animal_models%2C_photos_only.jpg/440px-ALS_animal_models%2C_photos_only.jpg" decoding="async" width="440" height="109" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f0/ALS_animal_models%2C_photos_only.jpg/660px-ALS_animal_models%2C_photos_only.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/f/f0/ALS_animal_models%2C_photos_only.jpg 2x" data-file-width="714" data-file-height="177" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:ALS_animal_models,_photos_only.jpg" class="internal" title="Enlarge"></a></div>Some of the most common models used to study ALS.</div></div></div>
<p>Many different organisms are used as models for studying ALS, including <i><a href="/wiki/Saccharomyces_cerevisiae" title="Saccharomyces cerevisiae">Saccharomyces cerevisiae</a></i> (a species of yeast),<sup id="cite_ref-Modelling_ALS_91-1" class="reference"><a href="#cite_note-Modelling_ALS-91">&#91;87&#93;</a></sup> <i><a href="/wiki/Caenorhabditis_elegans" title="Caenorhabditis elegans">Caenorhabditis elegans</a></i> (a roundworm), <i><a href="/wiki/Drosophila_melanogaster" title="Drosophila melanogaster">Drosophila melanogaster</a></i> (the common fruit fly), <i><a href="/wiki/Danio_rerio" class="mw-redirect" title="Danio rerio">Danio rerio</a></i> (the zebrafish), <i><a href="/wiki/Mus_musculus" class="mw-redirect" title="Mus musculus">Mus musculus</a></i> (the house mouse), and <i><a href="/wiki/Rattus_norvegicus" class="mw-redirect" title="Rattus norvegicus">Rattus norvegicus</a></i> (the common rat).<sup id="cite_ref-Lancet2017_13-19" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> None of these models perfectly represents ALS in humans, partly because most animal models are based on gene overexpression, meaning that multiple copies of the mutant human gene are inserted into the transgenic model, and partly because the human nervous system is very different from that of other animals.<sup id="cite_ref-Nature2017_12-26" class="reference"><a href="#cite_note-Nature2017-12">&#91;12&#93;</a></sup>
</p><p>The first animal model for ALS was the <i>SOD1</i><sup>G93A</sup> transgenic mouse,<sup id="cite_ref-155" class="reference"><a href="#cite_note-155">&#91;g&#93;</a></sup> which was developed in 1994. It expresses about 20–24 copies of the mutant human <i>SOD1</i> gene<sup id="cite_ref-CNS_Drugs_2016_156-0" class="reference"><a href="#cite_note-CNS_Drugs_2016-156">&#91;149&#93;</a></sup> and reproduces most of the clinical and pathological findings seen in ALS.<sup id="cite_ref-157" class="reference"><a href="#cite_note-157">&#91;150&#93;</a></sup> Although there are now over 20 different <i>SOD1</i> mouse models, the <i>SOD1</i><sup>G93A</sup> model remains both the most widely used <i>SOD1</i> mouse model<sup id="cite_ref-CNS_Drugs_2016_156-1" class="reference"><a href="#cite_note-CNS_Drugs_2016-156">&#91;149&#93;</a></sup> and the most widely used ALS mouse model overall.<sup id="cite_ref-MouseModels2018_27-2" class="reference"><a href="#cite_note-MouseModels2018-27">&#91;27&#93;</a></sup> Much of the present understanding of ALS pathophysiology came from studying mouse models that overexpress mutant <i>SOD1</i>,<sup id="cite_ref-CNS_Drugs_2016_156-2" class="reference"><a href="#cite_note-CNS_Drugs_2016-156">&#91;149&#93;</a></sup> especially <i>SOD1</i><sup>G93A</sup> mice.<sup id="cite_ref-MouseModels2018_27-3" class="reference"><a href="#cite_note-MouseModels2018-27">&#91;27&#93;</a></sup> However, many drug targets that were shown to be effective in the <i>SOD1</i><sup>G93A</sup> transgenic mouse failed in clinical trials in humans; other <i>SOD1</i> models have had similar problems.<sup id="cite_ref-CNS_Drugs_2016_156-3" class="reference"><a href="#cite_note-CNS_Drugs_2016-156">&#91;149&#93;</a></sup> Most of these drugs were identified as potentially effective based on a single study in a rodent <i>SOD1</i> model and then failed in clinical trials in patients who primarily had sporadic ALS.<sup id="cite_ref-Modelling_ALS_91-2" class="reference"><a href="#cite_note-Modelling_ALS-91">&#91;87&#93;</a></sup> It is thought that these clinical trials failed because <i>SOD1</i> mutations account for only 2% of all ALS cases<sup id="cite_ref-CNS_Drugs_2016_156-4" class="reference"><a href="#cite_note-CNS_Drugs_2016-156">&#91;149&#93;</a></sup> and because the pathology of <i>SOD1</i> ALS is thought to be distinct from all other types of ALS; it lacks the abnormal aggregations of TDP-43 protein or FUS protein seen in nearly all other cases of ALS.<sup id="cite_ref-Neuroscience2014_26-7" class="reference"><a href="#cite_note-Neuroscience2014-26">&#91;26&#93;</a></sup>
</p><p>As of 2018, there are about 20 <i>TARDBP</i> mouse models, a dozen <i>FUS</i> mouse models, and a number of <i>C9orf72</i>, <i>PFN1</i>, and <i>UBQLN2</i> mouse models. There are also new methods of developing animal models, including viral <a href="/wiki/Transgenesis" class="mw-redirect" title="Transgenesis">transgenesis</a>, in which viruses are used to deliver mutant genes to an animal model, and <a href="/wiki/CRISPR/Cas9" class="mw-redirect" title="CRISPR/Cas9">CRISPR/Cas9</a>, which can be used to give an animal model multiple mutated genes. Both of these methods are faster and cheaper than traditional methods of genetically engineering mice; they also allow scientists to study the effects of a mutation in mice of different genetic backgrounds, which better represents the genetic diversity seen in humans.<sup id="cite_ref-MouseModels2018_27-4" class="reference"><a href="#cite_note-MouseModels2018-27">&#91;27&#93;</a></sup>
</p><p>Cellular models used to study ALS include the yeast <i>Saccharomyces cerevisiae</i> and rat or mouse motor neurons in culture. Small-animal models include the fruit fly, the roundworm <i>C. elegans</i>, and the zebrafish. Of the three, the fruit fly is the most widely used; it has a rapid life-cycle, short lifespan, a sophisticated nervous system, and many genetic tools available. <i>C. elegans</i> has a short life-cycle, is easy to manipulate genetically, and has a simple but well-understood nervous system. The zebrafish has transparent embryos that can be injected with DNA or RNA and has a lifespan of up to two years.<sup id="cite_ref-Modelling_ALS_91-3" class="reference"><a href="#cite_note-Modelling_ALS-91">&#91;87&#93;</a></sup> <a href="/wiki/Induced_pluripotent_stem_cells" class="mw-redirect" title="Induced pluripotent stem cells">Induced pluripotent stem cells</a> (iPSCs) can be used to convert skin <a href="/wiki/Fibroblasts" class="mw-redirect" title="Fibroblasts">fibroblasts</a> into motor neurons.<sup id="cite_ref-Lancet2017_13-20" class="reference"><a href="#cite_note-Lancet2017-13">&#91;13&#93;</a></sup> It is now possible to generate iPSCs from people with ALS, which can then be converted into spinal motor neurons, which are useful for studying disease mechanisms and for testing potential drugs for ALS.<sup id="cite_ref-link.springer.com_92-1" class="reference"><a href="#cite_note-link.springer.com-92">&#91;88&#93;</a></sup> iPSCs allow sporadic ALS to be modelled, which cannot be done with animal models.<sup id="cite_ref-Modelling_ALS_91-4" class="reference"><a href="#cite_note-Modelling_ALS-91">&#91;87&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Treatments">Treatments</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=37" title="Edit section: Treatments">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>From the 1960s until 2014, about 50 drugs for ALS were tested in randomized controlled trials (RCTs);<sup id="cite_ref-158" class="reference"><a href="#cite_note-158">&#91;h&#93;</a></sup> of these, riluzole was the only one that showed a slight benefit in improving survival. Drugs tested and not shown to be effective in clinical trials in humans include antiviral drugs, anti-excitotoxic drugs, growth factors, neurotrophic factors, anti-inflammatory drugs, antioxidants, anti-apoptotic drugs, and drugs to improve mitochondria function.<sup id="cite_ref-Mitsumoto_2014_159-0" class="reference"><a href="#cite_note-Mitsumoto_2014-159">&#91;151&#93;</a></sup>
</p><p>An analysis of 23 large phase II and phase III RCTs that failed between 2004 and 2014 concluded that there were many potential reasons for their lack of success. These trials in humans went ahead on the basis of positive results in <i>SOD1</i> transgenic mice, which are not a good animal model for sporadic ALS. Additionally, in most preclinical studies the <i>SOD1</i> mice were given the drug during the presymptomatic stage; this makes the results less likely to apply to people with ALS, who begin treatment well after their symptoms begin. Positive results in small phase II studies in humans could also be misleading and lead to failure in phase III trials. Other potential issues included the drug not reaching its intended site of action in the central nervous system and <a href="/wiki/Drug_interactions" class="mw-redirect" title="Drug interactions">drug interactions</a> between the study drug and riluzole.<sup id="cite_ref-Mitsumoto_2014_159-1" class="reference"><a href="#cite_note-Mitsumoto_2014-159">&#91;151&#93;</a></sup>
</p><p>Repetitive <a href="/wiki/Transcranial_magnetic_stimulation" title="Transcranial magnetic stimulation">transcranial magnetic stimulation</a> had been studied in ALS in small and poorly designed clinical trials; as of 2013<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit">&#91;update&#93;</a></sup>, evidence was insufficient to know whether rTMS is safe or effective for ALS.<sup id="cite_ref-160" class="reference"><a href="#cite_note-160">&#91;152&#93;</a></sup> One 2016 review of <a href="/wiki/Stem-cell_therapy" title="Stem-cell therapy">stem-cell therapy</a> trials found tentative evidence that intraspinal stem cell implantation was relatively safe and possibly effective.<sup id="cite_ref-161" class="reference"><a href="#cite_note-161">&#91;153&#93;</a></sup> A 2019 <a href="/wiki/Cochrane_(organisation)" title="Cochrane (organisation)">Cochrane review</a> of cell-based therapies found that there was insufficient evidence to speculate about efficacy.<sup id="cite_ref-162" class="reference"><a href="#cite_note-162">&#91;154&#93;</a></sup> <a href="/wiki/Masitinib" title="Masitinib">Masitinib</a> has been approved as an <a href="/wiki/Orphan_drug" title="Orphan drug">orphan drug</a> in Europe and the United States, with studies ongoing as of 2016<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit">&#91;update&#93;</a></sup>.<sup id="cite_ref-163" class="reference"><a href="#cite_note-163">&#91;155&#93;</a></sup> <a href="/wiki/Beta-adrenergic_agonist" title="Beta-adrenergic agonist">Beta-adrenergic agonist</a> drugs have been proposed as a treatment for their effects on muscle growth and neuroprotection, but research in humans is insufficient to determine their efficacy.<sup id="cite_ref-164" class="reference"><a href="#cite_note-164">&#91;156&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Cause_2">Cause</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=38" title="Edit section: Cause">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>With the discovery that <i><a href="/wiki/TARDBP" class="mw-redirect" title="TARDBP">TDP-43</a></i>, <i><a href="/wiki/FUS_(gene)" class="mw-redirect" title="FUS (gene)">FUS</a></i>, and <i> <a href="/wiki/C9orf72" title="C9orf72">C9orf72</a></i> can cause ALS as well as related forms of frontotemporal dementia (FTD/ALS)<sup id="cite_ref-Brauer2018_165-0" class="reference"><a href="#cite_note-Brauer2018-165">&#91;157&#93;</a></sup><sup id="cite_ref-Lau2018_166-0" class="reference"><a href="#cite_note-Lau2018-166">&#91;158&#93;</a></sup> there has been intense effort to understand how these mutations cause disease, and whether other protein dysfunction may be important. As of 2013<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit">&#91;update&#93;</a></sup> it appeared that differences in the <a href="/wiki/Methylation" title="Methylation">methylation</a> of arginine residues in FUS protein may be relevant, and methylation status may be a way to distinguish some forms of FTD from ALS.<sup id="cite_ref-167" class="reference"><a href="#cite_note-167">&#91;159&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=39" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><a href="/wiki/Transportin_1" title="Transportin 1">Transportin 1</a></li></ul>
<h2><span class="mw-headline" id="Notes">Notes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=40" title="Edit section: Notes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1011085734">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist reflist-lower-alpha">
<div class="mw-references-wrap"><ol class="references">
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text">Additional names for <i>flail arm syndrome</i> include the scapulohumeral form of ALS, Vulpian–Bernart syndrome, hanging arm syndrome, and neurogenic man-in-a-barrel syndrome.<sup id="cite_ref-Nature2014_20-5" class="reference"><a href="#cite_note-Nature2014-20">&#91;20&#93;</a></sup></span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text">Additional names for <i>flail leg syndrome</i> that involves both lower legs (bilateral distal involvement) include pseudopolyneuritic ALS, Patrikios syndrome, Marie-Patrikios ALS, and the peroneal form of ALS.<sup id="cite_ref-Nature2014_20-6" class="reference"><a href="#cite_note-Nature2014-20">&#91;20&#93;</a></sup></span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text">According to one cohort study, 11.5% of people with ALS have extraocular muscle dysfunction.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">&#91;38&#93;</a></sup></span>
</li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text">In 2013, the NFL reached a $765 million agreement to compensate more than five thousand former NFL players for concussion-related injuries and illnesses.<sup id="cite_ref-81" class="reference"><a href="#cite_note-81">&#91;78&#93;</a></sup> Some NFL players involved in the legal settlement complained that the NFL was not doing enough to help players. The judge in the case concurred, and in 2015 the NFL agreed to pay an unlimited amount of damages for players found to have ALS, <a href="/wiki/Parkinson%27s_disease" title="Parkinson&#39;s disease">Parkinson's disease</a>, <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer&#39;s disease">Alzheimer's disease</a>, or dementia.<sup id="cite_ref-82" class="reference"><a href="#cite_note-82">&#91;79&#93;</a></sup></span>
</li>
<li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text">The criteria are "scores of at least 2 points on all 12 items of ALSFRS-R, forced vital capacity of 80% or more, definite or probable ALS according to the revised El Escorial criteria, and disease duration of 2 years or less."<sup id="cite_ref-Edaravone_Trial_106-1" class="reference"><a href="#cite_note-Edaravone_Trial-106">&#91;102&#93;</a></sup></span>
</li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text">Based on population-based ALS registries, it is estimated that less than 7% of people with ALS meet these criteria.<sup id="cite_ref-119" class="reference"><a href="#cite_note-119">&#91;114&#93;</a></sup></span>
</li>
<li id="cite_note-155"><span class="mw-cite-backlink"><b><a href="#cite_ref-155">^</a></b></span> <span class="reference-text">"G93A" means that the 93rd amino acid residue in the SOD1 protein has been changed from glycine to alanine.</span>
</li>
<li id="cite_note-158"><span class="mw-cite-backlink"><b><a href="#cite_ref-158">^</a></b></span> <span class="reference-text">For the complete list, see <a href="/wiki/Amyotrophic_lateral_sclerosis_research#Past_clinical_trials" title="Amyotrophic lateral sclerosis research">Amyotrophic lateral sclerosis research#Past clinical trials</a>.</span>
</li>
</ol></div></div>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=41" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-Orphanet2009-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Orphanet2009_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Orphanet2009_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Orphanet2009_1-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r999302996">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite id="CITEREFWijesekeraLeigh2009" class="citation journal cs1">Wijesekera LC, Leigh PN (February 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2656493">"Amyotrophic lateral sclerosis"</a>. <i>Orphanet Journal of Rare Diseases</i>. <b>3</b> (4): 3. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2F1750-1172-4-3">10.1186/1750-1172-4-3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2656493">2656493</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19192301">19192301</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Orphanet+Journal+of+Rare+Diseases&amp;rft.atitle=Amyotrophic+lateral+sclerosis&amp;rft.volume=3&amp;rft.issue=4&amp;rft.pages=3&amp;rft.date=2009-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2656493%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19192301&amp;rft_id=info%3Adoi%2F10.1186%2F1750-1172-4-3&amp;rft.aulast=Wijesekera&amp;rft.aufirst=LC&amp;rft.au=Leigh%2C+PN&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2656493&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-NINDS2020-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-NINDS2020_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-NINDS2020_2-24"><sup><i><b>y</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Amyotrophic-Lateral-Sclerosis-ALS-Fact-Sheet">"Amyotrophic Lateral Sclerosis (ALS) Fact Sheet | National Institute of Neurological Disorders and Stroke"</a>. <i>www.ninds.nih.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">22 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.ninds.nih.gov&amp;rft.atitle=Amyotrophic+Lateral+Sclerosis+%28ALS%29+Fact+Sheet+%7C+National+Institute+of+Neurological+Disorders+and+Stroke&amp;rft_id=https%3A%2F%2Fwww.ninds.nih.gov%2FDisorders%2FPatient-Caregiver-Education%2FFact-Sheets%2FAmyotrophic-Lateral-Sclerosis-ALS-Fact-Sheet&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Lancet2011-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lancet2011_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lancet2011_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Lancet2011_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Lancet2011_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Lancet2011_3-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Lancet2011_3-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Lancet2011_3-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Lancet2011_3-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Lancet2011_3-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Lancet2011_3-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Lancet2011_3-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFKiernanVucicCheahTurner2011" class="citation journal cs1">Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (March 2011). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0140-6736%2810%2961156-7">"Amyotrophic lateral sclerosis"</a>. <i>Lancet</i>. <b>377</b> (9769): 942–55. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0140-6736%2810%2961156-7">10.1016/s0140-6736(10)61156-7</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21296405">21296405</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Amyotrophic+lateral+sclerosis&amp;rft.volume=377&amp;rft.issue=9769&amp;rft.pages=942-55&amp;rft.date=2011-03&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2810%2961156-7&amp;rft_id=info%3Apmid%2F21296405&amp;rft.aulast=Kiernan&amp;rft.aufirst=MC&amp;rft.au=Vucic%2C+S&amp;rft.au=Cheah%2C+BC&amp;rft.au=Turner%2C+MR&amp;rft.au=Eisen%2C+A&amp;rft.au=Hardiman%2C+O&amp;rft.au=Burrell%2C+JR&amp;rft.au=Zoing%2C+MC&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252Fs0140-6736%252810%252961156-7&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Support2016-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Support2016_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Support2016_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Support2016_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Support2016_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Support2016_4-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Support2016_4-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Support2016_4-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Support2016_4-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Support2016_4-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Support2016_4-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Support2016_4-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Support2016_4-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Support2016_4-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Support2016_4-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Support2016_4-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Support2016_4-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Support2016_4-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Support2016_4-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Support2016_4-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Support2016_4-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-Support2016_4-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-Support2016_4-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-Support2016_4-22"><sup><i><b>w</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFHobsonMcDermott2016" class="citation journal cs1">Hobson EV, McDermott CJ (September 2016). <a rel="nofollow" class="external text" href="http://eprints.whiterose.ac.uk/104445/1/16.pdf">"Supportive and symptomatic management of amyotrophic lateral sclerosis"</a> <span class="cs1-format">(PDF)</span>. <i>Nature Reviews. Neurology</i>. <b>12</b> (9): 526–38. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrneurol.2016.111">10.1038/nrneurol.2016.111</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27514291">27514291</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:8547381">8547381</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neurology&amp;rft.atitle=Supportive+and+symptomatic+management+of+amyotrophic+lateral+sclerosis&amp;rft.volume=12&amp;rft.issue=9&amp;rft.pages=526-38&amp;rft.date=2016-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A8547381%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27514291&amp;rft_id=info%3Adoi%2F10.1038%2Fnrneurol.2016.111&amp;rft.aulast=Hobson&amp;rft.aufirst=EV&amp;rft.au=McDermott%2C+CJ&amp;rft_id=http%3A%2F%2Feprints.whiterose.ac.uk%2F104445%2F1%2F16.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-CD001447-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-CD001447_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CD001447_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-CD001447_5-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-CD001447_5-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-CD001447_5-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-CD001447_5-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-CD001447_5-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFMillerMitchellMoore2012" class="citation journal cs1">Miller RG, Mitchell JD, Moore DH (March 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7055506">"Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>3</b> (3): CD001447. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD001447.pub3">10.1002/14651858.CD001447.pub3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7055506">7055506</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22419278">22419278</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Riluzole+for+amyotrophic+lateral+sclerosis+%28ALS%29%2Fmotor+neuron+disease+%28MND%29&amp;rft.volume=3&amp;rft.issue=3&amp;rft.pages=CD001447&amp;rft.date=2012-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7055506%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22419278&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD001447.pub3&amp;rft.aulast=Miller&amp;rft.aufirst=RG&amp;rft.au=Mitchell%2C+JD&amp;rft.au=Moore%2C+DH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7055506&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-FDA2017-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDA2017_6-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm557102.htm">"FDA approves drug to treat ALS"</a>. U.S. Food and Drug Administration. 5 May 2017. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170508180037/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm557102.htm">Archived</a> from the original on 8 May 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+drug+to+treat+ALS&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft.date=2017-05-05&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm557102.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Har2017-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-Har2017_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Har2017_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Har2017_7-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFHardimanAl-ChalabiBrayneBeghi2017" class="citation journal cs1">Hardiman O, Al-Chalabi A, Brayne C, Beghi E, van den Berg LH, Chio A, Martin S, Logroscino G, Rooney J (July 2017). <a rel="nofollow" class="external text" href="https://kclpure.kcl.ac.uk/portal/en/publications/the-changing-picture-of-amyotrophic-lateral-sclerosis(93e2a283-3125-4464-88ed-009897be906c).html">"The changing picture of amyotrophic lateral sclerosis: lessons from European registers"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>88</b> (7): 557–63. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2016-314495">10.1136/jnnp-2016-314495</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28285264">28285264</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:52871105">52871105</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=The+changing+picture+of+amyotrophic+lateral+sclerosis%3A+lessons+from+European+registers&amp;rft.volume=88&amp;rft.issue=7&amp;rft.pages=557-63&amp;rft.date=2017-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A52871105%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28285264&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2016-314495&amp;rft.aulast=Hardiman&amp;rft.aufirst=O&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Brayne%2C+C&amp;rft.au=Beghi%2C+E&amp;rft.au=van+den+Berg%2C+LH&amp;rft.au=Chio%2C+A&amp;rft.au=Martin%2C+S&amp;rft.au=Logroscino%2C+G&amp;rft.au=Rooney%2C+J&amp;rft_id=https%3A%2F%2Fkclpure.kcl.ac.uk%2Fportal%2Fen%2Fpublications%2Fthe-changing-picture-of-amyotrophic-lateral-sclerosis%2893e2a283-3125-4464-88ed-009897be906c%29.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-NHS-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-NHS_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NHS_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NHS_8-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NHS_8-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NHS_8-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.nhs.uk/conditions/motor-neurone-disease/">"Motor neurone disease – NHS"</a>. <i>nhs.uk</i>. 15 January 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">24 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=nhs.uk&amp;rft.atitle=Motor+neurone+disease+%E2%80%93+NHS&amp;rft.date=2018-01-15&amp;rft_id=https%3A%2F%2Fwww.nhs.uk%2Fconditions%2Fmotor-neurone-disease%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-healthdirectAU-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-healthdirectAU_9-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFAustralia2020" class="citation web cs1">Australia, Healthdirect (17 April 2020). <a rel="nofollow" class="external text" href="https://www.healthdirect.gov.au/motor-neurone-disease-mnd">"Motor neurone disease (MND)"</a>. <i>www.healthdirect.gov.au</i><span class="reference-accessdate">. Retrieved <span class="nowrap">24 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.healthdirect.gov.au&amp;rft.atitle=Motor+neurone+disease+%28MND%29&amp;rft.date=2020-04-17&amp;rft.aulast=Australia&amp;rft.aufirst=Healthdirect&amp;rft_id=https%3A%2F%2Fwww.healthdirect.gov.au%2Fmotor-neurone-disease-mnd&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Zucchi-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-Zucchi_10-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFZucchiBonettoSorarù2020" class="citation journal cs1">Zucchi E, Bonetto V, Sorarù G,  et&#160;al. (15 October 2020). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7559190">"Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers"</a>. <i>Molecular Neurodegeneration</i>. <b>15</b> (1): 58. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs13024-020-00406-3">10.1186/s13024-020-00406-3</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7559190">7559190</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/33059698">33059698</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:222385359">222385359</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+Neurodegeneration&amp;rft.atitle=Neurofilaments+in+motor+neuron+disorders%3A+towards+promising+diagnostic+and+prognostic+biomarkers&amp;rft.volume=15&amp;rft.issue=1&amp;rft.pages=58&amp;rft.date=2020-10-15&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7559190%23id-name%3DPMC&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A222385359%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F33059698&amp;rft_id=info%3Adoi%2F10.1186%2Fs13024-020-00406-3&amp;rft.aulast=Zucchi&amp;rft.aufirst=E&amp;rft.au=Bonetto%2C+V&amp;rft.au=Sorar%C3%B9%2C+G&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7559190&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-NIH2020-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-NIH2020_11-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ninds.nih.gov/disorders/patient-caregiver-education/fact-sheets/motor-neuron-diseases-fact-sheet">"Motor Neuron Diseases Fact Sheet | National Institute of Neurological Disorders and Stroke"</a>. <i>www.ninds.nih.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">27 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.ninds.nih.gov&amp;rft.atitle=Motor+Neuron+Diseases+Fact+Sheet+%7C+National+Institute+of+Neurological+Disorders+and+Stroke&amp;rft_id=https%3A%2F%2Fwww.ninds.nih.gov%2Fdisorders%2Fpatient-caregiver-education%2Ffact-sheets%2Fmotor-neuron-diseases-fact-sheet&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Nature2017-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nature2017_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nature2017_12-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nature2017_12-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Nature2017_12-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Nature2017_12-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Nature2017_12-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Nature2017_12-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Nature2017_12-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Nature2017_12-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Nature2017_12-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Nature2017_12-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Nature2017_12-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Nature2017_12-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Nature2017_12-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Nature2017_12-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Nature2017_12-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Nature2017_12-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Nature2017_12-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Nature2017_12-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Nature2017_12-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-Nature2017_12-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-Nature2017_12-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-Nature2017_12-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-Nature2017_12-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-Nature2017_12-24"><sup><i><b>y</b></i></sup></a> <a href="#cite_ref-Nature2017_12-25"><sup><i><b>z</b></i></sup></a> <a href="#cite_ref-Nature2017_12-26"><sup><i><b>aa</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFHardimanAl-ChalabiChioCorr2017" class="citation journal cs1">Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH (October 2017). <a rel="nofollow" class="external text" href="http://eprints.whiterose.ac.uk/122838/1/WR_ALS-Hardiman_V3_EDITED_FOR_AUTHOR_APPROVAL_FINAL_APPROVED-1.pdf">"Amyotrophic lateral sclerosis"</a> <span class="cs1-format">(PDF)</span>. <i>Nature Reviews. Disease Primers</i>. <b>3</b> (17071): 17071. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrdp.2017.71">10.1038/nrdp.2017.71</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28980624">28980624</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:1002680">1002680</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Disease+Primers&amp;rft.atitle=Amyotrophic+lateral+sclerosis&amp;rft.volume=3&amp;rft.issue=17071&amp;rft.pages=17071&amp;rft.date=2017-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A1002680%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28980624&amp;rft_id=info%3Adoi%2F10.1038%2Fnrdp.2017.71&amp;rft.aulast=Hardiman&amp;rft.aufirst=O&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Chio%2C+A&amp;rft.au=Corr%2C+EM&amp;rft.au=Logroscino%2C+G&amp;rft.au=Robberecht%2C+W&amp;rft.au=Shaw%2C+PJ&amp;rft.au=Simmons%2C+Z&amp;rft.au=van+den+Berg%2C+LH&amp;rft_id=http%3A%2F%2Feprints.whiterose.ac.uk%2F122838%2F1%2FWR_ALS-Hardiman_V3_EDITED_FOR_AUTHOR_APPROVAL_FINAL_APPROVED-1.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Lancet2017-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lancet2017_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-Lancet2017_13-20"><sup><i><b>u</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFvan_EsHardimanChioAl-Chalabi2017" class="citation journal cs1">van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, van den Berg LH (November 2017). "Amyotrophic lateral sclerosis". <i>Lancet</i>. <b>390</b> (10107): 2084–2098. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2817%2931287-4">10.1016/S0140-6736(17)31287-4</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28552366">28552366</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:24483077">24483077</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Amyotrophic+lateral+sclerosis&amp;rft.volume=390&amp;rft.issue=10107&amp;rft.pages=2084-2098&amp;rft.date=2017-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24483077%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28552366&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2817%2931287-4&amp;rft.aulast=van+Es&amp;rft.aufirst=MA&amp;rft.au=Hardiman%2C+O&amp;rft.au=Chio%2C+A&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Pasterkamp%2C+RJ&amp;rft.au=Veldink%2C+JH&amp;rft.au=van+den+Berg%2C+LH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Pain2017-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-Pain2017_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Pain2017_14-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Pain2017_14-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFChiòMoraLauria2017" class="citation journal cs1">Chiò A, Mora G, Lauria G (February 2017). "Pain in amyotrophic lateral sclerosis". <i>The Lancet. Neurology</i>. <b>16</b> (2): 144–57. <a href="/wiki/ArXiv_(identifier)" class="mw-redirect" title="ArXiv (identifier)">arXiv</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//arxiv.org/abs/1607.02870">1607.02870</a></span>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2816%2930358-1">10.1016/S1474-4422(16)30358-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27964824">27964824</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:38905437">38905437</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Pain+in+amyotrophic+lateral+sclerosis&amp;rft.volume=16&amp;rft.issue=2&amp;rft.pages=144-57&amp;rft.date=2017-02&amp;rft_id=info%3Aarxiv%2F1607.02870&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A38905437%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27964824&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2816%2930358-1&amp;rft.aulast=Chi%C3%B2&amp;rft.aufirst=A&amp;rft.au=Mora%2C+G&amp;rft.au=Lauria%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Hilton-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hilton_15-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFHiltonWhiteCrouch2015" class="citation journal cs1">Hilton JB, White AR, Crouch PJ (May 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4408375">"Metal-deficient SOD1 in amyotrophic lateral sclerosis"</a>. <i>Journal of Molecular Medicine (Berlin, Germany)</i>. <b>93</b> (5): 481–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00109-015-1273-3">10.1007/s00109-015-1273-3</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4408375">4408375</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25754173">25754173</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:12043749">12043749</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Molecular+Medicine+%28Berlin%2C+Germany%29&amp;rft.atitle=Metal-deficient+SOD1+in+amyotrophic+lateral+sclerosis&amp;rft.volume=93&amp;rft.issue=5&amp;rft.pages=481-7&amp;rft.date=2015-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4408375%23id-name%3DPMC&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A12043749%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25754173&amp;rft_id=info%3Adoi%2F10.1007%2Fs00109-015-1273-3&amp;rft.aulast=Hilton&amp;rft.aufirst=JB&amp;rft.au=White%2C+AR&amp;rft.au=Crouch%2C+PJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4408375&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-alsa-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-alsa_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-alsa_16-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.als.org/understanding-als">"Understanding ALS"</a>. <i>The ALS Association</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+ALS+Association&amp;rft.atitle=Understanding+ALS&amp;rft_id=https%3A%2F%2Fwww.als.org%2Funderstanding-als&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Wingo2011-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-Wingo2011_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wingo2011_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Wingo2011_17-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFWingoCutlerYarabKelly2011" class="citation journal cs1">Wingo TS, Cutler DJ, Yarab N, Kelly CM, Glass JD (2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3222666">"The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry"</a>. <i>PLOS ONE</i>. <b>6</b> (11): e27985. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2011PLoSO...627985W">2011PLoSO...627985W</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0027985">10.1371/journal.pone.0027985</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3222666">3222666</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22132186">22132186</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=The+heritability+of+amyotrophic+lateral+sclerosis+in+a+clinically+ascertained+United+States+research+registry&amp;rft.volume=6&amp;rft.issue=11&amp;rft.pages=e27985&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3222666%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22132186&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0027985&amp;rft_id=info%3Abibcode%2F2011PLoSO...627985W&amp;rft.aulast=Wingo&amp;rft.aufirst=TS&amp;rft.au=Cutler%2C+DJ&amp;rft.au=Yarab%2C+N&amp;rft.au=Kelly%2C+CM&amp;rft.au=Glass%2C+JD&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3222666&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Care2017-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-Care2017_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Care2017_18-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Care2017_18-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Care2017_18-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Care2017_18-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Care2017_18-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Care2017_18-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Care2017_18-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Care2017_18-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Care2017_18-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Care2017_18-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Care2017_18-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Care2017_18-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Care2017_18-13"><sup><i><b>n</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFSorianiDesnuelle2017" class="citation journal cs1">Soriani M, Desnuelle C (May 2017). "Care management in amyotrophic lateral sclerosis". <i>Revue Neurologique</i>. <b>173</b> (5): 288–89. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2017.03.031">10.1016/j.neurol.2017.03.031</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28461024">28461024</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=Care+management+in+amyotrophic+lateral+sclerosis&amp;rft.volume=173&amp;rft.issue=5&amp;rft.pages=288-89&amp;rft.date=2017-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2017.03.031&amp;rft_id=info%3Apmid%2F28461024&amp;rft.aulast=Soriani&amp;rft.aufirst=M&amp;rft.au=Desnuelle%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Conn2015-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-Conn2015_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Conn2015_19-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Conn2015_19-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Conn2015_19-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Conn2015_19-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Conn2015_19-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Conn2015_19-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Conn2015_19-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Conn2015_19-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Conn2015_19-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Conn2015_19-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFConnollyGalvinHardiman2015" class="citation journal cs1">Connolly S, Galvin M, Hardiman O (April 2015). "End-of-life management in patients with amyotrophic lateral sclerosis". <i>The Lancet. Neurology</i>. <b>14</b> (4): 435–42. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2814%2970221-2">10.1016/S1474-4422(14)70221-2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25728958">25728958</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34109901">34109901</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=End-of-life+management+in+patients+with+amyotrophic+lateral+sclerosis&amp;rft.volume=14&amp;rft.issue=4&amp;rft.pages=435-42&amp;rft.date=2015-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34109901%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25728958&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2814%2970221-2&amp;rft.aulast=Connolly&amp;rft.aufirst=S&amp;rft.au=Galvin%2C+M&amp;rft.au=Hardiman%2C+O&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Nature2014-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nature2014_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nature2014_20-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nature2014_20-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Nature2014_20-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Nature2014_20-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Nature2014_20-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Nature2014_20-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Nature2014_20-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFSwinnenRobberecht2014" class="citation journal cs1">Swinnen B, Robberecht W (November 2014). <a rel="nofollow" class="external text" href="https://lirias.kuleuven.be/handle/123456789/469667">"The phenotypic variability of amyotrophic lateral sclerosis"</a>. <i>Nature Reviews. Neurology</i>. <b>10</b> (11): 661–70. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrneurol.2014.184">10.1038/nrneurol.2014.184</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25311585">25311585</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:205516010">205516010</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neurology&amp;rft.atitle=The+phenotypic+variability+of+amyotrophic+lateral+sclerosis&amp;rft.volume=10&amp;rft.issue=11&amp;rft.pages=661-70&amp;rft.date=2014-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A205516010%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25311585&amp;rft_id=info%3Adoi%2F10.1038%2Fnrneurol.2014.184&amp;rft.aulast=Swinnen&amp;rft.aufirst=B&amp;rft.au=Robberecht%2C+W&amp;rft_id=https%3A%2F%2Flirias.kuleuven.be%2Fhandle%2F123456789%2F469667&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Conspiracy-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-Conspiracy_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Conspiracy_21-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Conspiracy_21-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Conspiracy_21-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Conspiracy_21-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Conspiracy_21-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Conspiracy_21-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFAl-ChalabiHardiman2013" class="citation journal cs1">Al-Chalabi A, Hardiman O (November 2013). "The epidemiology of ALS: a conspiracy of genes, environment and time". <i>Nature Reviews. Neurology</i>. <b>9</b> (11): 617–28. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrneurol.2013.203">10.1038/nrneurol.2013.203</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24126629">24126629</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25040863">25040863</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neurology&amp;rft.atitle=The+epidemiology+of+ALS%3A+a+conspiracy+of+genes%2C+environment+and+time&amp;rft.volume=9&amp;rft.issue=11&amp;rft.pages=617-28&amp;rft.date=2013-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25040863%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F24126629&amp;rft_id=info%3Adoi%2F10.1038%2Fnrneurol.2013.203&amp;rft.aulast=Al-Chalabi&amp;rft.aufirst=A&amp;rft.au=Hardiman%2C+O&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-MMWR_2015-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-MMWR_2015_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MMWR_2015_22-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MMWR_2015_22-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-MMWR_2015_22-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-MMWR_2015_22-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-MMWR_2015_22-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFMehtaKayeRaymondPunjabi2018" class="citation journal cs1">Mehta P, Kaye W, Raymond J, Punjabi R, Larson T, Cohen J, Muravov O, Horton K (November 2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5858037">"Prevalence of Amyotrophic Lateral Sclerosis – United States, 2015"</a>. <i>Morbidity and Mortality Weekly Report</i>. <b>67</b> (46): 1285–1289. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.15585%2Fmmwr.mm6746a1">10.15585/mmwr.mm6746a1</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5858037">5858037</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30462626">30462626</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Morbidity+and+Mortality+Weekly+Report&amp;rft.atitle=Prevalence+of+Amyotrophic+Lateral+Sclerosis+%E2%80%93+United+States%2C+2015&amp;rft.volume=67&amp;rft.issue=46&amp;rft.pages=1285-1289&amp;rft.date=2018-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5858037%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30462626&amp;rft_id=info%3Adoi%2F10.15585%2Fmmwr.mm6746a1&amp;rft.aulast=Mehta&amp;rft.aufirst=P&amp;rft.au=Kaye%2C+W&amp;rft.au=Raymond%2C+J&amp;rft.au=Punjabi%2C+R&amp;rft.au=Larson%2C+T&amp;rft.au=Cohen%2C+J&amp;rft.au=Muravov%2C+O&amp;rft.au=Horton%2C+K&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5858037&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Rowland2001-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rowland2001_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rowland2001_23-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Rowland2001_23-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Rowland2001_23-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Rowland2001_23-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFRowland2001" class="citation journal cs1">Rowland LP (March 2001). "How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot". <i>Archives of Neurology</i>. <b>58</b> (3): 512–15. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchneur.58.3.512">10.1001/archneur.58.3.512</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11255459">11255459</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Neurology&amp;rft.atitle=How+amyotrophic+lateral+sclerosis+got+its+name%3A+the+clinical-pathologic+genius+of+Jean-Martin+Charcot&amp;rft.volume=58&amp;rft.issue=3&amp;rft.pages=512-15&amp;rft.date=2001-03&amp;rft_id=info%3Adoi%2F10.1001%2Farchneur.58.3.512&amp;rft_id=info%3Apmid%2F11255459&amp;rft.aulast=Rowland&amp;rft.aufirst=LP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Kel2013-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kel2013_24-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFKelly2013" class="citation book cs1">Kelly, Evelyn B. (2013). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=gqMYt17klVIC&amp;pg=PA79"><i>Encyclopedia of human genetics and disease</i></a>. Santa Barbara, CA: Greenwood. pp.&#160;79–80. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-313-38713-5" title="Special:BookSources/978-0-313-38713-5"><bdi>978-0-313-38713-5</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908005608/https://books.google.com/books?id=gqMYt17klVIC&amp;pg=PA79">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Encyclopedia+of+human+genetics+and+disease&amp;rft.place=Santa+Barbara%2C+CA&amp;rft.pages=79-80&amp;rft.pub=Greenwood&amp;rft.date=2013&amp;rft.isbn=978-0-313-38713-5&amp;rft.aulast=Kelly&amp;rft.aufirst=Evelyn+B.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DgqMYt17klVIC%26pg%3DPA79&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFYoungson2004" class="citation book cs1">Youngson, David B. Jacoby, Robert M. (2004). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=VUA8DQCONgUC&amp;pg=PA1256"><i>Encyclopedia of family health</i></a> (3rd&#160;ed.). Tarrytown, NY: Marshall Cavendish. p.&#160;1256. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-7614-7486-9" title="Special:BookSources/978-0-7614-7486-9"><bdi>978-0-7614-7486-9</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908005608/https://books.google.com/books?id=VUA8DQCONgUC&amp;pg=PA1256">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Encyclopedia+of+family+health&amp;rft.place=Tarrytown%2C+NY&amp;rft.pages=1256&amp;rft.edition=3rd&amp;rft.pub=Marshall+Cavendish&amp;rft.date=2004&amp;rft.isbn=978-0-7614-7486-9&amp;rft.aulast=Youngson&amp;rft.aufirst=David+B.+Jacoby%2C+Robert+M.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DVUA8DQCONgUC%26pg%3DPA1256&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Neuroscience2014-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-Neuroscience2014_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Neuroscience2014_26-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Neuroscience2014_26-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Neuroscience2014_26-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Neuroscience2014_26-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Neuroscience2014_26-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Neuroscience2014_26-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Neuroscience2014_26-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFRentonChiòTraynor2014" class="citation journal cs1">Renton AE, Chiò A, Traynor BJ (January 2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4544832">"State of play in amyotrophic lateral sclerosis genetics"</a>. <i>Nature Neuroscience</i>. <b>17</b> (1): 17–23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnn.3584">10.1038/nn.3584</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<a rel="nofollow" class="external text" href="//hdl.handle.net/2318%2F156177">2318/156177</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4544832">4544832</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24369373">24369373</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Neuroscience&amp;rft.atitle=State+of+play+in+amyotrophic+lateral+sclerosis+genetics&amp;rft.volume=17&amp;rft.issue=1&amp;rft.pages=17-23&amp;rft.date=2014-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4544832%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24369373&amp;rft_id=info%3Ahdl%2F2318%2F156177&amp;rft_id=info%3Adoi%2F10.1038%2Fnn.3584&amp;rft.aulast=Renton&amp;rft.aufirst=AE&amp;rft.au=Chi%C3%B2%2C+A&amp;rft.au=Traynor%2C+BJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4544832&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-MouseModels2018-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-MouseModels2018_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MouseModels2018_27-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MouseModels2018_27-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-MouseModels2018_27-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-MouseModels2018_27-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFLutz2018" class="citation journal cs1">Lutz C (August 2018). "Mouse models of ALS: Past, present and future". <i>Brain Research</i>. <b>1693</b> (Part A): 1–10. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.brainres.2018.03.024">10.1016/j.brainres.2018.03.024</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29577886">29577886</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4641251">4641251</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain+Research&amp;rft.atitle=Mouse+models+of+ALS%3A+Past%2C+present+and+future&amp;rft.volume=1693&amp;rft.issue=Part+A&amp;rft.pages=1-10&amp;rft.date=2018-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4641251%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29577886&amp;rft_id=info%3Adoi%2F10.1016%2Fj.brainres.2018.03.024&amp;rft.aulast=Lutz&amp;rft.aufirst=C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFSong2014" class="citation journal cs1">Song P (August 2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4214244">"The Ice Bucket Challenge: The public sector should get ready to promptly promote the sustained development of a system of medical care for and research into rare diseases"</a>. <i>Intractable &amp; Rare Diseases Research</i>. <b>3</b> (3): 94–96. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.5582%2Firdr.2014.01015">10.5582/irdr.2014.01015</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4214244">4214244</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25364651">25364651</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Intractable+%26+Rare+Diseases+Research&amp;rft.atitle=The+Ice+Bucket+Challenge%3A+The+public+sector+should+get+ready+to+promptly+promote+the+sustained+development+of+a+system+of+medical+care+for+and+research+into+rare+diseases&amp;rft.volume=3&amp;rft.issue=3&amp;rft.pages=94-96&amp;rft.date=2014-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4214244%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25364651&amp;rft_id=info%3Adoi%2F10.5582%2Firdr.2014.01015&amp;rft.aulast=Song&amp;rft.aufirst=P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4214244&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/661720689">"8B60 Motor neuron disease"</a>. <i>ICD-11 for Mortality and Morbidity Statistics</i>. World Health Organization<span class="reference-accessdate">. Retrieved <span class="nowrap">24 January</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ICD-11+for+Mortality+and+Morbidity+Statistics&amp;rft.atitle=8B60+Motor+neuron+disease&amp;rft_id=https%3A%2F%2Ficd.who.int%2Fbrowse11%2Fl-m%2Fen%23%2Fhttp%3A%2F%2Fid.who.int%2Ficd%2Fentity%2F661720689&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Regional_ALS_Variants-30"><span class="mw-cite-backlink">^ <a href="#cite_ref-Regional_ALS_Variants_30-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Regional_ALS_Variants_30-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Regional_ALS_Variants_30-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFJawdatStatlandBarohnKatz2015" class="citation journal cs1">Jawdat O, Statland JM, Barohn RJ, Katz JS, Dimachkie MM (November 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4629514">"Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis)"</a>. <i>Neurologic Clinics</i>. <b>33</b> (4): 775–85. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ncl.2015.07.003">10.1016/j.ncl.2015.07.003</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4629514">4629514</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26515621">26515621</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurologic+Clinics&amp;rft.atitle=Amyotrophic+Lateral+Sclerosis+Regional+Variants+%28Brachial+Amyotrophic+Diplegia%2C+Leg+Amyotrophic+Diplegia%2C+and+Isolated+Bulbar+Amyotrophic+Lateral+Sclerosis%29&amp;rft.volume=33&amp;rft.issue=4&amp;rft.pages=775-85&amp;rft.date=2015-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4629514%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26515621&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ncl.2015.07.003&amp;rft.aulast=Jawdat&amp;rft.aufirst=O&amp;rft.au=Statland%2C+JM&amp;rft.au=Barohn%2C+RJ&amp;rft.au=Katz%2C+JS&amp;rft.au=Dimachkie%2C+MM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4629514&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Cold_Spring_Harbor_2017-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cold_Spring_Harbor_2017_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cold_Spring_Harbor_2017_31-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Cold_Spring_Harbor_2017_31-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Cold_Spring_Harbor_2017_31-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Cold_Spring_Harbor_2017_31-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Cold_Spring_Harbor_2017_31-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFGradRouleauRavitsCashman2017" class="citation journal cs1">Grad LI, Rouleau GA, Ravits J, Cashman NR (August 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5538408">"Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS)"</a>. <i>Cold Spring Harbor Perspectives in Medicine</i>. <b>7</b> (8): a024117. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1101%2Fcshperspect.a024117">10.1101/cshperspect.a024117</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5538408">5538408</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28003278">28003278</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cold+Spring+Harbor+Perspectives+in+Medicine&amp;rft.atitle=Clinical+Spectrum+of+Amyotrophic+Lateral+Sclerosis+%28ALS%29&amp;rft.volume=7&amp;rft.issue=8&amp;rft.pages=a024117&amp;rft.date=2017-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5538408%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28003278&amp;rft_id=info%3Adoi%2F10.1101%2Fcshperspect.a024117&amp;rft.aulast=Grad&amp;rft.aufirst=LI&amp;rft.au=Rouleau%2C+GA&amp;rft.au=Ravits%2C+J&amp;rft.au=Cashman%2C+NR&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5538408&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-JNNP_July_2011-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-JNNP_July_2011_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-JNNP_July_2011_32-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-JNNP_July_2011_32-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-JNNP_July_2011_32-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFChiòCalvoMogliaMazzini2011" class="citation journal cs1">Chiò A, Calvo A, Moglia C, Mazzini L, Mora G (July 2011). "Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study". <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>82</b> (7): 740–46. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp.2010.235952">10.1136/jnnp.2010.235952</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21402743">21402743</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:13416164">13416164</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Phenotypic+heterogeneity+of+amyotrophic+lateral+sclerosis%3A+a+population+based+study&amp;rft.volume=82&amp;rft.issue=7&amp;rft.pages=740-46&amp;rft.date=2011-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13416164%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21402743&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.2010.235952&amp;rft.aulast=Chi%C3%B2&amp;rft.aufirst=A&amp;rft.au=Calvo%2C+A&amp;rft.au=Moglia%2C+C&amp;rft.au=Mazzini%2C+L&amp;rft.au=Mora%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFGautierVerschuerenMonnierAttarian2010" class="citation journal cs1">Gautier G, Verschueren A, Monnier A, Attarian S, Salort-Campana E, Pouget J (August 2010). "ALS with respiratory onset: Clinical features and effects of non-invasive ventilation on the prognosis". <i>Amyotrophic Lateral Sclerosis</i>. <b>11</b> (4): 379–82. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F17482960903426543">10.3109/17482960903426543</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20001486">20001486</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:27672209">27672209</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis&amp;rft.atitle=ALS+with+respiratory+onset%3A+Clinical+features+and+effects+of+non-invasive+ventilation+on+the+prognosis&amp;rft.volume=11&amp;rft.issue=4&amp;rft.pages=379-82&amp;rft.date=2010-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A27672209%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20001486&amp;rft_id=info%3Adoi%2F10.3109%2F17482960903426543&amp;rft.aulast=Gautier&amp;rft.aufirst=G&amp;rft.au=Verschueren%2C+A&amp;rft.au=Monnier%2C+A&amp;rft.au=Attarian%2C+S&amp;rft.au=Salort-Campana%2C+E&amp;rft.au=Pouget%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Classification2016-34"><span class="mw-cite-backlink">^ <a href="#cite_ref-Classification2016_34-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Classification2016_34-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Classification2016_34-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Classification2016_34-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Classification2016_34-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFAl-ChalabiHardimanKiernanChiò2016" class="citation journal cs1">Al-Chalabi A, Hardiman O, Kiernan MC, Chiò A, Rix-Brooks B, van den Berg LH (October 2016). "Amyotrophic lateral sclerosis: moving towards a new classification system". <i>The Lancet. Neurology</i>. <b>15</b> (11): 1182–94. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2816%2930199-5">10.1016/S1474-4422(16)30199-5</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//hdl.handle.net/2318%2F1636249">2318/1636249</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27647646">27647646</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:45285510">45285510</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Amyotrophic+lateral+sclerosis%3A+moving+towards+a+new+classification+system&amp;rft.volume=15&amp;rft.issue=11&amp;rft.pages=1182-94&amp;rft.date=2016-10&amp;rft_id=info%3Ahdl%2F2318%2F1636249&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A45285510%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27647646&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2816%2930199-5&amp;rft.aulast=Al-Chalabi&amp;rft.aufirst=A&amp;rft.au=Hardiman%2C+O&amp;rft.au=Kiernan%2C+MC&amp;rft.au=Chi%C3%B2%2C+A&amp;rft.au=Rix-Brooks%2C+B&amp;rft.au=van+den+Berg%2C+LH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFTeohCareySampaioMowat2017" class="citation journal cs1">Teoh HL, Carey K, Sampaio H, Mowat D, Roscioli T, Farrar M (2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5467325">"Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy"</a>. <i>Neural Plasticity</i>. <b>2017</b>: 6509493. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1155%2F2017%2F6509493">10.1155/2017/6509493</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5467325">5467325</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28634552">28634552</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neural+Plasticity&amp;rft.atitle=Inherited+Paediatric+Motor+Neuron+Disorders%3A+Beyond+Spinal+Muscular+Atrophy&amp;rft.volume=2017&amp;rft.pages=6509493&amp;rft.date=2017&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5467325%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28634552&amp;rft_id=info%3Adoi%2F10.1155%2F2017%2F6509493&amp;rft.aulast=Teoh&amp;rft.aufirst=HL&amp;rft.au=Carey%2C+K&amp;rft.au=Sampaio%2C+H&amp;rft.au=Mowat%2C+D&amp;rft.au=Roscioli%2C+T&amp;rft.au=Farrar%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5467325&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Clinical_Features_of_ALS-38"><span class="mw-cite-backlink">^ <a href="#cite_ref-Clinical_Features_of_ALS_38-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Clinical_Features_of_ALS_38-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFTardDefebvreMoreauDevos2017" class="citation journal cs1">Tard C, Defebvre L, Moreau C, Devos D, Danel-Brunaud V (May 2017). "Clinical features of amyotrophic lateral sclerosis and their prognostic value". <i>Revue Neurologique</i>. <b>173</b> (5): 263–72. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2017.03.029">10.1016/j.neurol.2017.03.029</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28477850">28477850</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=Clinical+features+of+amyotrophic+lateral+sclerosis+and+their+prognostic+value&amp;rft.volume=173&amp;rft.issue=5&amp;rft.pages=263-72&amp;rft.date=2017-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2017.03.029&amp;rft_id=info%3Apmid%2F28477850&amp;rft.aulast=Tard&amp;rft.aufirst=C&amp;rft.au=Defebvre%2C+L&amp;rft.au=Moreau%2C+C&amp;rft.au=Devos%2C+D&amp;rft.au=Danel-Brunaud%2C+V&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFLuiByl2009" class="citation journal cs1">Lui AJ, Byl NN (June 2009). "A Systematic Review of the Effect of Moderate Intensity Exercise on Function and Disease Progression in Amyotrophic Lateral Sclerosis". <i>Journal of Neurologic Physical Therapy</i>. <b>33</b> (2): 68–87. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FNPT.0b013e31819912d0">10.1097/NPT.0b013e31819912d0</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19556916">19556916</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:7650356">7650356</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurologic+Physical+Therapy&amp;rft.atitle=A+Systematic+Review+of+the+Effect+of+Moderate+Intensity+Exercise+on+Function+and+Disease+Progression+in+Amyotrophic+Lateral+Sclerosis&amp;rft.volume=33&amp;rft.issue=2&amp;rft.pages=68-87&amp;rft.date=2009-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7650356%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19556916&amp;rft_id=info%3Adoi%2F10.1097%2FNPT.0b013e31819912d0&amp;rft.aulast=Lui&amp;rft.aufirst=AJ&amp;rft.au=Byl%2C+NN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFMcCluskeyVandrielElmanVan_Deerlin2014" class="citation journal cs1">McCluskey L, Vandriel S, Elman L, Van Deerlin VM, Powers J, Boller A,  et&#160;al. (15 October 2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4177937">"ALS-Plus syndrome: Non-pyramidal features in a large ALS cohort"</a>. <i>Journal of the Neurological Sciences</i>. <b>345</b> (1–2): 118–24. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jns.2014.07.022">10.1016/j.jns.2014.07.022</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4177937">4177937</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25086858">25086858</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Neurological+Sciences&amp;rft.atitle=ALS-Plus+syndrome%3A+Non-pyramidal+features+in+a+large+ALS+cohort&amp;rft.volume=345&amp;rft.issue=1%E2%80%932&amp;rft.pages=118-24&amp;rft.date=2014-10-15&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4177937%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25086858&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jns.2014.07.022&amp;rft.aulast=McCluskey&amp;rft.aufirst=L&amp;rft.au=Vandriel%2C+S&amp;rft.au=Elman%2C+L&amp;rft.au=Van+Deerlin%2C+VM&amp;rft.au=Powers%2C+J&amp;rft.au=Boller%2C+A&amp;rft.au=Wood%2C+EM&amp;rft.au=Woo%2C+J&amp;rft.au=McMillan%2C+CT&amp;rft.au=Rascovsky%2C+K&amp;rft.au=Grossman%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4177937&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-NEJM_2017-42"><span class="mw-cite-backlink">^ <a href="#cite_ref-NEJM_2017_42-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NEJM_2017_42-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NEJM_2017_42-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NEJM_2017_42-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NEJM_2017_42-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NEJM_2017_42-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-NEJM_2017_42-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-NEJM_2017_42-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-NEJM_2017_42-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-NEJM_2017_42-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBrownAl-Chalabi2017" class="citation journal cs1">Brown RH, Al-Chalabi A (13 July 2017). <a rel="nofollow" class="external text" href="https://kclpure.kcl.ac.uk/portal/en/publications/amyotrophic-lateral-sclerosis(70a10b6b-0121-46ae-896b-7108a6666dcb).html">"Amyotrophic Lateral Sclerosis"</a>. <i>The New England Journal of Medicine</i>. <b>377</b> (2): 162–172. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMra1603471">10.1056/NEJMra1603471</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28700839">28700839</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Amyotrophic+Lateral+Sclerosis&amp;rft.volume=377&amp;rft.issue=2&amp;rft.pages=162-172&amp;rft.date=2017-07-13&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra1603471&amp;rft_id=info%3Apmid%2F28700839&amp;rft.aulast=Brown&amp;rft.aufirst=RH&amp;rft.au=Al-Chalabi%2C+A&amp;rft_id=https%3A%2F%2Fkclpure.kcl.ac.uk%2Fportal%2Fen%2Fpublications%2Famyotrophic-lateral-sclerosis%2870a10b6b-0121-46ae-896b-7108a6666dcb%29.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Martin2017-43"><span class="mw-cite-backlink">^ <a href="#cite_ref-Martin2017_43-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Martin2017_43-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Martin2017_43-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFMartinAl_KhleifatAl-Chalabi2017" class="citation journal cs1">Martin S, Al Khleifat A, Al-Chalabi A (2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5373425">"What causes amyotrophic lateral sclerosis?"</a>. <i>F1000Research</i>. <b>6</b>: 371. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.12688%2Ff1000research.10476.1">10.12688/f1000research.10476.1</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5373425">5373425</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28408982">28408982</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=F1000Research&amp;rft.atitle=What+causes+amyotrophic+lateral+sclerosis%3F&amp;rft.volume=6&amp;rft.pages=371&amp;rft.date=2017&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5373425%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28408982&amp;rft_id=info%3Adoi%2F10.12688%2Ff1000research.10476.1&amp;rft.aulast=Martin&amp;rft.aufirst=S&amp;rft.au=Al+Khleifat%2C+A&amp;rft.au=Al-Chalabi%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5373425&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFRaaphorstBeeldmanDe_VisserDe_Haan2012" class="citation journal cs1">Raaphorst J, Beeldman E, De Visser M, De Haan RJ, Schmand B (October 2012). "A systematic review of behavioural changes in motor neuron disease". <i>Amyotrophic Lateral Sclerosis</i>. <b>13</b> (6): 493–501. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F17482968.2012.656652">10.3109/17482968.2012.656652</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22424127">22424127</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22224140">22224140</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis&amp;rft.atitle=A+systematic+review+of+behavioural+changes+in+motor+neuron+disease&amp;rft.volume=13&amp;rft.issue=6&amp;rft.pages=493-501&amp;rft.date=2012-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22224140%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22424127&amp;rft_id=info%3Adoi%2F10.3109%2F17482968.2012.656652&amp;rft.aulast=Raaphorst&amp;rft.aufirst=J&amp;rft.au=Beeldman%2C+E&amp;rft.au=De+Visser%2C+M&amp;rft.au=De+Haan%2C+RJ&amp;rft.au=Schmand%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-2016cog-45"><span class="mw-cite-backlink">^ <a href="#cite_ref-2016cog_45-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-2016cog_45-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBeeldmanRaaphorstKlein_Twennaarde_Visser2016" class="citation journal cs1">Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand BA, de Haan RJ (June 2016). "The cognitive profile of ALS: a systematic review and meta-analysis update". <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>87</b> (6): 611–19. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2015-310734">10.1136/jnnp-2015-310734</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26283685">26283685</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22082109">22082109</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=The+cognitive+profile+of+ALS%3A+a+systematic+review+and+meta-analysis+update&amp;rft.volume=87&amp;rft.issue=6&amp;rft.pages=611-19&amp;rft.date=2016-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22082109%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26283685&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2015-310734&amp;rft.aulast=Beeldman&amp;rft.aufirst=E&amp;rft.au=Raaphorst%2C+J&amp;rft.au=Klein+Twennaar%2C+M&amp;rft.au=de+Visser%2C+M&amp;rft.au=Schmand%2C+BA&amp;rft.au=de+Haan%2C+RJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFGordonMillerMoore2004" class="citation journal cs1">Gordon PH, Miller RG, Moore DH (September 2004). "ALSFRS-R". <i>Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders</i>. 5 Suppl 1: 90–93. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F17434470410019906">10.1080/17434470410019906</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15512883">15512883</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:218987659">218987659</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis+and+Other+Motor+Neuron+Disorders&amp;rft.atitle=ALSFRS-R&amp;rft.volume=5+Suppl+1&amp;rft.pages=90-93&amp;rft.date=2004-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A218987659%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15512883&amp;rft_id=info%3Adoi%2F10.1080%2F17434470410019906&amp;rft.aulast=Gordon&amp;rft.aufirst=PH&amp;rft.au=Miller%2C+RG&amp;rft.au=Moore%2C+DH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFCreemersGrupstraNolletvan_den_Berg2015" class="citation journal cs1">Creemers H, Grupstra H, Nollet F, van den Berg LH, Beelen A (June 2015). "Prognostic factors for the course of functional status of patients with ALS: a systematic review". <i>Journal of Neurology</i>. <b>262</b> (6): 1407–23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00415-014-7564-8">10.1007/s00415-014-7564-8</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25385051">25385051</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:31734765">31734765</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology&amp;rft.atitle=Prognostic+factors+for+the+course+of+functional+status+of+patients+with+ALS%3A+a+systematic+review&amp;rft.volume=262&amp;rft.issue=6&amp;rft.pages=1407-23&amp;rft.date=2015-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A31734765%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25385051&amp;rft_id=info%3Adoi%2F10.1007%2Fs00415-014-7564-8&amp;rft.aulast=Creemers&amp;rft.aufirst=H&amp;rft.au=Grupstra%2C+H&amp;rft.au=Nollet%2C+F&amp;rft.au=van+den+Berg%2C+LH&amp;rft.au=Beelen%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFCastrillo-VigueraGrassoSimpsonShefner2010" class="citation journal cs1">Castrillo-Viguera C, Grasso DL, Simpson E, Shefner J, Cudkowicz ME (2010). "Clinical significance in the change of decline in ALSFRS-R". <i>Amyotrophic Lateral Sclerosis</i> (Journal Article). <b>11</b> (1–2): 178–80. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F17482960903093710">10.3109/17482960903093710</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19634063">19634063</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:207619689">207619689</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis&amp;rft.atitle=Clinical+significance+in+the+change+of+decline+in+ALSFRS-R&amp;rft.volume=11&amp;rft.issue=1%E2%80%932&amp;rft.pages=178-80&amp;rft.date=2010&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A207619689%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19634063&amp;rft_id=info%3Adoi%2F10.3109%2F17482960903093710&amp;rft.aulast=Castrillo-Viguera&amp;rft.aufirst=C&amp;rft.au=Grasso%2C+DL&amp;rft.au=Simpson%2C+E&amp;rft.au=Shefner%2C+J&amp;rft.au=Cudkowicz%2C+ME&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFSabatelliMadiaConteLuigetti2008" class="citation journal cs1">Sabatelli M, Madia F, Conte A, Luigetti M, Zollino M, Mancuso I, Lo Monaco M, Lippi G, Tonali P (September 2008). "Natural history of young-adult amyotrophic lateral sclerosis". <i>Neurology</i>. <b>71</b> (12): 876–81. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2F01.wnl.0000312378.94737.45">10.1212/01.wnl.0000312378.94737.45</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18596241">18596241</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:10848454">10848454</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Natural+history+of+young-adult+amyotrophic+lateral+sclerosis&amp;rft.volume=71&amp;rft.issue=12&amp;rft.pages=876-81&amp;rft.date=2008-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A10848454%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18596241&amp;rft_id=info%3Adoi%2F10.1212%2F01.wnl.0000312378.94737.45&amp;rft.aulast=Sabatelli&amp;rft.aufirst=M&amp;rft.au=Madia%2C+F&amp;rft.au=Conte%2C+A&amp;rft.au=Luigetti%2C+M&amp;rft.au=Zollino%2C+M&amp;rft.au=Mancuso%2C+I&amp;rft.au=Lo+Monaco%2C+M&amp;rft.au=Lippi%2C+G&amp;rft.au=Tonali%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFPaganoniDengJaffaCudkowicz2011" class="citation journal cs1">Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM (July 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4441750">"Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis"</a>. <i>Muscle &amp; Nerve</i>. <b>44</b> (1): 20–24. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmus.22114">10.1002/mus.22114</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4441750">4441750</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21607987">21607987</a>. <a rel="nofollow" class="external text" href="http://www.massgeneral.org/about/pressrelease.aspx?id=1361">Lay summary</a> &#8211; <i>Massachusetts General Hospital</i> (11 May 2011).</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Muscle+%26+Nerve&amp;rft.atitle=Body+mass+index%2C+not+dyslipidemia%2C+is+an+independent+predictor+of+survival+in+amyotrophic+lateral+sclerosis&amp;rft.volume=44&amp;rft.issue=1&amp;rft.pages=20-24&amp;rft.date=2011-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4441750%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21607987&amp;rft_id=info%3Adoi%2F10.1002%2Fmus.22114&amp;rft.aulast=Paganoni&amp;rft.aufirst=S&amp;rft.au=Deng%2C+J&amp;rft.au=Jaffa%2C+M&amp;rft.au=Cudkowicz%2C+ME&amp;rft.au=Wills%2C+AM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4441750&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.cnn.com/2009/HEALTH/04/20/hawking.als/index.html">"Stephen Hawking serves as role model for ALS patients"</a>. CNN. 20 April 2009. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160815000537/http://www.cnn.com/2009/HEALTH/04/20/hawking.als/index.html">Archived</a> from the original on 15 August 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Stephen+Hawking+serves+as+role+model+for+ALS+patients&amp;rft.pub=CNN&amp;rft.date=2009-04-20&amp;rft_id=http%3A%2F%2Fwww.cnn.com%2F2009%2FHEALTH%2F04%2F20%2Fhawking.als%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-fALS-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-fALS_52-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.als-research.org/familial-als/">"About Familial ALS – ALS Research Collaboration"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">27 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=About+Familial+ALS+%E2%80%93+ALS+Research+Collaboration&amp;rft_id=https%3A%2F%2Fwww.als-research.org%2Ffamilial-als%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Neurology_2017-53"><span class="mw-cite-backlink">^ <a href="#cite_ref-Neurology_2017_53-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Neurology_2017_53-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFVajdaMcLaughlinHeverinThorpe2017" class="citation journal cs1">Vajda A, McLaughlin RL, Heverin M, Thorpe O, Abrahams S, Al-Chalabi A, Hardiman O (March 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5333513">"Genetic testing in ALS: A survey of current practices"</a>. <i>Neurology</i>. <b>88</b> (10): 991–999. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0000000000003686">10.1212/WNL.0000000000003686</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5333513">5333513</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28159885">28159885</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Genetic+testing+in+ALS%3A+A+survey+of+current+practices&amp;rft.volume=88&amp;rft.issue=10&amp;rft.pages=991-999&amp;rft.date=2017-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5333513%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28159885&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0000000000003686&amp;rft.aulast=Vajda&amp;rft.aufirst=A&amp;rft.au=McLaughlin%2C+RL&amp;rft.au=Heverin%2C+M&amp;rft.au=Thorpe%2C+O&amp;rft.au=Abrahams%2C+S&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Hardiman%2C+O&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5333513&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFByrneWalshLynchBede2011" class="citation journal cs1">Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, McLaughlin R, Hardiman O (June 2011). "Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis". <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>82</b> (6): 623–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp.2010.224501">10.1136/jnnp.2010.224501</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//hdl.handle.net/2262%2F53330">2262/53330</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21047878">21047878</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:6254190">6254190</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Rate+of+familial+amyotrophic+lateral+sclerosis%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=82&amp;rft.issue=6&amp;rft.pages=623-7&amp;rft.date=2011-06&amp;rft_id=info%3Ahdl%2F2262%2F53330&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A6254190%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21047878&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.2010.224501&amp;rft.aulast=Byrne&amp;rft.aufirst=S&amp;rft.au=Walsh%2C+C&amp;rft.au=Lynch%2C+C&amp;rft.au=Bede%2C+P&amp;rft.au=Elamin%2C+M&amp;rft.au=Kenna%2C+K&amp;rft.au=McLaughlin%2C+R&amp;rft.au=Hardiman%2C+O&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-The_Neuroscientist_2015-55"><span class="mw-cite-backlink">^ <a href="#cite_ref-The_Neuroscientist_2015_55-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-The_Neuroscientist_2015_55-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-The_Neuroscientist_2015_55-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFHeMangelsdorfFanBartlett2015" class="citation journal cs1">He J, Mangelsdorf M, Fan D, Bartlett P, Brown MA (December 2015). <a rel="nofollow" class="external text" href="https://eprints.qut.edu.au/110861/2/UQ351652_OA.pdf">"Amyotrophic Lateral Sclerosis Genetic Studies: From Genome-wide Association Mapping to Genome Sequencing"</a> <span class="cs1-format">(PDF)</span>. <i>The Neuroscientist</i>. <b>21</b> (6): 599–615. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1073858414555404">10.1177/1073858414555404</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25378359">25378359</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3437565">3437565</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Neuroscientist&amp;rft.atitle=Amyotrophic+Lateral+Sclerosis+Genetic+Studies%3A+From+Genome-wide+Association+Mapping+to+Genome+Sequencing&amp;rft.volume=21&amp;rft.issue=6&amp;rft.pages=599-615&amp;rft.date=2015-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3437565%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25378359&amp;rft_id=info%3Adoi%2F10.1177%2F1073858414555404&amp;rft.aulast=He&amp;rft.aufirst=J&amp;rft.au=Mangelsdorf%2C+M&amp;rft.au=Fan%2C+D&amp;rft.au=Bartlett%2C+P&amp;rft.au=Brown%2C+MA&amp;rft_id=https%3A%2F%2Feprints.qut.edu.au%2F110861%2F2%2FUQ351652_OA.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Revue_Neurologique-56"><span class="mw-cite-backlink">^ <a href="#cite_ref-Revue_Neurologique_56-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Revue_Neurologique_56-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFCorciaCouratierBlascoAndres2017" class="citation journal cs1">Corcia P, Couratier P, Blasco H, Andres CR, Beltran S, Meininger V, Vourc'h P (May 2017). "Genetics of amyotrophic lateral sclerosis". <i>Revue Neurologique</i>. <b>173</b> (5): 254–262. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2017.03.030">10.1016/j.neurol.2017.03.030</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28449881">28449881</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=Genetics+of+amyotrophic+lateral+sclerosis&amp;rft.volume=173&amp;rft.issue=5&amp;rft.pages=254-262&amp;rft.date=2017-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2017.03.030&amp;rft_id=info%3Apmid%2F28449881&amp;rft.aulast=Corcia&amp;rft.aufirst=P&amp;rft.au=Couratier%2C+P&amp;rft.au=Blasco%2C+H&amp;rft.au=Andres%2C+CR&amp;rft.au=Beltran%2C+S&amp;rft.au=Meininger%2C+V&amp;rft.au=Vourc%27h%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFChiaChiòTraynor2018" class="citation journal cs1">Chia R, Chiò A, Traynor BJ (January 2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5901717">"Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications"</a>. <i>The Lancet. Neurology</i>. <b>17</b> (1): 94–102. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2817%2930401-5">10.1016/S1474-4422(17)30401-5</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5901717">5901717</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29154141">29154141</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Novel+genes+associated+with+amyotrophic+lateral+sclerosis%3A+diagnostic+and+clinical+implications&amp;rft.volume=17&amp;rft.issue=1&amp;rft.pages=94-102&amp;rft.date=2018-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5901717%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29154141&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2817%2930401-5&amp;rft.aulast=Chia&amp;rft.aufirst=R&amp;rft.au=Chi%C3%B2%2C+A&amp;rft.au=Traynor%2C+BJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5901717&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFZouLiuCheHuang2016" class="citation journal cs1">Zou ZY, Liu CY, Che CH, Huang HP (January 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4731596">"Toward precision medicine in amyotrophic lateral sclerosis"</a>. <i>Annals of Translational Medicine</i>. <b>4</b> (2): 27. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3978%2Fj.issn.2305-5839.2016.01.16">10.3978/j.issn.2305-5839.2016.01.16</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4731596">4731596</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26889480">26889480</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Translational+Medicine&amp;rft.atitle=Toward+precision+medicine+in+amyotrophic+lateral+sclerosis&amp;rft.volume=4&amp;rft.issue=2&amp;rft.pages=27&amp;rft.date=2016-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4731596%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26889480&amp;rft_id=info%3Adoi%2F10.3978%2Fj.issn.2305-5839.2016.01.16&amp;rft.aulast=Zou&amp;rft.aufirst=ZY&amp;rft.au=Liu%2C+CY&amp;rft.au=Che%2C+CH&amp;rft.au=Huang%2C+HP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4731596&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFSontheimer2015" class="citation book cs1">Sontheimer, Harald (2015). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=U_1PBAAAQBAJ"><i>Diseases of the Nervous System</i></a>. Academic Press. p.&#160;170. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-12-800403-6" title="Special:BookSources/978-0-12-800403-6"><bdi>978-0-12-800403-6</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908005608/https://books.google.com/books?id=U_1PBAAAQBAJ">Archived</a> from the original on 8 September 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">2 May</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Diseases+of+the+Nervous+System&amp;rft.pages=170&amp;rft.pub=Academic+Press&amp;rft.date=2015&amp;rft.isbn=978-0-12-800403-6&amp;rft.aulast=Sontheimer&amp;rft.aufirst=Harald&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DU_1PBAAAQBAJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFCouratierCorciaLautretteNicol2017" class="citation journal cs1">Couratier P, Corcia P, Lautrette G, Nicol M, Marin B (May 2017). "ALS and frontotemporal dementia belong to a common disease spectrum". <i>Revue Neurologique</i>. <b>173</b> (5): 273–279. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2017.04.001">10.1016/j.neurol.2017.04.001</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28449882">28449882</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=ALS+and+frontotemporal+dementia+belong+to+a+common+disease+spectrum&amp;rft.volume=173&amp;rft.issue=5&amp;rft.pages=273-279&amp;rft.date=2017-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2017.04.001&amp;rft_id=info%3Apmid%2F28449882&amp;rft.aulast=Couratier&amp;rft.aufirst=P&amp;rft.au=Corcia%2C+P&amp;rft.au=Lautrette%2C+G&amp;rft.au=Nicol%2C+M&amp;rft.au=Marin%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Trends_in_Genetics_2018-61"><span class="mw-cite-backlink">^ <a href="#cite_ref-Trends_in_Genetics_2018_61-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Trends_in_Genetics_2018_61-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFNguyenVan_Broeckhovenvan_der_Zee2018" class="citation journal cs1">Nguyen HP, Van Broeckhoven C, van der Zee J (June 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.tig.2018.03.001">"ALS Genes in the Genomic Era and their Implications for FTD"</a>. <i>Trends in Genetics</i>. <b>34</b> (6): 404–423. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.tig.2018.03.001">10.1016/j.tig.2018.03.001</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29605155">29605155</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Genetics&amp;rft.atitle=ALS+Genes+in+the+Genomic+Era+and+their+Implications+for+FTD&amp;rft.volume=34&amp;rft.issue=6&amp;rft.pages=404-423&amp;rft.date=2018-06&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tig.2018.03.001&amp;rft_id=info%3Apmid%2F29605155&amp;rft.aulast=Nguyen&amp;rft.aufirst=HP&amp;rft.au=Van+Broeckhoven%2C+C&amp;rft.au=van+der+Zee%2C+J&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252Fj.tig.2018.03.001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-beard-62"><span class="mw-cite-backlink">^ <a href="#cite_ref-beard_62-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-beard_62-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBeardKamel2015" class="citation journal cs1">Beard JD, Kamel F (1 January 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4325667">"Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival"</a>. <i>Epidemiologic Reviews</i>. <b>37</b> (1): 55–70. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fepirev%2Fmxu001">10.1093/epirev/mxu001</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4325667">4325667</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25365170">25365170</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Epidemiologic+Reviews&amp;rft.atitle=Military+service%2C+deployments%2C+and+exposures+in+relation+to+amyotrophic+lateral+sclerosis+etiology+and+survival&amp;rft.volume=37&amp;rft.issue=1&amp;rft.pages=55-70&amp;rft.date=2015-01-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4325667%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25365170&amp;rft_id=info%3Adoi%2F10.1093%2Fepirev%2Fmxu001&amp;rft.aulast=Beard&amp;rft.aufirst=JD&amp;rft.au=Kamel%2C+F&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4325667&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBelbasisBellouEvangelou2016" class="citation journal cs1">Belbasis L, Bellou V, Evangelou E (March 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000443146">"Environmental Risk Factors and Amyotrophic Lateral Sclerosis: An Umbrella Review and Critical Assessment of Current Evidence from Systematic Reviews and Meta-Analyses of Observational Studies"</a>. <i>Neuroepidemiology</i>. <b>46</b> (2): 96–105. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000443146">10.1159/000443146</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26731747">26731747</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:13163292">13163292</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroepidemiology&amp;rft.atitle=Environmental+Risk+Factors+and+Amyotrophic+Lateral+Sclerosis%3A+An+Umbrella+Review+and+Critical+Assessment+of+Current+Evidence+from+Systematic+Reviews+and+Meta-Analyses+of+Observational+Studies&amp;rft.volume=46&amp;rft.issue=2&amp;rft.pages=96-105&amp;rft.date=2016-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13163292%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26731747&amp;rft_id=info%3Adoi%2F10.1159%2F000443146&amp;rft.aulast=Belbasis&amp;rft.aufirst=L&amp;rft.au=Bellou%2C+V&amp;rft.au=Evangelou%2C+E&amp;rft_id=%2F%2Fdoi.org%2F10.1159%252F000443146&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBeardSteegeJuLu2017" class="citation journal cs1">Beard JD, Steege AL, Ju J, Lu J, Luckhaupt SE, Schubauer-Berigan MK (July 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5687590">"Mortality from Amyotrophic Lateral Sclerosis and Parkinson's Disease Among Different Occupation Groups - United States, 1985-2011"</a>. <i>MMWR. Morbidity and Mortality Weekly Report</i>. <b>66</b> (27): 718–722. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.15585%2Fmmwr.mm6627a2">10.15585/mmwr.mm6627a2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5687590">5687590</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28704346">28704346</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MMWR.+Morbidity+and+Mortality+Weekly+Report&amp;rft.atitle=Mortality+from+Amyotrophic+Lateral+Sclerosis+and+Parkinson%27s+Disease+Among+Different+Occupation+Groups+-+United+States%2C+1985-2011&amp;rft.volume=66&amp;rft.issue=27&amp;rft.pages=718-722&amp;rft.date=2017-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5687590%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28704346&amp;rft_id=info%3Adoi%2F10.15585%2Fmmwr.mm6627a2&amp;rft.aulast=Beard&amp;rft.aufirst=JD&amp;rft.au=Steege%2C+AL&amp;rft.au=Ju%2C+J&amp;rft.au=Lu%2C+J&amp;rft.au=Luckhaupt%2C+SE&amp;rft.au=Schubauer-Berigan%2C+MK&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5687590&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFSutedjaFischerVeldinkvan_der_Heijden2009" class="citation journal cs1">Sutedja NA, Fischer K, Veldink JH, van der Heijden GJ, Kromhout H, Heederik D, Huisman MH, Wokke JJ, van den Berg LH (2009). "What we truly know about occupation as a risk factor for ALS: a critical and systematic review". <i>Amyotrophic Lateral Sclerosis</i>. <b>10</b> (5–6): 295–301. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F17482960802430799">10.3109/17482960802430799</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19922116">19922116</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25772664">25772664</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis&amp;rft.atitle=What+we+truly+know+about+occupation+as+a+risk+factor+for+ALS%3A+a+critical+and+systematic+review&amp;rft.volume=10&amp;rft.issue=5%E2%80%936&amp;rft.pages=295-301&amp;rft.date=2009&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25772664%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19922116&amp;rft_id=info%3Adoi%2F10.3109%2F17482960802430799&amp;rft.aulast=Sutedja&amp;rft.aufirst=NA&amp;rft.au=Fischer%2C+K&amp;rft.au=Veldink%2C+JH&amp;rft.au=van+der+Heijden%2C+GJ&amp;rft.au=Kromhout%2C+H&amp;rft.au=Heederik%2C+D&amp;rft.au=Huisman%2C+MH&amp;rft.au=Wokke%2C+JJ&amp;rft.au=van+den+Berg%2C+LH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Ingre_2015-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ingre_2015_66-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFIngreRoosPiehlKamel2015" class="citation journal cs1">Ingre C, Roos PM, Piehl F, Kamel F, Fang F (2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4334292">"Risk factors for amyotrophic lateral sclerosis"</a>. <i>Clinical Epidemiology</i>. <b>7</b>: 181–93. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2147%2FCLEP.S37505">10.2147/CLEP.S37505</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4334292">4334292</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25709501">25709501</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Epidemiology&amp;rft.atitle=Risk+factors+for+amyotrophic+lateral+sclerosis&amp;rft.volume=7&amp;rft.pages=181-93&amp;rft.date=2015&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4334292%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25709501&amp;rft_id=info%3Adoi%2F10.2147%2FCLEP.S37505&amp;rft.aulast=Ingre&amp;rft.aufirst=C&amp;rft.au=Roos%2C+PM&amp;rft.au=Piehl%2C+F&amp;rft.au=Kamel%2C+F&amp;rft.au=Fang%2C+F&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4334292&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFKamelUmbachBedlackRichards2012" class="citation journal cs1">Kamel F, Umbach DM, Bedlack RS, Richards M, Watson M, Alavanja MC, Blair A, Hoppin JA, Schmidt S, Sandler DP (June 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3358481">"Pesticide exposure and amyotrophic lateral sclerosis"</a>. <i>Neurotoxicology</i>. <b>33</b> (3): 457–62. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neuro.2012.04.001">10.1016/j.neuro.2012.04.001</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3358481">3358481</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22521219">22521219</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurotoxicology&amp;rft.atitle=Pesticide+exposure+and+amyotrophic+lateral+sclerosis&amp;rft.volume=33&amp;rft.issue=3&amp;rft.pages=457-62&amp;rft.date=2012-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3358481%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22521219&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuro.2012.04.001&amp;rft.aulast=Kamel&amp;rft.aufirst=F&amp;rft.au=Umbach%2C+DM&amp;rft.au=Bedlack%2C+RS&amp;rft.au=Richards%2C+M&amp;rft.au=Watson%2C+M&amp;rft.au=Alavanja%2C+MC&amp;rft.au=Blair%2C+A&amp;rft.au=Hoppin%2C+JA&amp;rft.au=Schmidt%2C+S&amp;rft.au=Sandler%2C+DP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3358481&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBozzoniPansarasaDiamantiNosari2016" class="citation journal cs1">Bozzoni V, Pansarasa O, Diamanti L, Nosari G, Cereda C, Ceroni M (2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4819821">"Amyotrophic lateral sclerosis and environmental factors"</a>. <i>Functional Neurology</i>. <b>31</b> (1): 7–19. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4819821">4819821</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27027889">27027889</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Functional+Neurology&amp;rft.atitle=Amyotrophic+lateral+sclerosis+and+environmental+factors&amp;rft.volume=31&amp;rft.issue=1&amp;rft.pages=7-19&amp;rft.date=2016&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4819821%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27027889&amp;rft.aulast=Bozzoni&amp;rft.aufirst=V&amp;rft.au=Pansarasa%2C+O&amp;rft.au=Diamanti%2C+L&amp;rft.au=Nosari%2C+G&amp;rft.au=Cereda%2C+C&amp;rft.au=Ceroni%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4819821&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFMalekBarchowskyBowserYouk2012" class="citation journal cs1">Malek AM, Barchowsky A, Bowser R, Youk A, Talbott EO (August 2012). "Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta-analysis of epidemiological studies: pesticide exposure as a risk factor for ALS". <i>Environmental Research</i>. <b>117</b>: 112–9. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2012ER....117..112M">2012ER....117..112M</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.envres.2012.06.007">10.1016/j.envres.2012.06.007</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22819005">22819005</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Environmental+Research&amp;rft.atitle=Pesticide+exposure+as+a+risk+factor+for+amyotrophic+lateral+sclerosis%3A+a+meta-analysis+of+epidemiological+studies%3A+pesticide+exposure+as+a+risk+factor+for+ALS&amp;rft.volume=117&amp;rft.pages=112-9&amp;rft.date=2012-08&amp;rft_id=info%3Apmid%2F22819005&amp;rft_id=info%3Adoi%2F10.1016%2Fj.envres.2012.06.007&amp;rft_id=info%3Abibcode%2F2012ER....117..112M&amp;rft.aulast=Malek&amp;rft.aufirst=AM&amp;rft.au=Barchowsky%2C+A&amp;rft.au=Bowser%2C+R&amp;rft.au=Youk%2C+A&amp;rft.au=Talbott%2C+EO&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Gard2015-70"><span class="mw-cite-backlink">^ <a href="#cite_ref-Gard2015_70-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Gard2015_70-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFGardnerYaffe2015" class="citation journal cs1">Gardner RC, Yaffe K (May 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4461453">"Epidemiology of mild traumatic brain injury and neurodegenerative disease"</a>. <i>Molecular and Cellular Neurosciences</i>. <b>66</b> (Pt B): 75–80. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.mcn.2015.03.001">10.1016/j.mcn.2015.03.001</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4461453">4461453</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25748121">25748121</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+and+Cellular+Neurosciences&amp;rft.atitle=Epidemiology+of+mild+traumatic+brain+injury+and+neurodegenerative+disease&amp;rft.volume=66&amp;rft.issue=Pt+B&amp;rft.pages=75-80&amp;rft.date=2015-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4461453%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25748121&amp;rft_id=info%3Adoi%2F10.1016%2Fj.mcn.2015.03.001&amp;rft.aulast=Gardner&amp;rft.aufirst=RC&amp;rft.au=Yaffe%2C+K&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4461453&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFWatanabeWatanabe2017" class="citation journal cs1">Watanabe Y, Watanabe T (October 2017). <a rel="nofollow" class="external text" href="https://discovery.ucl.ac.uk/id/eprint/10036040/">"Meta-analytic evaluation of the association between head injury and risk of amyotrophic lateral sclerosis"</a>. <i>European Journal of Epidemiology</i>. <b>32</b> (10): 867–879. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs10654-017-0327-y">10.1007/s10654-017-0327-y</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29080013">29080013</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:449855">449855</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Epidemiology&amp;rft.atitle=Meta-analytic+evaluation+of+the+association+between+head+injury+and+risk+of+amyotrophic+lateral+sclerosis&amp;rft.volume=32&amp;rft.issue=10&amp;rft.pages=867-879&amp;rft.date=2017-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A449855%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29080013&amp;rft_id=info%3Adoi%2F10.1007%2Fs10654-017-0327-y&amp;rft.aulast=Watanabe&amp;rft.aufirst=Y&amp;rft.au=Watanabe%2C+T&amp;rft_id=https%3A%2F%2Fdiscovery.ucl.ac.uk%2Fid%2Feprint%2F10036040%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFLunaLogroscinoCouratierMarin2017" class="citation journal cs1">Luna, J.; Logroscino, G.; Couratier, P.; Marin, B. (May 2017). "Current issues in ALS epidemiology: Variation of ALS occurrence between populations and physical activity as a risk factor". <i>Revue Neurologique</i>. <b>173</b> (5): 244–253. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2017.03.035">10.1016/j.neurol.2017.03.035</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0035-3787">0035-3787</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28477849">28477849</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=Current+issues+in+ALS+epidemiology%3A+Variation+of+ALS+occurrence+between+populations+and+physical+activity+as+a+risk+factor&amp;rft.volume=173&amp;rft.issue=5&amp;rft.pages=244-253&amp;rft.date=2017-05&amp;rft.issn=0035-3787&amp;rft_id=info%3Apmid%2F28477849&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2017.03.035&amp;rft.aulast=Luna&amp;rft.aufirst=J.&amp;rft.au=Logroscino%2C+G.&amp;rft.au=Couratier%2C+P.&amp;rft.au=Marin%2C+B.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFVeldinkKalmijnGroeneveldTitulaer2005" class="citation journal cs1">Veldink JH, Kalmijn S, Groeneveld GJ, Titulaer MJ, Wokke JH, van den Berg LH (January 2005). "Physical activity and the association with sporadic ALS". <i>Neurology</i>. <b>64</b> (2): 241–5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2F01.WNL.0000149513.82332.5C">10.1212/01.WNL.0000149513.82332.5C</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15668420">15668420</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:36449771">36449771</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Physical+activity+and+the+association+with+sporadic+ALS&amp;rft.volume=64&amp;rft.issue=2&amp;rft.pages=241-5&amp;rft.date=2005-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A36449771%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15668420&amp;rft_id=info%3Adoi%2F10.1212%2F01.WNL.0000149513.82332.5C&amp;rft.aulast=Veldink&amp;rft.aufirst=JH&amp;rft.au=Kalmijn%2C+S&amp;rft.au=Groeneveld%2C+GJ&amp;rft.au=Titulaer%2C+MJ&amp;rft.au=Wokke%2C+JH&amp;rft.au=van+den+Berg%2C+LH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Armon_2007-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-Armon_2007_74-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFArmon2007" class="citation journal cs1">Armon C (November 2007). "Sports and trauma in amyotrophic lateral sclerosis revisited". <i>Journal of the Neurological Sciences</i>. <b>262</b> (1–2): 45–53. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jns.2007.06.021">10.1016/j.jns.2007.06.021</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17681549">17681549</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20733887">20733887</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Neurological+Sciences&amp;rft.atitle=Sports+and+trauma+in+amyotrophic+lateral+sclerosis+revisited&amp;rft.volume=262&amp;rft.issue=1%E2%80%932&amp;rft.pages=45-53&amp;rft.date=2007-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20733887%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17681549&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jns.2007.06.021&amp;rft.aulast=Armon&amp;rft.aufirst=C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Physical_Activity_as_a_Risk_Factor-75"><span class="mw-cite-backlink">^ <a href="#cite_ref-Physical_Activity_as_a_Risk_Factor_75-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Physical_Activity_as_a_Risk_Factor_75-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFHarwoodMcDermottShaw2009" class="citation journal cs1">Harwood CA, McDermott CJ, Shaw PJ (August 2009). "Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence". <i>Amyotrophic Lateral Sclerosis</i>. <b>10</b> (4): 191–204. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F17482960802549739">10.1080/17482960802549739</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19263258">19263258</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:14749160">14749160</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis&amp;rft.atitle=Physical+activity+as+an+exogenous+risk+factor+in+motor+neuron+disease+%28MND%29%3A+a+review+of+the+evidence&amp;rft.volume=10&amp;rft.issue=4&amp;rft.pages=191-204&amp;rft.date=2009-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A14749160%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19263258&amp;rft_id=info%3Adoi%2F10.1080%2F17482960802549739&amp;rft.aulast=Harwood&amp;rft.aufirst=CA&amp;rft.au=McDermott%2C+CJ&amp;rft.au=Shaw%2C+PJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFHamidouCouratierBesançonNicol2014" class="citation journal cs1">Hamidou B, Couratier P, Besançon C, Nicol M, Preux PM, Marin B (July 2014). "Epidemiological evidence that physical activity is not a risk factor for ALS". <i>European Journal of Epidemiology</i>. <b>29</b> (7): 459–75. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs10654-014-9923-2">10.1007/s10654-014-9923-2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24986107">24986107</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20563636">20563636</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Epidemiology&amp;rft.atitle=Epidemiological+evidence+that+physical+activity+is+not+a+risk+factor+for+ALS&amp;rft.volume=29&amp;rft.issue=7&amp;rft.pages=459-75&amp;rft.date=2014-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20563636%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F24986107&amp;rft_id=info%3Adoi%2F10.1007%2Fs10654-014-9923-2&amp;rft.aulast=Hamidou&amp;rft.aufirst=B&amp;rft.au=Couratier%2C+P&amp;rft.au=Besan%C3%A7on%2C+C&amp;rft.au=Nicol%2C+M&amp;rft.au=Preux%2C+PM&amp;rft.au=Marin%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFLacorteFerrignoLeonciniCorbo2016" class="citation journal cs1">Lacorte E, Ferrigno L, Leoncini E, Corbo M, Boccia S, Vanacore N (July 2016). "Physical activity, and physical activity related to sports, leisure and occupational activity as risk factors for ALS: A systematic review". <i>Neuroscience and Biobehavioral Reviews</i>. <b>66</b>: 61–79. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neubiorev.2016.04.007">10.1016/j.neubiorev.2016.04.007</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27108217">27108217</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:24844638">24844638</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroscience+and+Biobehavioral+Reviews&amp;rft.atitle=Physical+activity%2C+and+physical+activity+related+to+sports%2C+leisure+and+occupational+activity+as+risk+factors+for+ALS%3A+A+systematic+review&amp;rft.volume=66&amp;rft.pages=61-79&amp;rft.date=2016-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24844638%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27108217&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neubiorev.2016.04.007&amp;rft.aulast=Lacorte&amp;rft.aufirst=E&amp;rft.au=Ferrigno%2C+L&amp;rft.au=Leoncini%2C+E&amp;rft.au=Corbo%2C+M&amp;rft.au=Boccia%2C+S&amp;rft.au=Vanacore%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFCouratierCorciaLautretteNicol2016" class="citation journal cs1">Couratier P, Corcia P, Lautrette G, Nicol M, Preux P, Marin B (January 2016). "Epidemiology of amyotrophic lateral sclerosis: A review of literature". <i>Neuroepidemiology</i>. <b>172</b> (1): 37–45. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2015.11.002">10.1016/j.neurol.2015.11.002</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26727307">26727307</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroepidemiology&amp;rft.atitle=Epidemiology+of+amyotrophic+lateral+sclerosis%3A+A+review+of+literature.&amp;rft.volume=172&amp;rft.issue=1&amp;rft.pages=37-45&amp;rft.date=2016-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2015.11.002&amp;rft_id=info%3Apmid%2F26727307&amp;rft.aulast=Couratier&amp;rft.aufirst=P&amp;rft.au=Corcia%2C+P&amp;rft.au=Lautrette%2C+G&amp;rft.au=Nicol%2C+M&amp;rft.au=Preux%2C+P&amp;rft.au=Marin%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFTharmaratnamIskandarTabobondungTobbia2018" class="citation journal cs1">Tharmaratnam T, Iskandar M, Tabobondung T, Tobbia I, Gopee-Ramanan P, Tabobondung T (19 June 2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6018081">"Chronic Traumatic Encephalopathy in Professional American Football Players: Where Are We Now?"</a>. <i>Frontiers in Neurology</i>. <b>19</b> (9): 445. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffneur.2018.00445">10.3389/fneur.2018.00445</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6018081">6018081</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29971037">29971037</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Neurology&amp;rft.atitle=Chronic+Traumatic+Encephalopathy+in+Professional+American+Football+Players%3A+Where+Are+We+Now%3F&amp;rft.volume=19&amp;rft.issue=9&amp;rft.pages=445&amp;rft.date=2018-06-19&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6018081%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29971037&amp;rft_id=info%3Adoi%2F10.3389%2Ffneur.2018.00445&amp;rft.aulast=Tharmaratnam&amp;rft.aufirst=T&amp;rft.au=Iskandar%2C+M&amp;rft.au=Tabobondung%2C+T&amp;rft.au=Tobbia%2C+I&amp;rft.au=Gopee-Ramanan%2C+P&amp;rft.au=Tabobondung%2C+T&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6018081&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFGardnerIversonMcCrory2014" class="citation journal cs1">Gardner A, Iverson G, McCrory P (January 2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbjsports-2013-092646">"Chronic traumatic encephalopathy in sport: a systematic review"</a>. <i>British Journal of Sports Medicine</i>. <b>48</b> (2): 84–90. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbjsports-2013-092646">10.1136/bjsports-2013-092646</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23803602">23803602</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:7182895">7182895</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Sports+Medicine&amp;rft.atitle=Chronic+traumatic+encephalopathy+in+sport%3A+a+systematic+review.&amp;rft.volume=48&amp;rft.issue=2&amp;rft.pages=84-90&amp;rft.date=2014-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7182895%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23803602&amp;rft_id=info%3Adoi%2F10.1136%2Fbjsports-2013-092646&amp;rft.aulast=Gardner&amp;rft.aufirst=A&amp;rft.au=Iverson%2C+G&amp;rft.au=McCrory%2C+P&amp;rft_id=%2F%2Fdoi.org%2F10.1136%252Fbjsports-2013-092646&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBelson2015" class="citation web cs1">Belson, Ken (22 April 2015). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2015/04/23/sports/football/nfl-concussion-settlement-is-given-final-approval.html">"Judge Approves Deal in N.F.L. Concussion Suit"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">10 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Judge+Approves+Deal+in+N.F.L.+Concussion+Suit&amp;rft.date=2015-04-22&amp;rft.aulast=Belson&amp;rft.aufirst=Ken&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2015%2F04%2F23%2Fsports%2Ffootball%2Fnfl-concussion-settlement-is-given-final-approval.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2016/03/25/sports/football/kevin-turner-nfl-lawsuit-dies-at-46-als.html">"Kevin Turner, N.F.L. Player Who Later Fought the League, Dies at 46"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. 24 March 2016. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160328090550/http://www.nytimes.com/2016/03/25/sports/football/kevin-turner-nfl-lawsuit-dies-at-46-als.html">Archived</a> from the original on 28 March 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">27 March</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Kevin+Turner%2C+N.F.L.+Player+Who+Later+Fought+the+League%2C+Dies+at+46&amp;rft.date=2016-03-24&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2016%2F03%2F25%2Fsports%2Ffootball%2Fkevin-turner-nfl-lawsuit-dies-at-46-als.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFArmon2009" class="citation journal cs1">Armon C (November 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2788806">"Smoking may be considered an established risk factor for sporadic ALS"</a>. <i>Neurology</i>. <b>73</b> (20): 1693–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0b013e3181c1df48">10.1212/WNL.0b013e3181c1df48</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2788806">2788806</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19917993">19917993</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Smoking+may+be+considered+an+established+risk+factor+for+sporadic+ALS&amp;rft.volume=73&amp;rft.issue=20&amp;rft.pages=1693-8&amp;rft.date=2009-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2788806%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19917993&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0b013e3181c1df48&amp;rft.aulast=Armon&amp;rft.aufirst=C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2788806&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFAlonsoLogroscinoHernán2010" class="citation journal cs1">Alonso A, Logroscino G, Hernán MA (November 2010). <a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp.2009.180232">"Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>81</b> (11): 1249–52. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp.2009.180232">10.1136/jnnp.2009.180232</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20639382">20639382</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:2079442">2079442</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Smoking+and+the+risk+of+amyotrophic+lateral+sclerosis%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=81&amp;rft.issue=11&amp;rft.pages=1249-52&amp;rft.date=2010-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A2079442%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20639382&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.2009.180232&amp;rft.aulast=Alonso&amp;rft.aufirst=A&amp;rft.au=Logroscino%2C+G&amp;rft.au=Hern%C3%A1n%2C+MA&amp;rft_id=%2F%2Fdoi.org%2F10.1136%252Fjnnp.2009.180232&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFWangO&#39;ReillyWeisskopfLogroscino2011" class="citation journal cs1">Wang H, O'Reilly ÉJ, Weisskopf MG, Logroscino G, McCullough ML, Thun MJ, Schatzkin A, Kolonel LN, Ascherio A (February 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3319086">"Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts"</a>. <i>Archives of Neurology</i>. <b>68</b> (2): 207–13. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchneurol.2010.367">10.1001/archneurol.2010.367</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3319086">3319086</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21320987">21320987</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Neurology&amp;rft.atitle=Smoking+and+risk+of+amyotrophic+lateral+sclerosis%3A+a+pooled+analysis+of+5+prospective+cohorts&amp;rft.volume=68&amp;rft.issue=2&amp;rft.pages=207-13&amp;rft.date=2011-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3319086%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21320987&amp;rft_id=info%3Adoi%2F10.1001%2Farchneurol.2010.367&amp;rft.aulast=Wang&amp;rft.aufirst=H&amp;rft.au=O%27Reilly%2C+%C3%89J&amp;rft.au=Weisskopf%2C+MG&amp;rft.au=Logroscino%2C+G&amp;rft.au=McCullough%2C+ML&amp;rft.au=Thun%2C+MJ&amp;rft.au=Schatzkin%2C+A&amp;rft.au=Kolonel%2C+LN&amp;rft.au=Ascherio%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3319086&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFRobberechtPhilips2013" class="citation journal cs1">Robberecht W, Philips T (April 2013). "The changing scene of amyotrophic lateral sclerosis". <i>Nature Reviews. Neuroscience</i>. <b>14</b> (4): 248–64. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrn3430">10.1038/nrn3430</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23463272">23463272</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:208941">208941</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neuroscience&amp;rft.atitle=The+changing+scene+of+amyotrophic+lateral+sclerosis&amp;rft.volume=14&amp;rft.issue=4&amp;rft.pages=248-64&amp;rft.date=2013-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A208941%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23463272&amp;rft_id=info%3Adoi%2F10.1038%2Fnrn3430&amp;rft.aulast=Robberecht&amp;rft.aufirst=W&amp;rft.au=Philips%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Okamoto-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-Okamoto_88-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFOkamotoMizuno2008" class="citation journal cs1">Okamoto K, Mizuno Y (April 2008). "Bunina bodies in amyotrophic lateral sclerosis". <i>Neuropathology</i>. <b>28</b> (2): 109–15. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1440-1789.2007.00873.x">10.1111/j.1440-1789.2007.00873.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18069968">18069968</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34398467">34398467</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropathology&amp;rft.atitle=Bunina+bodies+in+amyotrophic+lateral+sclerosis&amp;rft.volume=28&amp;rft.issue=2&amp;rft.pages=109-15&amp;rft.date=2008-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34398467%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18069968&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1440-1789.2007.00873.x&amp;rft.aulast=Okamoto&amp;rft.aufirst=K&amp;rft.au=Mizuno%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-White-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-White_89-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFWhiteBanerjeeGunawardena2016" class="citation journal cs1">White JA, Banerjee R, Gunawardena S (19 May 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4882576">"Axonal Transport and Neurodegeneration: How Marine Drugs Can Be Used for the Development of Therapeutics"</a>. <i>Marine Drugs</i>. <b>14</b> (5): 102. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fmd14050102">10.3390/md14050102</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4882576">4882576</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27213408">27213408</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Marine+Drugs&amp;rft.atitle=Axonal+Transport+and+Neurodegeneration%3A+How+Marine+Drugs+Can+Be+Used+for+the+Development+of+Therapeutics&amp;rft.volume=14&amp;rft.issue=5&amp;rft.pages=102&amp;rft.date=2016-05-19&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4882576%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27213408&amp;rft_id=info%3Adoi%2F10.3390%2Fmd14050102&amp;rft.aulast=White&amp;rft.aufirst=JA&amp;rft.au=Banerjee%2C+R&amp;rft.au=Gunawardena%2C+S&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4882576&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFNg_Kee_KwongMehtaNedergaardChandran2020" class="citation journal cs1">Ng Kee Kwong, Koy Chong; Mehta, Arpan R.; Nedergaard, Maiken; Chandran, Siddharthan (20 August 2020). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7439665">"Defining novel functions for cerebrospinal fluid in ALS pathophysiology"</a>. <i>Acta Neuropathologica Communications</i>. <b>8</b> (1): 140. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs40478-020-01018-0">10.1186/s40478-020-01018-0</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/2051-5960">2051-5960</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7439665">7439665</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/32819425">32819425</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Neuropathologica+Communications&amp;rft.atitle=Defining+novel+functions+for+cerebrospinal+fluid+in+ALS+pathophysiology&amp;rft.volume=8&amp;rft.issue=1&amp;rft.pages=140&amp;rft.date=2020-08-20&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7439665%23id-name%3DPMC&amp;rft.issn=2051-5960&amp;rft_id=info%3Apmid%2F32819425&amp;rft_id=info%3Adoi%2F10.1186%2Fs40478-020-01018-0&amp;rft.aulast=Ng+Kee+Kwong&amp;rft.aufirst=Koy+Chong&amp;rft.au=Mehta%2C+Arpan+R.&amp;rft.au=Nedergaard%2C+Maiken&amp;rft.au=Chandran%2C+Siddharthan&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7439665&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Modelling_ALS-91"><span class="mw-cite-backlink">^ <a href="#cite_ref-Modelling_ALS_91-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Modelling_ALS_91-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Modelling_ALS_91-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Modelling_ALS_91-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Modelling_ALS_91-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFPhilip_Van_DammeRobberechtVan_Den_Bosch2017" class="citation journal cs1">Philip Van Damme P, Robberecht W, Van Den Bosch L (May 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5451175">"Modelling amyotrophic lateral sclerosis: progress and possibilities"</a>. <i>Disease Models and Mechanisms</i>. <b>10</b> (5): 537–49. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1242%2Fdmm.029058">10.1242/dmm.029058</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5451175">5451175</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28468939">28468939</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Disease+Models+and+Mechanisms&amp;rft.atitle=Modelling+amyotrophic+lateral+sclerosis%3A+progress+and+possibilities&amp;rft.volume=10&amp;rft.issue=5&amp;rft.pages=537-49&amp;rft.date=2017-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5451175%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28468939&amp;rft_id=info%3Adoi%2F10.1242%2Fdmm.029058&amp;rft.aulast=Philip+Van+Damme&amp;rft.aufirst=P&amp;rft.au=Robberecht%2C+W&amp;rft.au=Van+Den+Bosch%2C+L&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5451175&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-link.springer.com-92"><span class="mw-cite-backlink">^ <a href="#cite_ref-link.springer.com_92-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-link.springer.com_92-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFMehtaGregoryDandoCarter2021" class="citation journal cs1">Mehta, Arpan R.; Gregory, Jenna M.; Dando, Owen; Carter, Roderick N.; Burr, Karen; Nanda, Jyoti; Story, David; McDade, Karina; Smith, Colin; Morton, Nicholas M.; Mahad, Don J. (4 January 2021). <a rel="nofollow" class="external text" href="http://link.springer.com/10.1007/s00401-020-02252-5">"Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis"</a>. <i>Acta Neuropathologica</i>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00401-020-02252-5">10.1007/s00401-020-02252-5</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0001-6322">0001-6322</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/33398403">33398403</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Neuropathologica&amp;rft.atitle=Mitochondrial+bioenergetic+deficits+in+C9orf72+amyotrophic+lateral+sclerosis+motor+neurons+cause+dysfunctional+axonal+homeostasis&amp;rft.date=2021-01-04&amp;rft.issn=0001-6322&amp;rft_id=info%3Apmid%2F33398403&amp;rft_id=info%3Adoi%2F10.1007%2Fs00401-020-02252-5&amp;rft.aulast=Mehta&amp;rft.aufirst=Arpan+R.&amp;rft.au=Gregory%2C+Jenna+M.&amp;rft.au=Dando%2C+Owen&amp;rft.au=Carter%2C+Roderick+N.&amp;rft.au=Burr%2C+Karen&amp;rft.au=Nanda%2C+Jyoti&amp;rft.au=Story%2C+David&amp;rft.au=McDade%2C+Karina&amp;rft.au=Smith%2C+Colin&amp;rft.au=Morton%2C+Nicholas+M.&amp;rft.au=Mahad%2C+Don+J.&amp;rft_id=http%3A%2F%2Flink.springer.com%2F10.1007%2Fs00401-020-02252-5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFXuHendersonDavidMcCombe2016" class="citation journal cs1">Xu Z, Henderson RD, David M, McCombe PA (2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5061412">"Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis"</a>. <i>PLOS ONE</i>. <b>11</b> (10): e0164625. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2016PLoSO..1164625X">2016PLoSO..1164625X</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0164625">10.1371/journal.pone.0164625</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5061412">5061412</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27732645">27732645</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=Neurofilaments+as+Biomarkers+for+Amyotrophic+Lateral+Sclerosis%3A+A+Systematic+Review+and+Meta-Analysis&amp;rft.volume=11&amp;rft.issue=10&amp;rft.pages=e0164625&amp;rft.date=2016&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5061412%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27732645&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0164625&amp;rft_id=info%3Abibcode%2F2016PLoSO..1164625X&amp;rft.aulast=Xu&amp;rft.aufirst=Z&amp;rft.au=Henderson%2C+RD&amp;rft.au=David%2C+M&amp;rft.au=McCombe%2C+PA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5061412&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-94">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFVuBowser2017" class="citation journal cs1">Vu LT, Bowser R (January 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5233638">"Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis"</a>. <i>Neurotherapeutics</i>. <b>14</b> (1): 119–134. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs13311-016-0503-x">10.1007/s13311-016-0503-x</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5233638">5233638</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27933485">27933485</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurotherapeutics&amp;rft.atitle=Fluid-Based+Biomarkers+for+Amyotrophic+Lateral+Sclerosis&amp;rft.volume=14&amp;rft.issue=1&amp;rft.pages=119-134&amp;rft.date=2017-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5233638%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27933485&amp;rft_id=info%3Adoi%2F10.1007%2Fs13311-016-0503-x&amp;rft.aulast=Vu&amp;rft.aufirst=LT&amp;rft.au=Bowser%2C+R&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5233638&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Awaji_Criteria_2008-95"><span class="mw-cite-backlink">^ <a href="#cite_ref-Awaji_Criteria_2008_95-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Awaji_Criteria_2008_95-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFde_CarvalhoDenglerEisenEngland2008" class="citation journal cs1">de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J,  et&#160;al. (March 2008). "Electrodiagnostic criteria for diagnosis of ALS". <i>Clinical Neurophysiology</i>. <b>119</b> (3): 497–503. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clinph.2007.09.143">10.1016/j.clinph.2007.09.143</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18164242">18164242</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:14851649">14851649</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Neurophysiology&amp;rft.atitle=Electrodiagnostic+criteria+for+diagnosis+of+ALS&amp;rft.volume=119&amp;rft.issue=3&amp;rft.pages=497-503&amp;rft.date=2008-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A14851649%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18164242&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clinph.2007.09.143&amp;rft.aulast=de+Carvalho&amp;rft.aufirst=M&amp;rft.au=Dengler%2C+R&amp;rft.au=Eisen%2C+A&amp;rft.au=England%2C+JD&amp;rft.au=Kaji%2C+R&amp;rft.au=Kimura%2C+J&amp;rft.au=Mills%2C+K&amp;rft.au=Mitsumoto%2C+H&amp;rft.au=Nodera%2C+H&amp;rft.au=Shefner%2C+J&amp;rft.au=Swash%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFCostaSwashde_Carvalho2012" class="citation journal cs1">Costa J, Swash M, de Carvalho M (November 2012). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchneurol.2012.254">"Awaji Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis: A Systematic Review"</a>. <i>Archives of Neurology</i>. <b>69</b> (11): 1410–1416. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchneurol.2012.254">10.1001/archneurol.2012.254</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22892641">22892641</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Neurology&amp;rft.atitle=Awaji+Criteria+for+the+Diagnosis+of+Amyotrophic+Lateral+Sclerosis%3A+A+Systematic+Review&amp;rft.volume=69&amp;rft.issue=11&amp;rft.pages=1410-1416&amp;rft.date=2012-11&amp;rft_id=info%3Adoi%2F10.1001%2Farchneurol.2012.254&amp;rft_id=info%3Apmid%2F22892641&amp;rft.aulast=Costa&amp;rft.aufirst=J&amp;rft.au=Swash%2C+M&amp;rft.au=de+Carvalho%2C+M&amp;rft_id=%2F%2Fdoi.org%2F10.1001%252Farchneurol.2012.254&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-97">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBelsh2000" class="citation journal cs1">Belsh JM (March 2000). "ALS diagnostic criteria of El Escorial Revisited: do they meet the needs of clinicians as well as researchers?". <i>Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders</i>. <b>1</b> (Supplement 1): S57–S60. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F14660820052415925">10.1080/14660820052415925</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11464928">11464928</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:6828235">6828235</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis+and+Other+Motor+Neuron+Disorders&amp;rft.atitle=ALS+diagnostic+criteria+of+El+Escorial+Revisited%3A+do+they+meet+the+needs+of+clinicians+as+well+as+researchers%3F&amp;rft.volume=1&amp;rft.issue=Supplement+1&amp;rft.pages=S57-S60&amp;rft.date=2000-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A6828235%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11464928&amp;rft_id=info%3Adoi%2F10.1080%2F14660820052415925&amp;rft.aulast=Belsh&amp;rft.aufirst=JM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFSilaniMessinaPolettiMorelli2011" class="citation journal cs1">Silani V, Messina S, Poletti B, Morelli C, Doretti A, Ticozzi N, Maderna L (March 2011). "The diagnosis of Amyotrophic lateral sclerosis in 2010". <i>Archives Italiennes de Biologie</i>. <b>149</b> (1): 5–27. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4449%2Faib.v149i1.1260">10.4449/aib.v149i1.1260</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21412713">21412713</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+Italiennes+de+Biologie&amp;rft.atitle=The+diagnosis+of+Amyotrophic+lateral+sclerosis+in+2010&amp;rft.volume=149&amp;rft.issue=1&amp;rft.pages=5-27&amp;rft.date=2011-03&amp;rft_id=info%3Adoi%2F10.4449%2Faib.v149i1.1260&amp;rft_id=info%3Apmid%2F21412713&amp;rft.aulast=Silani&amp;rft.aufirst=V&amp;rft.au=Messina%2C+S&amp;rft.au=Poletti%2C+B&amp;rft.au=Morelli%2C+C&amp;rft.au=Doretti%2C+A&amp;rft.au=Ticozzi%2C+N&amp;rft.au=Maderna%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-99">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://misc.medscape.com/pi/android/medscapeapp/html/A1170810-business.html">"Lambert-Eaton Myasthenic Syndrome (LEMS)"</a>. Misc.medscape.com. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130514014534/http://misc.medscape.com/pi/android/medscapeapp/html/A1170810-business.html">Archived</a> from the original on 14 May 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">18 April</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lambert-Eaton+Myasthenic+Syndrome+%28LEMS%29&amp;rft.pub=Misc.medscape.com&amp;rft_id=http%3A%2F%2Fmisc.medscape.com%2Fpi%2Fandroid%2Fmedscapeapp%2Fhtml%2FA1170810-business.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.lems.com/what_is_lems">"LEMS.com, Lambert-Eaton Myasthenic Syndrome: About"</a>. Lems.com. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130120025113/http://www.lems.com/what_is_lems">Archived</a> from the original on 20 January 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">18 April</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=LEMS.com%2C+Lambert-Eaton+Myasthenic+Syndrome%3A+About&amp;rft.pub=Lems.com&amp;rft_id=http%3A%2F%2Fwww.lems.com%2Fwhat_is_lems&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFMills2010" class="citation journal cs1">Mills KR (November 2010). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbrain%2Fawq290">"Characteristics of fasciculations in amyotrophic lateral sclerosis and the benign fasciculation syndrome"</a>. <i>Brain</i>. <b>133</b> (11): 3458–69. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbrain%2Fawq290">10.1093/brain/awq290</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20959307">20959307</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain&amp;rft.atitle=Characteristics+of+fasciculations+in+amyotrophic+lateral+sclerosis+and+the+benign+fasciculation+syndrome&amp;rft.volume=133&amp;rft.issue=11&amp;rft.pages=3458-69&amp;rft.date=2010-11&amp;rft_id=info%3Adoi%2F10.1093%2Fbrain%2Fawq290&amp;rft_id=info%3Apmid%2F20959307&amp;rft.aulast=Mills&amp;rft.aufirst=KR&amp;rft_id=%2F%2Fdoi.org%2F10.1093%252Fbrain%252Fawq290&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFEisen2002" class="citation journal cs1">Eisen A (2002). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130621222218/http://www.bcmj.org/article/amyotrophic-lateral-sclerosis-review">"Amyotrophic lateral sclerosis: A review"</a>. <i>BCMJ</i>. <b>44</b> (7): 362–366. Archived from <a rel="nofollow" class="external text" href="http://www.bcmj.org/article/amyotrophic-lateral-sclerosis-review">the original</a> on 21 June 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">21 August</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BCMJ&amp;rft.atitle=Amyotrophic+lateral+sclerosis%3A+A+review&amp;rft.volume=44&amp;rft.issue=7&amp;rft.pages=362-366&amp;rft.date=2002&amp;rft.aulast=Eisen&amp;rft.aufirst=A&amp;rft_id=http%3A%2F%2Fwww.bcmj.org%2Farticle%2Famyotrophic-lateral-sclerosis-review&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid8708642-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8708642_103-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFDavenportSwinglerChancellorWarlow1996" class="citation journal cs1">Davenport RJ, Swingler RJ, Chancellor AM, Warlow CP (February 1996). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1073793">"Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>60</b> (2): 147–51. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp.60.2.147">10.1136/jnnp.60.2.147</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1073793">1073793</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/8708642">8708642</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Avoiding+false+positive+diagnoses+of+motor+neuron+disease%3A+lessons+from+the+Scottish+Motor+Neuron+Disease+Register&amp;rft.volume=60&amp;rft.issue=2&amp;rft.pages=147-51&amp;rft.date=1996-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1073793%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F8708642&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.60.2.147&amp;rft.aulast=Davenport&amp;rft.aufirst=RJ&amp;rft.au=Swingler%2C+RJ&amp;rft.au=Chancellor%2C+AM&amp;rft.au=Warlow%2C+CP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1073793&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-104">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFChieiaOliveiraSilvaGabbai2010" class="citation journal cs1">Chieia MA, Oliveira AS, Silva HC, Gabbai AA (December 2010). <a rel="nofollow" class="external text" href="https://doi.org/10.1590%2FS0004-282X2010000600002">"Amyotrophic lateral sclerosis: considerations on diagnostic criteria"</a>. <i>Arquivos de Neuro-Psiquiatria</i>. <b>68</b> (6): 837–42. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1590%2FS0004-282X2010000600002">10.1590/S0004-282X2010000600002</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21243238">21243238</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arquivos+de+Neuro-Psiquiatria&amp;rft.atitle=Amyotrophic+lateral+sclerosis%3A+considerations+on+diagnostic+criteria&amp;rft.volume=68&amp;rft.issue=6&amp;rft.pages=837-42&amp;rft.date=2010-12&amp;rft_id=info%3Adoi%2F10.1590%2FS0004-282X2010000600002&amp;rft_id=info%3Apmid%2F21243238&amp;rft.aulast=Chieia&amp;rft.aufirst=MA&amp;rft.au=Oliveira%2C+AS&amp;rft.au=Silva%2C+HC&amp;rft.au=Gabbai%2C+AA&amp;rft_id=%2F%2Fdoi.org%2F10.1590%252FS0004-282X2010000600002&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-105">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFAl-AsmiNandhagopalJacobGujjar2012" class="citation journal cs1">Al-Asmi A, Nandhagopal R, Jacob PC, Gujjar A (February 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3286704">"Misdiagnosis of Myasthenia Gravis and Subsequent Clinical Implication: A case report and review of literature"</a>. <i>Sultan Qaboos University Medical Journal</i>. <b>12</b> (1): 103–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.12816%2F0003095">10.12816/0003095</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3286704">3286704</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22375266">22375266</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Sultan+Qaboos+University+Medical+Journal&amp;rft.atitle=Misdiagnosis+of+Myasthenia+Gravis+and+Subsequent+Clinical+Implication%3A+A+case+report+and+review+of+literature&amp;rft.volume=12&amp;rft.issue=1&amp;rft.pages=103-8&amp;rft.date=2012-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3286704%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22375266&amp;rft_id=info%3Adoi%2F10.12816%2F0003095&amp;rft.aulast=Al-Asmi&amp;rft.aufirst=A&amp;rft.au=Nandhagopal%2C+R&amp;rft.au=Jacob%2C+PC&amp;rft.au=Gujjar%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3286704&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Edaravone_Trial-106"><span class="mw-cite-backlink">^ <a href="#cite_ref-Edaravone_Trial_106-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Edaravone_Trial_106-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Edaravone_Trial_106-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFAbeMasashiTsujiItoyama2017" class="citation journal cs1">Abe K, Masashi A, Tsuji S, Itoyama Y, Sobue G, Togo M,  et&#160;al. (July 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2817%2930115-1">"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial"</a>. <i>The Lancet. Neurology</i>. <b>16</b> (7): 505–12. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2817%2930115-1">10.1016/S1474-4422(17)30115-1</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28522181">28522181</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Safety+and+efficacy+of+edaravone+in+well+defined+patients+with+amyotrophic+lateral+sclerosis%3A+a+randomised%2C+double-blind%2C+placebo-controlled+trial.&amp;rft.volume=16&amp;rft.issue=7&amp;rft.pages=505-12&amp;rft.date=2017-07&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2817%2930115-1&amp;rft_id=info%3Apmid%2F28522181&amp;rft.aulast=Abe&amp;rft.aufirst=K&amp;rft.au=Masashi%2C+A&amp;rft.au=Tsuji%2C+S&amp;rft.au=Itoyama%2C+Y&amp;rft.au=Sobue%2C+G&amp;rft.au=Togo%2C+M&amp;rft.au=Hamada%2C+C&amp;rft.au=Tanaka%2C+M&amp;rft.au=Akimoto%2C+M&amp;rft.au=Nakamura%2C+K&amp;rft.au=Takahashi%2C+F&amp;rft.au=Kondo%2C+K&amp;rft.au=Yoshino%2C+H&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252FS1474-4422%252817%252930115-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Eda2018-107"><span class="mw-cite-backlink">^ <a href="#cite_ref-Eda2018_107-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Eda2018_107-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Eda2018_107-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFYeoSimmons2018" class="citation journal cs1">Yeo CJ, Simmons Z (May 2018). "Discussing edaravone with the ALS patient: an ethical framework from a U.S. perspective". <i>Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration</i>. <b>19</b> (3–4): 167–72. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F21678421.2018.1425455">10.1080/21678421.2018.1425455</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29334251">29334251</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4627647">4627647</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis+and+Frontotemporal+Degeneration&amp;rft.atitle=Discussing+edaravone+with+the+ALS+patient%3A+an+ethical+framework+from+a+U.S.+perspective&amp;rft.volume=19&amp;rft.issue=3%E2%80%934&amp;rft.pages=167-72&amp;rft.date=2018-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4627647%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29334251&amp;rft_id=info%3Adoi%2F10.1080%2F21678421.2018.1425455&amp;rft.aulast=Yeo&amp;rft.aufirst=CJ&amp;rft.au=Simmons%2C+Z&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-British_Medical_Bulletin-108"><span class="mw-cite-backlink">^ <a href="#cite_ref-British_Medical_Bulletin_108-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-British_Medical_Bulletin_108-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-British_Medical_Bulletin_108-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-British_Medical_Bulletin_108-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFOrrell2010" class="citation journal cs1">Orrell RW (2010). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbmb%2Fldp049">"Motor neuron disease: systematic reviews of treatment for ALS and SMA"</a>. <i>British Medical Bulletin</i>. <b>93</b>: 145–59. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbmb%2Fldp049">10.1093/bmb/ldp049</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20015852">20015852</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Medical+Bulletin&amp;rft.atitle=Motor+neuron+disease%3A+systematic+reviews+of+treatment+for+ALS+and+SMA&amp;rft.volume=93&amp;rft.pages=145-59&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1093%2Fbmb%2Fldp049&amp;rft_id=info%3Apmid%2F20015852&amp;rft.aulast=Orrell&amp;rft.aufirst=RW&amp;rft_id=%2F%2Fdoi.org%2F10.1093%252Fbmb%252Fldp049&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Cochrane_NIV-109"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cochrane_NIV_109-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cochrane_NIV_109-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFRadunovicAnnaneRafiqBrassington2017" class="citation journal cs1">Radunovic A, Annane D, Rafiq M, Brassington R, Mustfa N (6 October 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6485636">"Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>10</b> (10): CD004427. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD004427.pub4">10.1002/14651858.CD004427.pub4</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6485636">6485636</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28982219">28982219</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Mechanical+ventilation+for+amyotrophic+lateral+sclerosis%2Fmotor+neuron+disease&amp;rft.volume=10&amp;rft.issue=10&amp;rft.pages=CD004427&amp;rft.date=2017-10-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6485636%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28982219&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004427.pub4&amp;rft.aulast=Radunovic&amp;rft.aufirst=A&amp;rft.au=Annane%2C+D&amp;rft.au=Rafiq%2C+M&amp;rft.au=Brassington%2C+R&amp;rft.au=Mustfa%2C+N&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6485636&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Sleep_Disorders_and_Respiratory_Function-110"><span class="mw-cite-backlink">^ <a href="#cite_ref-Sleep_Disorders_and_Respiratory_Function_110-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sleep_Disorders_and_Respiratory_Function_110-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Sleep_Disorders_and_Respiratory_Function_110-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFAhmedNewcombePiperLewis2016" class="citation journal cs1">Ahmed R, Newcombe R, Piper A, Lewis S, Yee B, Kiernan M, Grunstein R (April 2016). "Sleep disorders and respiratory function in amyotrophic lateral sclerosis". <i>Sleep Medicine Reviews</i>. <b>26</b>: 33–42. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.smrv.2015.05.007">10.1016/j.smrv.2015.05.007</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26166297">26166297</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Sleep+Medicine+Reviews&amp;rft.atitle=Sleep+disorders+and+respiratory+function+in+amyotrophic+lateral+sclerosis&amp;rft.volume=26&amp;rft.pages=33-42&amp;rft.date=2016-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.smrv.2015.05.007&amp;rft_id=info%3Apmid%2F26166297&amp;rft.aulast=Ahmed&amp;rft.aufirst=R&amp;rft.au=Newcombe%2C+R&amp;rft.au=Piper%2C+A&amp;rft.au=Lewis%2C+S&amp;rft.au=Yee%2C+B&amp;rft.au=Kiernan%2C+M&amp;rft.au=Grunstein%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-ALS_Ethics-111"><span class="mw-cite-backlink">^ <a href="#cite_ref-ALS_Ethics_111-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ALS_Ethics_111-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFEisenKrieger2013" class="citation journal cs1">Eisen A, Krieger C (November 2013). "Ethical considerations in the management of amyotrophic lateral sclerosis". <i>Progress in Neurobiology</i>. <b>110</b>: 45–53. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.pneurobio.2013.05.001">10.1016/j.pneurobio.2013.05.001</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23735671">23735671</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:26282198">26282198</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Progress+in+Neurobiology&amp;rft.atitle=Ethical+considerations+in+the+management+of+amyotrophic+lateral+sclerosis&amp;rft.volume=110&amp;rft.pages=45-53&amp;rft.date=2013-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A26282198%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23735671&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pneurobio.2013.05.001&amp;rft.aulast=Eisen&amp;rft.aufirst=A&amp;rft.au=Krieger%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Lewis_&amp;_Rushanan-112"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lewis_&amp;_Rushanan_112-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lewis_&amp;_Rushanan_112-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFLewisRushanan2007" class="citation journal cs1">Lewis M, Rushanan S (2007). "The role of physical therapy and occupational therapy in the treatment of amyotrophic lateral sclerosis". <i>NeuroRehabilitation</i>. <b>22</b> (6): 451–61. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FNRE-2007-22608">10.3233/NRE-2007-22608</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18198431">18198431</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NeuroRehabilitation&amp;rft.atitle=The+role+of+physical+therapy+and+occupational+therapy+in+the+treatment+of+amyotrophic+lateral+sclerosis&amp;rft.volume=22&amp;rft.issue=6&amp;rft.pages=451-61&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.3233%2FNRE-2007-22608&amp;rft_id=info%3Apmid%2F18198431&amp;rft.aulast=Lewis&amp;rft.aufirst=M&amp;rft.au=Rushanan%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-asha-113"><span class="mw-cite-backlink">^ <a href="#cite_ref-asha_113-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-asha_113-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-asha_113-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-asha_113-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-asha_113-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120802064043/http://www.asha.org/public/speech/disorders/ALS/">"Amyotrophic Lateral Sclerosis (ALS)"</a>. American Speech-Language-Hearing Association, Rockville, MD. Archived from <a rel="nofollow" class="external text" href="http://www.asha.org/public/speech/disorders/ALS/">the original</a> on 2 August 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">30 November</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amyotrophic+Lateral+Sclerosis+%28ALS%29&amp;rft.pub=American+Speech-Language-Hearing+Association%2C+Rockville%2C+MD&amp;rft_id=http%3A%2F%2Fwww.asha.org%2Fpublic%2Fspeech%2Fdisorders%2FALS%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-ajop-114"><span class="mw-cite-backlink">^ <a href="#cite_ref-ajop_114-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ajop_114-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-ajop_114-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFArbesmanSheard2014" class="citation journal cs1">Arbesman M, Sheard K (2014). <a rel="nofollow" class="external text" href="https://doi.org/10.5014%2Fajot.2014.008649">"Systematic review of the effectiveness of occupational therapy-related interventions for people with amyotrophic lateral sclerosis"</a>. <i>The American Journal of Occupational Therapy</i>. <b>68</b> (1): 20–26. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.5014%2Fajot.2014.008649">10.5014/ajot.2014.008649</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24367951">24367951</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Occupational+Therapy&amp;rft.atitle=Systematic+review+of+the+effectiveness+of+occupational+therapy-related+interventions+for+people+with+amyotrophic+lateral+sclerosis&amp;rft.volume=68&amp;rft.issue=1&amp;rft.pages=20-26&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.5014%2Fajot.2014.008649&amp;rft_id=info%3Apmid%2F24367951&amp;rft.aulast=Arbesman&amp;rft.aufirst=M&amp;rft.au=Sheard%2C+K&amp;rft_id=%2F%2Fdoi.org%2F10.5014%252Fajot.2014.008649&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Cochrane_Tube_Feeding-115"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cochrane_Tube_Feeding_115-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cochrane_Tube_Feeding_115-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFKatzbergBenatar2011" class="citation journal cs1">Katzberg HD, Benatar M (January 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7163276">"Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease"</a>. <i>The Cochrane Database of Systematic Reviews</i> (1): CD004030. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD004030.pub3">10.1002/14651858.CD004030.pub3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7163276">7163276</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21249659">21249659</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Enteral+tube+feeding+for+amyotrophic+lateral+sclerosis%2Fmotor+neuron+disease&amp;rft.issue=1&amp;rft.pages=CD004030&amp;rft.date=2011-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7163276%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21249659&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004030.pub3&amp;rft.aulast=Katzberg&amp;rft.aufirst=HD&amp;rft.au=Benatar%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7163276&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-EFNS_2012-116"><span class="mw-cite-backlink">^ <a href="#cite_ref-EFNS_2012_116-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-EFNS_2012_116-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-EFNS_2012_116-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFAndersenAbrahamsBorasiode_Carvalho2012" class="citation journal cs1">Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P,  et&#160;al. (March 2012). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1468-1331.2011.03501.x">"EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force"</a>. <i>European Journal of Neurology</i>. <b>19</b> (3): 360–75. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1468-1331.2011.03501.x">10.1111/j.1468-1331.2011.03501.x</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21914052">21914052</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:5746940">5746940</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Neurology&amp;rft.atitle=EFNS+guidelines+on+the+Clinical+Management+of+Amyotrophic+Lateral+Sclerosis+%28MALS%29+%E2%80%93+revised+report+of+an+EFNS+task+force&amp;rft.volume=19&amp;rft.issue=3&amp;rft.pages=360-75&amp;rft.date=2012-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5746940%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21914052&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1468-1331.2011.03501.x&amp;rft.aulast=Andersen&amp;rft.aufirst=PM&amp;rft.au=Abrahams%2C+S&amp;rft.au=Borasio%2C+GD&amp;rft.au=de+Carvalho%2C+M&amp;rft.au=Chio%2C+A&amp;rft.au=Van+Damme%2C+P&amp;rft.au=Hardiman%2C+O&amp;rft.au=Kollewe%2C+K&amp;rft.au=Morrison%2C+KE&amp;rft.au=Petri%2C+S&amp;rft.au=Pradat%2C+PF&amp;rft.au=Silani%2C+V&amp;rft.au=Tomik%2C+B&amp;rft.au=Wasner%2C+M&amp;rft.au=Weber%2C+M&amp;rft_id=%2F%2Fdoi.org%2F10.1111%252Fj.1468-1331.2011.03501.x&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFCarlesiPasqualiPiazzaLo_Gerfo2011" class="citation journal cs1">Carlesi C, Pasquali L, Piazza S, Lo Gerfo A, Caldarazzo Ienco E, Alessi R, Fornai F, Siciliano G (March 2011). "Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis". <i>Archives Italiennes de Biologie</i>. <b>149</b> (1): 151–67. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4449%2Faib.v149i1.1267">10.4449/aib.v149i1.1267</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21412722">21412722</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+Italiennes+de+Biologie&amp;rft.atitle=Strategies+for+clinical+approach+to+neurodegeneration+in+Amyotrophic+lateral+sclerosis&amp;rft.volume=149&amp;rft.issue=1&amp;rft.pages=151-67&amp;rft.date=2011-03&amp;rft_id=info%3Adoi%2F10.4449%2Faib.v149i1.1267&amp;rft_id=info%3Apmid%2F21412722&amp;rft.aulast=Carlesi&amp;rft.aufirst=C&amp;rft.au=Pasquali%2C+L&amp;rft.au=Piazza%2C+S&amp;rft.au=Lo+Gerfo%2C+A&amp;rft.au=Caldarazzo+Ienco%2C+E&amp;rft.au=Alessi%2C+R&amp;rft.au=Fornai%2C+F&amp;rft.au=Siciliano%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFHardimanvan_den_Berg2017" class="citation journal cs1">Hardiman O, van den Berg LH (July 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2817%2930163-1">"Edaravone: a new treatment for ALS on the horizon?"</a>. <i>The Lancet. Neurology</i>. <b>16</b> (7): 490–91. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2817%2930163-1">10.1016/S1474-4422(17)30163-1</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28522180">28522180</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:7609862">7609862</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Edaravone%3A+a+new+treatment+for+ALS+on+the+horizon%3F&amp;rft.volume=16&amp;rft.issue=7&amp;rft.pages=490-91&amp;rft.date=2017-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7609862%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28522180&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2817%2930163-1&amp;rft.aulast=Hardiman&amp;rft.aufirst=O&amp;rft.au=van+den+Berg%2C+LH&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252FS1474-4422%252817%252930163-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Therapeutic_Advances_in_Neurological_Disorders-121"><span class="mw-cite-backlink">^ <a href="#cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Therapeutic_Advances_in_Neurological_Disorders_121-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFDorstLudolphHuebers2018" class="citation journal cs1">Dorst J, Ludolph A, Huebers A (2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5784546">"Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis"</a>. <i>Therapeutic Advances in Neurological Disorders</i>. <b>11</b>: 1756285617734734. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1756285617734734">10.1177/1756285617734734</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5784546">5784546</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29399045">29399045</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Therapeutic+Advances+in+Neurological+Disorders&amp;rft.atitle=Disease-modifying+and+symptomatic+treatment+of+amyotrophic+lateral+sclerosis&amp;rft.volume=11&amp;rft.pages=1756285617734734&amp;rft.date=2018&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5784546%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29399045&amp;rft_id=info%3Adoi%2F10.1177%2F1756285617734734&amp;rft.aulast=Dorst&amp;rft.aufirst=J&amp;rft.au=Ludolph%2C+A&amp;rft.au=Huebers%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5784546&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Edaravone&#39;s_Clinical_Development-122"><span class="mw-cite-backlink">^ <a href="#cite_ref-Edaravone&#39;s_Clinical_Development_122-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Edaravone&#39;s_Clinical_Development_122-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFTakeiWatanabeYukiAkimoto2017" class="citation journal cs1">Takei K, Watanabe K, Yuki S, Akimoto M, Sakata T, Palumbo J (October 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F21678421.2017.1353101">"Edaravone and its clinical development for amyotrophic lateral sclerosis"</a>. <i>Amyotrophic Lateral Sclerosis</i>. <b>18</b> (sup 1): 5–10. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F21678421.2017.1353101">10.1080/21678421.2017.1353101</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28872907">28872907</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis&amp;rft.atitle=Edaravone+and+its+clinical+development+for+amyotrophic+lateral+sclerosis&amp;rft.volume=18&amp;rft.issue=sup+1&amp;rft.pages=5-10&amp;rft.date=2017-10&amp;rft_id=info%3Adoi%2F10.1080%2F21678421.2017.1353101&amp;rft_id=info%3Apmid%2F28872907&amp;rft.aulast=Takei&amp;rft.aufirst=K&amp;rft.au=Watanabe%2C+K&amp;rft.au=Yuki%2C+S&amp;rft.au=Akimoto%2C+M&amp;rft.au=Sakata%2C+T&amp;rft.au=Palumbo%2C+J&amp;rft_id=%2F%2Fdoi.org%2F10.1080%252F21678421.2017.1353101&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-123">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFPaganoniHendrixDicksonKnowlton2020" class="citation journal cs1">Paganoni, Sabrina; Hendrix, Suzanne; Dickson, Samuel P.; Knowlton, Newman; Macklin, Eric A.; Berry, James D.; Elliott, Michael A.; Maiser, Samuel; Karam, Chafic; Caress, James B.; Owegi, Margaret Ayo (2020). <a rel="nofollow" class="external text" href="https://onlinelibrary.wiley.com/doi/abs/10.1002/mus.27091">"Long-Term Survival of Participants in the CENTAUR Trial of Sodium Phenylbutyrate-Taurursodiol in ALS"</a>. <i>Muscle &amp; Nerve</i>. <b>n/a</b> (n/a): 31–39. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmus.27091">10.1002/mus.27091</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1097-4598">1097-4598</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/33063909">33063909</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Muscle+%26+Nerve&amp;rft.atitle=Long-Term+Survival+of+Participants+in+the+CENTAUR+Trial+of+Sodium+Phenylbutyrate-Taurursodiol+in+ALS&amp;rft.volume=n%2Fa&amp;rft.issue=n%2Fa&amp;rft.pages=31-39&amp;rft.date=2020&amp;rft.issn=1097-4598&amp;rft_id=info%3Apmid%2F33063909&amp;rft_id=info%3Adoi%2F10.1002%2Fmus.27091&amp;rft.aulast=Paganoni&amp;rft.aufirst=Sabrina&amp;rft.au=Hendrix%2C+Suzanne&amp;rft.au=Dickson%2C+Samuel+P.&amp;rft.au=Knowlton%2C+Newman&amp;rft.au=Macklin%2C+Eric+A.&amp;rft.au=Berry%2C+James+D.&amp;rft.au=Elliott%2C+Michael+A.&amp;rft.au=Maiser%2C+Samuel&amp;rft.au=Karam%2C+Chafic&amp;rft.au=Caress%2C+James+B.&amp;rft.au=Owegi%2C+Margaret+Ayo&amp;rft_id=https%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2Fabs%2F10.1002%2Fmus.27091&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-124">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBelluck" class="citation web cs1">Belluck, Pam. <a rel="nofollow" class="external text" href="https://www.chicagotribune.com/lifestyles/health/health-fitness/sns-nyt-als-treatment-20201018-uprze73apzcm3pkyinxpyzfgw4-story.html">"Drug may extend ALS patients' lives by several months, study finds"</a>. <i>chicagotribune.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">23 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=chicagotribune.com&amp;rft.atitle=Drug+may+extend+ALS+patients%27+lives+by+several+months%2C+study+finds&amp;rft.aulast=Belluck&amp;rft.aufirst=Pam&amp;rft_id=https%3A%2F%2Fwww.chicagotribune.com%2Flifestyles%2Fhealth%2Fhealth-fitness%2Fsns-nyt-als-treatment-20201018-uprze73apzcm3pkyinxpyzfgw4-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-NeuroRehabilitation_2015-125"><span class="mw-cite-backlink">^ <a href="#cite_ref-NeuroRehabilitation_2015_125-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NeuroRehabilitation_2015_125-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFPaganoniKaramJoyceBedlack2015" class="citation journal cs1">Paganoni S, Karam C, Joyce N, Bedlack R, Carter G (2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5223769">"Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis"</a>. <i>NeuroRehabilitation</i>. <b>37</b> (1): 53–68. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FNRE-151240">10.3233/NRE-151240</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5223769">5223769</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26409693">26409693</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NeuroRehabilitation&amp;rft.atitle=Comprehensive+rehabilitative+care+across+the+spectrum+of+amyotrophic+lateral+sclerosis.&amp;rft.volume=37&amp;rft.issue=1&amp;rft.pages=53-68&amp;rft.date=2015&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5223769%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26409693&amp;rft_id=info%3Adoi%2F10.3233%2FNRE-151240&amp;rft.aulast=Paganoni&amp;rft.aufirst=S&amp;rft.au=Karam%2C+C&amp;rft.au=Joyce%2C+N&amp;rft.au=Bedlack%2C+R&amp;rft.au=Carter%2C+G&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5223769&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-126">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFMacphersonBassile2016" class="citation journal cs1">Macpherson, Chelsea E.; Bassile, Clare C. (July 2016). <a rel="nofollow" class="external text" href="https://journals.lww.com/01253086-201607000-00002">"Pulmonary Physical Therapy Techniques to Enhance Survival in Amyotrophic Lateral Sclerosis: A Systematic Review"</a>. <i>Journal of Neurologic Physical Therapy</i>. <b>40</b> (3): 165–175. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FNPT.0000000000000136">10.1097/NPT.0000000000000136</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1557-0576">1557-0576</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurologic+Physical+Therapy&amp;rft.atitle=Pulmonary+Physical+Therapy+Techniques+to+Enhance+Survival+in+Amyotrophic+Lateral+Sclerosis%3A+A+Systematic+Review&amp;rft.volume=40&amp;rft.issue=3&amp;rft.pages=165-175&amp;rft.date=2016-07&amp;rft_id=info%3Adoi%2F10.1097%2FNPT.0000000000000136&amp;rft.issn=1557-0576&amp;rft.aulast=Macpherson&amp;rft.aufirst=Chelsea+E.&amp;rft.au=Bassile%2C+Clare+C.&amp;rft_id=https%3A%2F%2Fjournals.lww.com%2F01253086-201607000-00002&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-127">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFDanel-BrunaudTouzetChevalierMoreau2017" class="citation journal cs1">Danel-Brunaud V, Touzet L, Chevalier L, Moreau C, Devos D, Vandoolaeghe S, Lefebvre L (May 2017). "Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review". <i>Revue Neurologique</i>. <b>173</b> (5): 300–07. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2017.03.032">10.1016/j.neurol.2017.03.032</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28479121">28479121</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=Ethical+considerations+and+palliative+care+in+patients+with+amyotrophic+lateral+sclerosis%3A+A+review&amp;rft.volume=173&amp;rft.issue=5&amp;rft.pages=300-07&amp;rft.date=2017-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2017.03.032&amp;rft_id=info%3Apmid%2F28479121&amp;rft.aulast=Danel-Brunaud&amp;rft.aufirst=V&amp;rft.au=Touzet%2C+L&amp;rft.au=Chevalier%2C+L&amp;rft.au=Moreau%2C+C&amp;rft.au=Devos%2C+D&amp;rft.au=Vandoolaeghe%2C+S&amp;rft.au=Lefebvre%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-128">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFCheckowayLundinKelada2011" class="citation book cs1">Checkoway H, Lundin JI, Kelada SN (2011). "Chapter 22: Neurodegenerative diseases".  In Rothman N, Hainaut P, Schulte P, Smith M, Boffetta P, Perera F (eds.). <i>Molecular Epidemiology: Principles and Practices</i>. International Agency for Research on Cancer. pp.&#160;408–409. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-9283221630" title="Special:BookSources/978-9283221630"><bdi>978-9283221630</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+22%3A+Neurodegenerative+diseases&amp;rft.btitle=Molecular+Epidemiology%3A+Principles+and+Practices&amp;rft.pages=408-409&amp;rft.pub=International+Agency+for+Research+on+Cancer&amp;rft.date=2011&amp;rft.isbn=978-9283221630&amp;rft.aulast=Checkoway&amp;rft.aufirst=H&amp;rft.au=Lundin%2C+JI&amp;rft.au=Kelada%2C+SN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Global_Epidemiology-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-Global_Epidemiology_129-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFChiòLogroscinoTraynorCollins2013" class="citation journal cs1">Chiò A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA (2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4049265">"Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature"</a>. <i>Neuroepidemiology</i>. <b>41</b> (2): 118–30. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000351153">10.1159/000351153</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4049265">4049265</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23860588">23860588</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroepidemiology&amp;rft.atitle=Global+Epidemiology+of+Amyotrophic+Lateral+Sclerosis%3A+A+Systematic+Review+of+the+Published+Literature&amp;rft.volume=41&amp;rft.issue=2&amp;rft.pages=118-30&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4049265%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23860588&amp;rft_id=info%3Adoi%2F10.1159%2F000351153&amp;rft.aulast=Chi%C3%B2&amp;rft.aufirst=A&amp;rft.au=Logroscino%2C+G&amp;rft.au=Traynor%2C+BJ&amp;rft.au=Collins%2C+J&amp;rft.au=Simeone%2C+JC&amp;rft.au=Goldstein%2C+LA&amp;rft.au=White%2C+LA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4049265&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Projected2016-130"><span class="mw-cite-backlink">^ <a href="#cite_ref-Projected2016_130-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Projected2016_130-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFArthurCalvoPriceGeiger2016" class="citation journal cs1">Arthur KC, Calvo A, Price TR, Geiger JT, Chiò A, Traynor BJ (11 August 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4987527">"Projected increase in amyotrophic lateral sclerosis from 2015 to 2040"</a>. <i>Nature Communications</i>. <b>7</b> (12408): 12408. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2016NatCo...712408A">2016NatCo...712408A</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fncomms12408">10.1038/ncomms12408</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4987527">4987527</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27510634">27510634</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Communications&amp;rft.atitle=Projected+increase+in+amyotrophic+lateral+sclerosis+from+2015+to+2040&amp;rft.volume=7&amp;rft.issue=12408&amp;rft.pages=12408&amp;rft.date=2016-08-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4987527%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27510634&amp;rft_id=info%3Adoi%2F10.1038%2Fncomms12408&amp;rft_id=info%3Abibcode%2F2016NatCo...712408A&amp;rft.aulast=Arthur&amp;rft.aufirst=KC&amp;rft.au=Calvo%2C+A&amp;rft.au=Price%2C+TR&amp;rft.au=Geiger%2C+JT&amp;rft.au=Chi%C3%B2%2C+A&amp;rft.au=Traynor%2C+BJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4987527&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Current_Issues_in_ALS_Epidemiology-131"><span class="mw-cite-backlink">^ <a href="#cite_ref-Current_Issues_in_ALS_Epidemiology_131-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Current_Issues_in_ALS_Epidemiology_131-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFLunaLogroscinoCouratierMarin2017" class="citation journal cs1">Luna J, Logroscino G, Couratier P, Marin B (May 2017). "Current issues in ALS epidemiology: Variation of ALS occurrence between populations and physical activity as a risk factor". <i>Revue Neurologique</i>. <b>173</b> (5): 244–53. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2017.03.035">10.1016/j.neurol.2017.03.035</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28477849">28477849</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=Current+issues+in+ALS+epidemiology%3A+Variation+of+ALS+occurrence+between+populations+and+physical+activity+as+a+risk+factor&amp;rft.volume=173&amp;rft.issue=5&amp;rft.pages=244-53&amp;rft.date=2017-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2017.03.035&amp;rft_id=info%3Apmid%2F28477849&amp;rft.aulast=Luna&amp;rft.aufirst=J&amp;rft.au=Logroscino%2C+G&amp;rft.au=Couratier%2C+P&amp;rft.au=Marin%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-132">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFZouZhouCheLiu2017" class="citation journal cs1">Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP (July 2017). "Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis". <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>88</b> (77): 540–49. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2016-315018">10.1136/jnnp-2016-315018</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28057713">28057713</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:41974606">41974606</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Genetic+epidemiology+of+amyotrophic+lateral+sclerosis%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=88&amp;rft.issue=77&amp;rft.pages=540-49&amp;rft.date=2017-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A41974606%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28057713&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2016-315018&amp;rft.aulast=Zou&amp;rft.aufirst=ZY&amp;rft.au=Zhou%2C+ZR&amp;rft.au=Che%2C+CH&amp;rft.au=Liu%2C+CY&amp;rft.au=He%2C+RL&amp;rft.au=Huang%2C+HP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-133"><span class="mw-cite-backlink"><b><a href="#cite_ref-133">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFVisserde_Jongde_Visser2008" class="citation journal cs1">Visser J, de Jong JM, de Visser M (February 2008). "The history of progressive muscular atrophy: syndrome or disease?". <i>Neurology</i>. <b>70</b> (9): 723–27. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2F01.wnl.0000302187.20239.93">10.1212/01.wnl.0000302187.20239.93</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18299524">18299524</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22629725">22629725</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=The+history+of+progressive+muscular+atrophy%3A+syndrome+or+disease%3F&amp;rft.volume=70&amp;rft.issue=9&amp;rft.pages=723-27&amp;rft.date=2008-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22629725%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18299524&amp;rft_id=info%3Adoi%2F10.1212%2F01.wnl.0000302187.20239.93&amp;rft.aulast=Visser&amp;rft.aufirst=J&amp;rft.au=de+Jong%2C+JM&amp;rft.au=de+Visser%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-134"><span class="mw-cite-backlink"><b><a href="#cite_ref-134">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFWijesekeraMathersTalmanGaltrey2009" class="citation journal cs1">Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, Willey E, Ampong MA, Ellis CM, Shaw CE, Al-Chalabi A, Leigh PN (March 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2821838">"Natural history and clinical features of the flail arm and flail leg ALS variants"</a>. <i>Neurology</i>. <b>72</b> (12): 1087–94. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2F01.wnl.0000345041.83406.a2">10.1212/01.wnl.0000345041.83406.a2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2821838">2821838</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19307543">19307543</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Natural+history+and+clinical+features+of+the+flail+arm+and+flail+leg+ALS+variants&amp;rft.volume=72&amp;rft.issue=12&amp;rft.pages=1087-94&amp;rft.date=2009-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2821838%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19307543&amp;rft_id=info%3Adoi%2F10.1212%2F01.wnl.0000345041.83406.a2&amp;rft.aulast=Wijesekera&amp;rft.aufirst=LC&amp;rft.au=Mathers%2C+S&amp;rft.au=Talman%2C+P&amp;rft.au=Galtrey%2C+C&amp;rft.au=Parkinson%2C+MH&amp;rft.au=Ganesalingam%2C+J&amp;rft.au=Willey%2C+E&amp;rft.au=Ampong%2C+MA&amp;rft.au=Ellis%2C+CM&amp;rft.au=Shaw%2C+CE&amp;rft.au=Al-Chalabi%2C+A&amp;rft.au=Leigh%2C+PN&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2821838&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-135">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFLee2011" class="citation journal cs1">Lee SE (December 2011). "Guam dementia syndrome revisited in 2011". <i>Current Opinion in Neurology</i>. <b>24</b> (6): 517–24. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FWCO.0b013e32834cd50a">10.1097/WCO.0b013e32834cd50a</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21986681">21986681</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Neurology&amp;rft.atitle=Guam+dementia+syndrome+revisited+in+2011&amp;rft.volume=24&amp;rft.issue=6&amp;rft.pages=517-24&amp;rft.date=2011-12&amp;rft_id=info%3Adoi%2F10.1097%2FWCO.0b013e32834cd50a&amp;rft_id=info%3Apmid%2F21986681&amp;rft.aulast=Lee&amp;rft.aufirst=SE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-136">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBrooksSanjakRingelEngland1996" class="citation journal cs1">Brooks BR, Sanjak M, Ringel S, England J, Brinkmann J, Pestronk A,  et&#160;al. (February 1996). "The Amyotrophic Lateral Sclerosis Functional Rating Scale: Assessment of Activities of Daily Living in Patients with Amyotrophic Lateral Sclerosis". <i>Archives of Neurology</i>. <b>53</b> (2): 141–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchneur.1996.00550020045014">10.1001/archneur.1996.00550020045014</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/8639063">8639063</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Neurology&amp;rft.atitle=The+Amyotrophic+Lateral+Sclerosis+Functional+Rating+Scale%3A+Assessment+of+Activities+of+Daily+Living+in+Patients+with+Amyotrophic+Lateral+Sclerosis&amp;rft.volume=53&amp;rft.issue=2&amp;rft.pages=141-7&amp;rft.date=1996-02&amp;rft_id=info%3Adoi%2F10.1001%2Farchneur.1996.00550020045014&amp;rft_id=info%3Apmid%2F8639063&amp;rft.aulast=Brooks&amp;rft.aufirst=BR&amp;rft.au=Sanjak%2C+M&amp;rft.au=Ringel%2C+S&amp;rft.au=England%2C+J&amp;rft.au=Brinkmann%2C+J&amp;rft.au=Pestronk%2C+A&amp;rft.au=Florence%2C+J&amp;rft.au=Mitsumoto%2C+H&amp;rft.au=Szirony%2C+K&amp;rft.au=Wittes%2C+J&amp;rft.au=Charatan%2C+M&amp;rft.au=Stampfer%2C+N&amp;rft.au=Cedarbaum%2C+JM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-137">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFCedarbaumStamblerMaltaFuller1999" class="citation journal cs1">Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (October 1999). "The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function". <i>Journal of the Neurological Sciences</i>. <b>162</b> (1–2): 13–21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0022-510x%2899%2900210-5">10.1016/s0022-510x(99)00210-5</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/10540002">10540002</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:7057926">7057926</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Neurological+Sciences&amp;rft.atitle=The+ALSFRS-R%3A+a+revised+ALS+functional+rating+scale+that+incorporates+assessments+of+respiratory+function&amp;rft.volume=162&amp;rft.issue=1%E2%80%932&amp;rft.pages=13-21&amp;rft.date=1999-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7057926%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F10540002&amp;rft_id=info%3Adoi%2F10.1016%2Fs0022-510x%2899%2900210-5&amp;rft.aulast=Cedarbaum&amp;rft.aufirst=JM&amp;rft.au=Stambler%2C+N&amp;rft.au=Malta%2C+E&amp;rft.au=Fuller%2C+C&amp;rft.au=Hilt%2C+D&amp;rft.au=Thurmond%2C+B&amp;rft.au=Nakanishi%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-138">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFWilbourn1998" class="citation journal cs1">Wilbourn AJ (October 1998). "Clinical neurophysiology in the diagnosis of amyotrophic lateral sclerosis: The Lambert and the El Escorial criteria". <i>Journal of the Neurological Sciences</i>. <b>160</b> (Supplement 1): S25–29. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0022-510x%2898%2900194-4">10.1016/s0022-510x(98)00194-4</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/9851644">9851644</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:32884687">32884687</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Neurological+Sciences&amp;rft.atitle=Clinical+neurophysiology+in+the+diagnosis+of+amyotrophic+lateral+sclerosis%3A+The+Lambert+and+the+El+Escorial+criteria&amp;rft.volume=160&amp;rft.issue=Supplement+1&amp;rft.pages=S25-29&amp;rft.date=1998-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A32884687%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F9851644&amp;rft_id=info%3Adoi%2F10.1016%2Fs0022-510x%2898%2900194-4&amp;rft.aulast=Wilbourn&amp;rft.aufirst=AJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-139">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBrooks1994" class="citation journal cs1">Brooks BR (July 1994). "El Escorial World Federation of Neurology Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis". <i>Journal of the Neurological Sciences</i>. <b>124</b> (Supplement): 96–107. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2F0022-510x%2894%2990191-0">10.1016/0022-510x(94)90191-0</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/7807156">7807156</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:32678612">32678612</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Neurological+Sciences&amp;rft.atitle=El+Escorial+World+Federation+of+Neurology+Criteria+for+the+Diagnosis+of+Amyotrophic+Lateral+Sclerosis&amp;rft.volume=124&amp;rft.issue=Supplement&amp;rft.pages=96-107&amp;rft.date=1994-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A32678612%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F7807156&amp;rft_id=info%3Adoi%2F10.1016%2F0022-510x%2894%2990191-0&amp;rft.aulast=Brooks&amp;rft.aufirst=BR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-140">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBrooksMillerSwashMunsat2000" class="citation journal cs1">Brooks BR, Miller RG, Swash M, Munsat TL (December 2000). "El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis". <i>Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders</i>. <b>1</b> (5): 293–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F146608200300079536">10.1080/146608200300079536</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11464847">11464847</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22725949">22725949</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amyotrophic+Lateral+Sclerosis+and+Other+Motor+Neuron+Disorders&amp;rft.atitle=El+Escorial+revisited%3A+Revised+criteria+for+the+diagnosis+of+amyotrophic+lateral+sclerosis&amp;rft.volume=1&amp;rft.issue=5&amp;rft.pages=293-9&amp;rft.date=2000-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22725949%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11464847&amp;rft_id=info%3Adoi%2F10.1080%2F146608200300079536&amp;rft.aulast=Brooks&amp;rft.aufirst=BR&amp;rft.au=Miller%2C+RG&amp;rft.au=Swash%2C+M&amp;rft.au=Munsat%2C+TL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-What’s_in_a_name?-141"><span class="mw-cite-backlink">^ <a href="#cite_ref-What’s_in_a_name?_141-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-What’s_in_a_name?_141-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFTeiveLimaGerminianiMunhoz2016" class="citation journal cs1">Teive HA, Lima PM, Germiniani FM, Munhoz RP (May 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1590%2F0004-282X20160040">"What's in a name? Problems, facts and controversies regarding neurological eponyms"</a>. <i>Arquivos de Neuro-Psiquiatria</i>. <b>74</b> (5): 423–25. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1590%2F0004-282X20160040">10.1590/0004-282X20160040</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27191240">27191240</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arquivos+de+Neuro-Psiquiatria&amp;rft.atitle=What%27s+in+a+name%3F+Problems%2C+facts+and+controversies+regarding+neurological+eponyms&amp;rft.volume=74&amp;rft.issue=5&amp;rft.pages=423-25&amp;rft.date=2016-05&amp;rft_id=info%3Adoi%2F10.1590%2F0004-282X20160040&amp;rft_id=info%3Apmid%2F27191240&amp;rft.aulast=Teive&amp;rft.aufirst=HA&amp;rft.au=Lima%2C+PM&amp;rft.au=Germiniani%2C+FM&amp;rft.au=Munhoz%2C+RP&amp;rft_id=%2F%2Fdoi.org%2F10.1590%252F0004-282X20160040&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-What_is_ALS?-142"><span class="mw-cite-backlink">^ <a href="#cite_ref-What_is_ALS?_142-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-What_is_ALS?_142-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.alsa.org/about-als/what-is-als.html">"What is ALS?"</a>. <i>The ALS Association</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20181221191534/http://www.alsa.org/about-als/what-is-als.html">Archived</a> from the original on 21 December 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">23 December</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+ALS+Association&amp;rft.atitle=What+is+ALS%3F&amp;rft_id=http%3A%2F%2Fwww.alsa.org%2Fabout-als%2Fwhat-is-als.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-143"><span class="mw-cite-backlink"><b><a href="#cite_ref-143">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.mda.org/disease/amyotrophic-lateral-sclerosis">"ALS: Amyotrophic Lateral Sclerosis"</a>. <i>Muscular Dystrophy Association</i>. 18 December 2015. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20180806173221/https://www.mda.org/disease/amyotrophic-lateral-sclerosis">Archived</a> from the original on 6 August 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">23 December</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Muscular+Dystrophy+Association&amp;rft.atitle=ALS%3A+Amyotrophic+Lateral+Sclerosis&amp;rft.date=2015-12-18&amp;rft_id=https%3A%2F%2Fwww.mda.org%2Fdisease%2Famyotrophic-lateral-sclerosis&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-144"><span class="mw-cite-backlink"><b><a href="#cite_ref-144">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFGoetz2000" class="citation journal cs1">Goetz CG (March 2000). "Amyotrophic lateral sclerosis: early contributions of Jean-Martin Charcot". <i>Muscle &amp; Nerve</i>. <b>23</b> (3): 336–43. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F%28SICI%291097-4598%28200003%2923%3A3%3C336%3A%3AAID-MUS4%3E3.0.CO%3B2-L">10.1002/(SICI)1097-4598(200003)23:3&#60;336::AID-MUS4&#62;3.0.CO;2-L</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/10679709">10679709</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Muscle+%26+Nerve&amp;rft.atitle=Amyotrophic+lateral+sclerosis%3A+early+contributions+of+Jean-Martin+Charcot&amp;rft.volume=23&amp;rft.issue=3&amp;rft.pages=336-43&amp;rft.date=2000-03&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291097-4598%28200003%2923%3A3%3C336%3A%3AAID-MUS4%3E3.0.CO%3B2-L&amp;rft_id=info%3Apmid%2F10679709&amp;rft.aulast=Goetz&amp;rft.aufirst=CG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-145"><span class="mw-cite-backlink"><b><a href="#cite_ref-145">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFGordon2006" class="citation book cs1">Gordon PH (2006). "Chapter 1: History of ALS".  In Mitsumoto H, Przedborski S, Gordon PH (eds.). <i>Amyotrophic Lateral Sclerosis</i>. CRC Press. p.&#160;9. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0824729240" title="Special:BookSources/978-0824729240"><bdi>978-0824729240</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+1%3A+History+of+ALS&amp;rft.btitle=Amyotrophic+Lateral+Sclerosis&amp;rft.pages=9&amp;rft.pub=CRC+Press&amp;rft.date=2006&amp;rft.isbn=978-0824729240&amp;rft.aulast=Gordon&amp;rft.aufirst=PH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-146"><span class="mw-cite-backlink"><b><a href="#cite_ref-146">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFMehtaMehtaAndersonMacKinnon2020" class="citation journal cs1">Mehta AR, Mehta PR, Anderson SP, MacKinnon BL, Compston A (January 2020). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6935745">"Grey Matter Etymology and the neuron(e)"</a>. <i>Brain</i>. <b>143</b> (1): 374–379. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbrain%2Fawz367">10.1093/brain/awz367</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6935745">6935745</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31844876">31844876</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain&amp;rft.atitle=Grey+Matter+Etymology+and+the+neuron%28e%29&amp;rft.volume=143&amp;rft.issue=1&amp;rft.pages=374-379&amp;rft.date=2020-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6935745%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31844876&amp;rft_id=info%3Adoi%2F10.1093%2Fbrain%2Fawz367&amp;rft.aulast=Mehta&amp;rft.aufirst=AR&amp;rft.au=Mehta%2C+PR&amp;rft.au=Anderson%2C+SP&amp;rft.au=MacKinnon%2C+BL&amp;rft.au=Compston%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6935745&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-147"><span class="mw-cite-backlink"><b><a href="#cite_ref-147">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFGordon2013" class="citation journal cs1">Gordon PH (October 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3794725">"Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials"</a>. <i>Aging and Disease</i>. <b>4</b> (5): 295–310. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.14336%2FAD.2013.0400295">10.14336/AD.2013.0400295</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3794725">3794725</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24124634">24124634</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Aging+and+Disease&amp;rft.atitle=Amyotrophic+Lateral+Sclerosis%3A+An+update+for+2013+Clinical+Features%2C+Pathophysiology%2C+Management+and+Therapeutic+Trials&amp;rft.volume=4&amp;rft.issue=5&amp;rft.pages=295-310&amp;rft.date=2013-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3794725%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24124634&amp;rft_id=info%3Adoi%2F10.14336%2FAD.2013.0400295&amp;rft.aulast=Gordon&amp;rft.aufirst=PH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3794725&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-UMN_Assessment-148"><span class="mw-cite-backlink">^ <a href="#cite_ref-UMN_Assessment_148-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-UMN_Assessment_148-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFHuynhSimonGrosskreutzTurner2016" class="citation journal cs1">Huynh W, Simon NG, Grosskreutz J, Turner MR, Vucic S, Kiernan MC (July 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clinph.2016.04.025">"Assessment of the upper motor neuron in amyotrophic lateral sclerosis"</a>. <i>Clinical Neurophysiology</i>. <b>127</b> (7): 2643–2660. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clinph.2016.04.025">10.1016/j.clinph.2016.04.025</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27291884">27291884</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3757685">3757685</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Neurophysiology&amp;rft.atitle=Assessment+of+the+upper+motor+neuron+in+amyotrophic+lateral+sclerosis&amp;rft.volume=127&amp;rft.issue=7&amp;rft.pages=2643-2660&amp;rft.date=2016-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3757685%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27291884&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clinph.2016.04.025&amp;rft.aulast=Huynh&amp;rft.aufirst=W&amp;rft.au=Simon%2C+NG&amp;rft.au=Grosskreutz%2C+J&amp;rft.au=Turner%2C+MR&amp;rft.au=Vucic%2C+S&amp;rft.au=Kiernan%2C+MC&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252Fj.clinph.2016.04.025&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-UCLH-149"><span class="mw-cite-backlink"><b><a href="#cite_ref-UCLH_149-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.uclh.nhs.uk/OurServices/ServiceA-Z/Neuro/MND/Pages/Home.aspx">"Motor Neuron Diseases"</a>. <i>www.uclh.nhs.uk</i><span class="reference-accessdate">. Retrieved <span class="nowrap">26 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.uclh.nhs.uk&amp;rft.atitle=Motor+Neuron+Diseases&amp;rft_id=https%3A%2F%2Fwww.uclh.nhs.uk%2FOurServices%2FServiceA-Z%2FNeuro%2FMND%2FPages%2FHome.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-bush-150"><span class="mw-cite-backlink"><b><a href="#cite_ref-bush_150-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.independent.co.uk/news/people/george-bush-delivers-possibly-the-best-als-ice-bucket-challenge-yet-9680934.html">"George Bush delivers possibly the best ALS ice bucket challenge yet"</a>. <i>The Independent</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140821095115/http://www.independent.co.uk/news/people/george-bush-delivers-possibly-the-best-als-ice-bucket-challenge-yet-9680934.html">Archived</a> from the original on 21 August 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">20 August</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Independent&amp;rft.atitle=George+Bush+delivers+possibly+the+best+ALS+ice+bucket+challenge+yet&amp;rft_id=https%3A%2F%2Fwww.independent.co.uk%2Fnews%2Fpeople%2Fgeorge-bush-delivers-possibly-the-best-als-ice-bucket-challenge-yet-9680934.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-151"><span class="mw-cite-backlink"><b><a href="#cite_ref-151">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.bbc.com/news/health-36901867">"Ice Bucket Challenge funds gene discovery in ALS (MND) research"</a>. <i>BBC News</i>. 27 July 2016. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160728152513/http://www.bbc.com/news/health-36901867">Archived</a> from the original on 28 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">27 July</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Ice+Bucket+Challenge+funds+gene+discovery+in+ALS+%28MND%29+research&amp;rft.date=2016-07-27&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Fhealth-36901867&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-152"><span class="mw-cite-backlink"><b><a href="#cite_ref-152">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFAlexander" class="citation news cs1">Alexander, Ella. "Ice Bucket Challenge: Lady Gaga, Justin Bieber, G-Dragon and Oprah – the most entertaining reactions so far".</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Ice+Bucket+Challenge%3A+Lady+Gaga%2C+Justin+Bieber%2C+G-Dragon+and+Oprah+%E2%80%93+the+most+entertaining+reactions+so+far&amp;rft.aulast=Alexander&amp;rft.aufirst=Ella&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-153"><span class="mw-cite-backlink"><b><a href="#cite_ref-153">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation news cs1"><a rel="nofollow" class="external text" href="http://www.nydailynews.com/news/national/ice-bucket-challenge-funds-discovery-gene-linked-als-article-1.2726954">"Ice Bucket Challenge funds discovery of gene linked to ALS"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160727133501/http://www.nydailynews.com/news/national/ice-bucket-challenge-funds-discovery-gene-linked-als-article-1.2726954">Archived</a> from the original on 27 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">27 July</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Ice+Bucket+Challenge+funds+discovery+of+gene+linked+to+ALS&amp;rft_id=http%3A%2F%2Fwww.nydailynews.com%2Fnews%2Fnational%2Fice-bucket-challenge-funds-discovery-gene-linked-als-article-1.2726954&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-154"><span class="mw-cite-backlink"><b><a href="#cite_ref-154">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFKennavan_DoormaalDekker2016" class="citation journal cs1">Kenna KP, van Doormaal PT, Dekker AM,  et&#160;al. (September 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5560030">"NEK1 variants confer susceptibility to amyotrophic lateral sclerosis"</a>. <i>Nature Genetics</i>. <b>48</b> (9): 1037–42. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fng.3626">10.1038/ng.3626</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5560030">5560030</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27455347">27455347</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Genetics&amp;rft.atitle=NEK1+variants+confer+susceptibility+to+amyotrophic+lateral+sclerosis&amp;rft.volume=48&amp;rft.issue=9&amp;rft.pages=1037-42&amp;rft.date=2016-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5560030%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27455347&amp;rft_id=info%3Adoi%2F10.1038%2Fng.3626&amp;rft.aulast=Kenna&amp;rft.aufirst=KP&amp;rft.au=van+Doormaal%2C+PT&amp;rft.au=Dekker%2C+AM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5560030&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-CNS_Drugs_2016-156"><span class="mw-cite-backlink">^ <a href="#cite_ref-CNS_Drugs_2016_156-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CNS_Drugs_2016_156-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-CNS_Drugs_2016_156-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-CNS_Drugs_2016_156-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-CNS_Drugs_2016_156-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFMoujalledWhite2016" class="citation journal cs1">Moujalled D, White AR (March 2016). "Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis". <i>CNS Drugs</i>. <b>30</b> (3): 227–43. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40263-016-0317-8">10.1007/s40263-016-0317-8</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//hdl.handle.net/11343%2F216653">11343/216653</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26895253">26895253</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:13487502">13487502</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drugs&amp;rft.atitle=Advances+in+the+Development+of+Disease-Modifying+Treatments+for+Amyotrophic+Lateral+Sclerosis&amp;rft.volume=30&amp;rft.issue=3&amp;rft.pages=227-43&amp;rft.date=2016-03&amp;rft_id=info%3Ahdl%2F11343%2F216653&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13487502%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26895253&amp;rft_id=info%3Adoi%2F10.1007%2Fs40263-016-0317-8&amp;rft.aulast=Moujalled&amp;rft.aufirst=D&amp;rft.au=White%2C+AR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-157"><span class="mw-cite-backlink"><b><a href="#cite_ref-157">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFPicher-MartelValdmanisGouldJulien2016" class="citation journal cs1">Picher-Martel V, Valdmanis PN, Gould PV, Julien JP, Dupré N (July 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4940869">"From animal models to human disease: a genetic approach for personalized medicine in ALS"</a>. <i>Acta Neuropathologica Communications</i>. <b>11</b> (4): 70. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs40478-016-0340-5">10.1186/s40478-016-0340-5</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4940869">4940869</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27400686">27400686</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Neuropathologica+Communications&amp;rft.atitle=From+animal+models+to+human+disease%3A+a+genetic+approach+for+personalized+medicine+in+ALS&amp;rft.volume=11&amp;rft.issue=4&amp;rft.pages=70&amp;rft.date=2016-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4940869%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27400686&amp;rft_id=info%3Adoi%2F10.1186%2Fs40478-016-0340-5&amp;rft.aulast=Picher-Martel&amp;rft.aufirst=V&amp;rft.au=Valdmanis%2C+PN&amp;rft.au=Gould%2C+PV&amp;rft.au=Julien%2C+JP&amp;rft.au=Dupr%C3%A9%2C+N&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4940869&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Mitsumoto_2014-159"><span class="mw-cite-backlink">^ <a href="#cite_ref-Mitsumoto_2014_159-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Mitsumoto_2014_159-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFMitsumotoBrooksSilani2014" class="citation journal cs1">Mitsumoto H, Brooks BR, Silani V (November 2014). "Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?". <i>The Lancet. Neurology</i>. <b>13</b> (11): 1127–38. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2814%2970129-2">10.1016/S1474-4422(14)70129-2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25316019">25316019</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:28510979">28510979</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Clinical+trials+in+amyotrophic+lateral+sclerosis%3A+why+so+many+negative+trials+and+how+can+trials+be+improved%3F&amp;rft.volume=13&amp;rft.issue=11&amp;rft.pages=1127-38&amp;rft.date=2014-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A28510979%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25316019&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2814%2970129-2&amp;rft.aulast=Mitsumoto&amp;rft.aufirst=H&amp;rft.au=Brooks%2C+BR&amp;rft.au=Silani%2C+V&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-160"><span class="mw-cite-backlink"><b><a href="#cite_ref-160">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFFangZhouYangZhu2013" class="citation journal cs1">Fang J, Zhou M, Yang M, Zhu C, He L (May 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7173713">"Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease"</a>. <i>The Cochrane Database of Systematic Reviews</i> (5): CD008554. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD008554.pub3">10.1002/14651858.CD008554.pub3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7173713">7173713</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23728676">23728676</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Repetitive+transcranial+magnetic+stimulation+for+the+treatment+of+amyotrophic+lateral+sclerosis+or+motor+neuron+disease&amp;rft.issue=5&amp;rft.pages=CD008554&amp;rft.date=2013-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7173713%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23728676&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008554.pub3&amp;rft.aulast=Fang&amp;rft.aufirst=J&amp;rft.au=Zhou%2C+M&amp;rft.au=Yang%2C+M&amp;rft.au=Zhu%2C+C&amp;rft.au=He%2C+L&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7173713&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-161"><span class="mw-cite-backlink"><b><a href="#cite_ref-161">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFChenSakowskiFeldman2016" class="citation journal cs1">Chen KS, Sakowski SA, Feldman EL (March 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4789073">"Intraspinal stem cell transplantation for amyotrophic lateral sclerosis"</a>. <i>Annals of Neurology</i>. <b>79</b> (3): 342–53. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fana.24584">10.1002/ana.24584</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4789073">4789073</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26696091">26696091</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=Intraspinal+stem+cell+transplantation+for+amyotrophic+lateral+sclerosis&amp;rft.volume=79&amp;rft.issue=3&amp;rft.pages=342-53&amp;rft.date=2016-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4789073%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26696091&amp;rft_id=info%3Adoi%2F10.1002%2Fana.24584&amp;rft.aulast=Chen&amp;rft.aufirst=KS&amp;rft.au=Sakowski%2C+SA&amp;rft.au=Feldman%2C+EL&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4789073&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-162"><span class="mw-cite-backlink"><b><a href="#cite_ref-162">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFAbdul_WahidLawIsmailLai2019" class="citation journal cs1">Abdul Wahid, S. Fadilah; Law, Zhe Kang; Ismail, Nor Azimah; Lai, Nai Ming (19 December 2019). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6920743">"Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>12</b>: CD011742. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD011742.pub3">10.1002/14651858.CD011742.pub3</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1469-493X">1469-493X</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6920743">6920743</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31853962">31853962</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Cell-based+therapies+for+amyotrophic+lateral+sclerosis%2Fmotor+neuron+disease&amp;rft.volume=12&amp;rft.pages=CD011742&amp;rft.date=2019-12-19&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6920743%23id-name%3DPMC&amp;rft.issn=1469-493X&amp;rft_id=info%3Apmid%2F31853962&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD011742.pub3&amp;rft.aulast=Abdul+Wahid&amp;rft.aufirst=S.+Fadilah&amp;rft.au=Law%2C+Zhe+Kang&amp;rft.au=Ismail%2C+Nor+Azimah&amp;rft.au=Lai%2C+Nai+Ming&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6920743&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-163"><span class="mw-cite-backlink"><b><a href="#cite_ref-163">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2016/10/WC500213508.pdf">"Public summary of opinion on orphan designation Masitinib mesilate for treatment of amyotrophic lateral sclerosis"</a> <span class="cs1-format">(PDF)</span>. <i>EMA</i>. European Medicines Agency, Committee for Orphan Medicinal Products. 22 September 2016. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20161106185457/http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2016/10/WC500213508.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 6 November 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">6 November</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=EMA&amp;rft.atitle=Public+summary+of+opinion+on+orphan+designation+Masitinib+mesilate+for+treatment+of+amyotrophic+lateral+sclerosis&amp;rft.date=2016-09-22&amp;rft_id=http%3A%2F%2Fwww.ema.europa.eu%2Fdocs%2Fen_GB%2Fdocument_library%2FOrphan_designation%2F2016%2F10%2FWC500213508.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-164"><span class="mw-cite-backlink"><b><a href="#cite_ref-164">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBartusBétournéBasilePeterson2016" class="citation journal cs1">Bartus RT, Bétourné A, Basile A, Peterson BL, Glass J, Boulis NM (January 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.nbd.2015.10.006">"β2-Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS)"</a>. <i>Neurobiology of Disease</i>. <b>85</b>: 11–24. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.nbd.2015.10.006">10.1016/j.nbd.2015.10.006</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26459114">26459114</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:536279">536279</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurobiology+of+Disease&amp;rft.atitle=%CE%B22-Adrenoceptor+agonists+as+novel%2C+safe+and+potentially+effective+therapies+for+Amyotrophic+lateral+sclerosis+%28ALS%29&amp;rft.volume=85&amp;rft.pages=11-24&amp;rft.date=2016-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A536279%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26459114&amp;rft_id=info%3Adoi%2F10.1016%2Fj.nbd.2015.10.006&amp;rft.aulast=Bartus&amp;rft.aufirst=RT&amp;rft.au=B%C3%A9tourn%C3%A9%2C+A&amp;rft.au=Basile%2C+A&amp;rft.au=Peterson%2C+BL&amp;rft.au=Glass%2C+J&amp;rft.au=Boulis%2C+NM&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252Fj.nbd.2015.10.006&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Brauer2018-165"><span class="mw-cite-backlink"><b><a href="#cite_ref-Brauer2018_165-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFBräuerZimyaninHermann2018" class="citation journal cs1">Bräuer S, Zimyanin V, Hermann A (April 2018). "Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis". <i>Journal of Neural Transmission</i>. <b>125</b> (4): 591–613. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00702-018-1851-y">10.1007/s00702-018-1851-y</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29417336">29417336</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3895544">3895544</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neural+Transmission&amp;rft.atitle=Prion-like+properties+of+disease-relevant+proteins+in+amyotrophic+lateral+sclerosis&amp;rft.volume=125&amp;rft.issue=4&amp;rft.pages=591-613&amp;rft.date=2018-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3895544%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29417336&amp;rft_id=info%3Adoi%2F10.1007%2Fs00702-018-1851-y&amp;rft.aulast=Br%C3%A4uer&amp;rft.aufirst=S&amp;rft.au=Zimyanin%2C+V&amp;rft.au=Hermann%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-Lau2018-166"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lau2018_166-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFLauHartoppWelshMueller2018" class="citation journal cs1">Lau DH, Hartopp N, Welsh NJ, Mueller S, Glennon EB, Mórotz GM, Annibali A, Gomez-Suaga P, Stoica R, Paillusson S, Miller CC (February 2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5832427">"Disruption of ER-mitochondria signalling in fronto-temporal dementia and related amyotrophic lateral sclerosis"</a>. <i>Cell Death &amp; Disease</i>. <b>9</b> (3): 327. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41419-017-0022-7">10.1038/s41419-017-0022-7</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5832427">5832427</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29491392">29491392</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell+Death+%26+Disease&amp;rft.atitle=Disruption+of+ER-mitochondria+signalling+in+fronto-temporal+dementia+and+related+amyotrophic+lateral+sclerosis&amp;rft.volume=9&amp;rft.issue=3&amp;rft.pages=327&amp;rft.date=2018-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5832427%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29491392&amp;rft_id=info%3Adoi%2F10.1038%2Fs41419-017-0022-7&amp;rft.aulast=Lau&amp;rft.aufirst=DH&amp;rft.au=Hartopp%2C+N&amp;rft.au=Welsh%2C+NJ&amp;rft.au=Mueller%2C+S&amp;rft.au=Glennon%2C+EB&amp;rft.au=M%C3%B3rotz%2C+GM&amp;rft.au=Annibali%2C+A&amp;rft.au=Gomez-Suaga%2C+P&amp;rft.au=Stoica%2C+R&amp;rft.au=Paillusson%2C+S&amp;rft.au=Miller%2C+CC&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5832427&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
<li id="cite_note-167"><span class="mw-cite-backlink"><b><a href="#cite_ref-167">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r999302996"/><cite id="CITEREFNeumann2013" class="citation journal cs1">Neumann M (October 2013). "Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences". <i>Revue Neurologique</i>. <b>169</b> (10): 793–98. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neurol.2013.07.019">10.1016/j.neurol.2013.07.019</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24011641">24011641</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+Neurologique&amp;rft.atitle=Frontotemporal+lobar+degeneration+and+amyotrophic+lateral+sclerosis%3A+molecular+similarities+and+differences&amp;rft.volume=169&amp;rft.issue=10&amp;rft.pages=793-98&amp;rft.date=2013-10&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2013.07.019&amp;rft_id=info%3Apmid%2F24011641&amp;rft.aulast=Neumann&amp;rft.aufirst=M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmyotrophic+lateral+sclerosis" class="Z3988"></span></span>
</li>
</ol></div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit&amp;section=42" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table role="presentation" class="mbox-small plainlinks sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000">
<tbody><tr>
<td class="mbox-image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png" decoding="async" width="30" height="40" class="noviewer" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x" data-file-width="1024" data-file-height="1376" /></td>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="https://commons.wikimedia.org/wiki/Category:Amyotrophic_lateral_sclerosis" class="extiw" title="commons:Category:Amyotrophic lateral sclerosis"><span style="">Amyotrophic lateral sclerosis</span></a></b></i>.</td></tr>
</tbody></table>
<ul><li><a rel="nofollow" class="external text" href="https://curlie.org/Health/Conditions_and_Diseases/Neurological_Disorders/Amyotrophic_Lateral_Sclerosis/">Amyotrophic lateral sclerosis</a> at <a href="/wiki/Curlie" class="mw-redirect" title="Curlie">Curlie</a></li></ul>
<table class="infobox" style="width:100%; margin:0.5em 0 0.5em 0;"><tbody><tr><th scope="row" class="infobox-label">Classification</th><td class="infobox-data" style="text-align:left;"><div style="position:relative; float:right; font-size:0.8em;"><a href="https://www.wikidata.org/wiki/Q206901" class="extiw" title="d:Q206901">D</a></div><div class="hlist hlist-separated" style="text-align:left;"><ul><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></b>: <a rel="nofollow" class="external text" href="https://icd.who.int/browse10/2019/en#/G12.2">G12.2</a></li><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10-CM" title="ICD-10-CM">10-CM</a></b>: <a rel="nofollow" class="external text" href="https://icdcodelookup.com/icd-10/codes/G12.21">G12.21</a></li><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></b>: <a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=335.20">335.20</a></li><li><b><a href="/wiki/Online_Mendelian_Inheritance_in_Man" title="Online Mendelian Inheritance in Man">OMIM</a></b>: <a rel="nofollow" class="external text" href="https://omim.org/entry/105400">105400</a></li><li><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b>: <a rel="nofollow" class="external text" href="https://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D000690">D000690</a></li><li><b><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></b>: <a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb29148.htm">29148</a></li></ul></div></td></tr><tr><th scope="row" class="infobox-label">External resources</th><td class="infobox-data" style="text-align:left;"><div class="hlist hlist-separated" style="text-align:left;"><ul><li><b><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></b>: <a rel="nofollow" class="external text" href="https://www.nlm.nih.gov/medlineplus/ency/article/000688.htm">000688</a></li><li><b><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></b>: <a rel="nofollow" class="external text" href="https://emedicine.medscape.com/neuro/14-overview">neuro/14</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/emerg/topic24.htm#">emerg/24</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/pmr/topic10.htm#">pmr/10</a></li><li><b><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></b>: <a rel="nofollow" class="external text" href="https://patient.info/doctor/Motor-Neurone-Disease-(MND)">Amyotrophic lateral sclerosis</a></li><li><b><a href="/wiki/GeneReviews" title="GeneReviews">GeneReviews</a></b>: <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/books/NBK1450/">Amyotrophic lateral sclerosis</a></li><li><b><a href="/wiki/Orphanet" title="Orphanet">Orphanet</a></b>: <a rel="nofollow" class="external text" href="https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=803">803</a></li><li><b>Scholia</b>: <a class="external text" href="https://tools.wmflabs.org/scholia/topic/Q206901">Q206901</a></li></ul></div></td></tr></tbody></table>
<div role="navigation" class="navbox" aria-labelledby="Diseases_of_the_nervous_system,_primarily_CNS" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><style data-mw-deduplicate="TemplateStyles:r992953826">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}.mw-parser-output .infobox .navbar{font-size:100%}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Central_nervous_system_disease" title="Template:Central nervous system disease"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Central_nervous_system_disease" title="Template talk:Central nervous system disease"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Central_nervous_system_disease&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Diseases_of_the_nervous_system,_primarily_CNS" style="font-size:114%;margin:0 4em">Diseases of the <a href="/wiki/Nervous_system" title="Nervous system">nervous system</a>, primarily <a href="/wiki/Central_nervous_system_disease" title="Central nervous system disease">CNS</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Inflammation" title="Inflammation">Inflammation</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Brain" scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Human_brain" title="Human brain">Brain</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Encephalitis" title="Encephalitis">Encephalitis</a>
<ul><li><a href="/wiki/Viral_encephalitis" title="Viral encephalitis">Viral encephalitis</a></li>
<li><a href="/wiki/Herpesviral_encephalitis" title="Herpesviral encephalitis">Herpesviral encephalitis</a></li>
<li><a href="/wiki/Limbic_encephalitis" title="Limbic encephalitis">Limbic encephalitis</a></li>
<li><a href="/wiki/Encephalitis_lethargica" title="Encephalitis lethargica">Encephalitis lethargica</a></li></ul></li>
<li><a href="/wiki/Cavernous_sinus_thrombosis" title="Cavernous sinus thrombosis">Cavernous sinus thrombosis</a></li>
<li><a href="/wiki/Brain_abscess" title="Brain abscess">Brain abscess</a>
<ul><li><a href="/wiki/Amoebic_brain_abscess" title="Amoebic brain abscess">Amoebic</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Brain and <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Encephalomyelitis" title="Encephalomyelitis">Encephalomyelitis</a>
<ul><li><a href="/wiki/Acute_disseminated_encephalomyelitis" title="Acute disseminated encephalomyelitis">Acute disseminated</a></li></ul></li>
<li><a href="/wiki/Meningitis" title="Meningitis">Meningitis</a></li>
<li><a href="/wiki/Meningoencephalitis" title="Meningoencephalitis">Meningoencephalitis</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Human_brain" title="Human brain">Brain</a>/<br /><a href="/wiki/Encephalopathy" title="Encephalopathy">encephalopathy</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Neurodegeneration" title="Neurodegeneration">Degenerative</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Extrapyramidal_system" title="Extrapyramidal system">Extrapyramidal</a> and<br /><a href="/wiki/Movement_disorders" title="Movement disorders">movement disorders</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Basal_ganglia_disease" title="Basal ganglia disease">Basal ganglia disease</a>
<ul><li><a href="/wiki/Parkinsonism" title="Parkinsonism">Parkinsonism</a>
<ul><li><a href="/wiki/Parkinson%27s_disease" title="Parkinson&#39;s disease">PD</a></li>
<li><a href="/wiki/Postencephalitic_parkinsonism" title="Postencephalitic parkinsonism">Postencephalitic</a></li>
<li><a href="/wiki/Neuroleptic_malignant_syndrome" title="Neuroleptic malignant syndrome">NMS</a></li></ul></li>
<li><a href="/wiki/Pantothenate_kinase-associated_neurodegeneration" title="Pantothenate kinase-associated neurodegeneration">PKAN</a></li>
<li><a href="/wiki/Tauopathy" title="Tauopathy">Tauopathy</a>
<ul><li><a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">PSP</a></li></ul></li>
<li><a href="/wiki/Multiple_system_atrophy" title="Multiple system atrophy">Striatonigral degeneration</a></li>
<li><a href="/wiki/Hemiballismus" title="Hemiballismus">Hemiballismus</a></li>
<li><a href="/wiki/Huntington%27s_disease" title="Huntington&#39;s disease">HD</a></li>
<li><a href="/wiki/Olivopontocerebellar_atrophy" title="Olivopontocerebellar atrophy">OA</a></li></ul></li></ul>
<ul><li><a href="/wiki/Dyskinesia" title="Dyskinesia">Dyskinesia</a>
<ul><li><a href="/wiki/Dystonia" title="Dystonia">Dystonia</a>
<ul><li><a href="/wiki/Status_dystonicus" title="Status dystonicus">Status dystonicus</a></li>
<li><a href="/wiki/Spasmodic_torticollis" title="Spasmodic torticollis">Spasmodic torticollis</a></li>
<li><a href="/wiki/Meige%27s_syndrome" title="Meige&#39;s syndrome">Meige's</a></li>
<li><a href="/wiki/Blepharospasm" title="Blepharospasm">Blepharospasm</a></li></ul></li>
<li><a href="/wiki/Athetosis" title="Athetosis">Athetosis</a></li>
<li><a href="/wiki/Chorea" title="Chorea">Chorea</a>
<ul><li><a href="/wiki/Choreoathetosis" title="Choreoathetosis">Choreoathetosis</a></li></ul></li>
<li><a href="/wiki/Myoclonus" title="Myoclonus">Myoclonus</a>
<ul><li><a href="/wiki/Myoclonic_epilepsy" title="Myoclonic epilepsy">Myoclonic epilepsy</a></li></ul></li>
<li><a href="/wiki/Akathisia" title="Akathisia">Akathisia</a></li></ul></li></ul>
<ul><li><a href="/wiki/Tremor" title="Tremor">Tremor</a>
<ul><li><a href="/wiki/Essential_tremor" title="Essential tremor">Essential tremor</a></li>
<li><a href="/wiki/Intention_tremor" title="Intention tremor">Intention tremor</a></li></ul></li>
<li><a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">Restless legs</a></li>
<li><a href="/wiki/Stiff-person_syndrome" title="Stiff-person syndrome">Stiff-person</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Dementia" title="Dementia">Dementia</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Tauopathy" title="Tauopathy">Tauopathy</a>
<ul><li><a href="/wiki/Alzheimer%27s_disease" title="Alzheimer&#39;s disease">Alzheimer's</a>
<ul><li><a href="/wiki/Early-onset_Alzheimer%27s_disease" title="Early-onset Alzheimer&#39;s disease">Early-onset</a></li></ul></li>
<li><a href="/wiki/Primary_progressive_aphasia" title="Primary progressive aphasia">Primary progressive aphasia</a></li></ul></li>
<li><a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">Frontotemporal dementia</a>/<a href="/wiki/Frontotemporal_lobar_degeneration" title="Frontotemporal lobar degeneration">Frontotemporal lobar degeneration</a>
<ul><li><a href="/wiki/Pick%27s_disease" class="mw-redirect" title="Pick&#39;s disease">Pick's</a></li>
<li><a href="/wiki/Dementia_with_Lewy_bodies" title="Dementia with Lewy bodies">Dementia with Lewy bodies</a></li></ul></li>
<li><a href="/wiki/Posterior_cortical_atrophy" title="Posterior cortical atrophy">Posterior cortical atrophy</a></li></ul>
<ul><li><a href="/wiki/Vascular_dementia" title="Vascular dementia">Vascular dementia</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Mitochondrial_disease" title="Mitochondrial disease">Mitochondrial disease</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Leigh_syndrome" title="Leigh syndrome">Leigh syndrome</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Demyelinating_disease" title="Demyelinating disease">Demyelinating</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/CNS_demyelinating_autoimmune_diseases" title="CNS demyelinating autoimmune diseases">Autoimmune</a></li>
<li><a href="/wiki/Inflammatory_demyelinating_diseases_of_the_central_nervous_system" title="Inflammatory demyelinating diseases of the central nervous system">Inflammatory</a></li>
<li><a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">Multiple sclerosis</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Demyelinating_diseases_of_CNS" title="Template:Demyelinating diseases of CNS">Template:Demyelinating diseases of CNS</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Episodic/<br /><a href="/wiki/Paroxysmal_attack" title="Paroxysmal attack">paroxysmal</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Epileptic_seizure" class="mw-redirect" title="Epileptic seizure">Seizures</a> and <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Focal_seizure" title="Focal seizure">Focal</a></li>
<li><a href="/wiki/Generalized_epilepsy" title="Generalized epilepsy">Generalised</a></li>
<li><a href="/wiki/Status_epilepticus" title="Status epilepticus">Status epilepticus</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Epilepsy" class="mw-redirect" title="Template:Epilepsy">Template:Epilepsy</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Headache" title="Headache">Headache</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Migraine" title="Migraine">Migraine</a></li>
<li><a href="/wiki/Cluster_headache" title="Cluster headache">Cluster</a></li>
<li><a href="/wiki/Tension_headache" title="Tension headache">Tension</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Headache" title="Template:Headache">Template:Headache</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Cerebrovascular_disease" title="Cerebrovascular disease">Cerebrovascular</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Transient_ischemic_attack" title="Transient ischemic attack">TIA</a></li>
<li><a href="/wiki/Stroke" title="Stroke">Stroke</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Cerebrovascular_diseases" title="Template:Cerebrovascular diseases">Template:Cerebrovascular diseases</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Sleep_disorders" class="mw-redirect" title="Sleep disorders">Sleep disorders</a>
<ul><li>For more detailed coverage, see <a href="/wiki/Template:Sleep" title="Template:Sleep">Template:Sleep</a></li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Cerebrospinal_fluid" title="Cerebrospinal fluid">CSF</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Intracranial_pressure" title="Intracranial pressure">Intracranial hypertension</a>
<ul><li><a href="/wiki/Hydrocephalus" title="Hydrocephalus">Hydrocephalus</a></li>
<li><a href="/wiki/Normal_pressure_hydrocephalus" title="Normal pressure hydrocephalus">Normal pressure hydrocephalus</a></li>
<li><a href="/wiki/Choroid_plexus_papilloma" title="Choroid plexus papilloma">Choroid plexus papilloma</a></li>
<li><a href="/wiki/Idiopathic_intracranial_hypertension" title="Idiopathic intracranial hypertension">Idiopathic intracranial hypertension</a></li></ul></li>
<li><a href="/wiki/Cerebral_edema" title="Cerebral edema">Cerebral edema</a></li>
<li><a href="/wiki/Spontaneous_cerebrospinal_fluid_leak" title="Spontaneous cerebrospinal fluid leak">Intracranial hypotension</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Brain_herniation" title="Brain herniation">Brain herniation</a></li>
<li><a href="/wiki/Reye_syndrome" title="Reye syndrome">Reye syndrome</a></li>
<li><a href="/wiki/Hepatic_encephalopathy" title="Hepatic encephalopathy">Hepatic encephalopathy</a></li>
<li><a href="/wiki/Toxic_encephalopathy" title="Toxic encephalopathy">Toxic encephalopathy</a></li>
<li><a href="/wiki/Hashimoto%27s_encephalopathy" title="Hashimoto&#39;s encephalopathy">Hashimoto's encephalopathy</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Both/either</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Degenerative" scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Neurodegeneration" title="Neurodegeneration">Degenerative</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Spinocerebellar_ataxia" title="Spinocerebellar ataxia">SA</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Friedreich%27s_ataxia" title="Friedreich&#39;s ataxia">Friedreich's ataxia</a></li>
<li><a href="/wiki/Ataxia%E2%80%93telangiectasia" title="Ataxia–telangiectasia">Ataxia–telangiectasia</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Motor_neuron_disease" title="Motor neuron disease">MND</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i><a href="/wiki/Upper_motor_neuron" title="Upper motor neuron">UMN</a> only:</i>
<ul><li><a href="/wiki/Primary_lateral_sclerosis" title="Primary lateral sclerosis">Primary lateral sclerosis</a></li>
<li><a href="/wiki/Pseudobulbar_palsy" title="Pseudobulbar palsy">Pseudobulbar palsy</a></li>
<li><a href="/wiki/Hereditary_spastic_paraplegia" title="Hereditary spastic paraplegia">Hereditary spastic paraplegia</a></li></ul></li></ul>
<ul><li><i><a href="/wiki/Lower_motor_neuron" title="Lower motor neuron">LMN</a> only:</i>
<ul><li><a href="/wiki/Distal_hereditary_motor_neuronopathies" title="Distal hereditary motor neuronopathies">Distal hereditary motor neuronopathies</a></li>
<li><a href="/wiki/Spinal_muscular_atrophies" title="Spinal muscular atrophies">Spinal muscular atrophies</a>
<ul><li><a href="/wiki/Spinal_muscular_atrophy" title="Spinal muscular atrophy">SMA</a></li>
<li><a href="/wiki/Spinal_and_bulbar_muscular_atrophy" title="Spinal and bulbar muscular atrophy">SMAX1</a></li>
<li><a href="/wiki/X-linked_spinal_muscular_atrophy_type_2" title="X-linked spinal muscular atrophy type 2">SMAX2</a></li>
<li><a href="/wiki/Distal_spinal_muscular_atrophy_type_1" title="Distal spinal muscular atrophy type 1">DSMA1</a></li>
<li><a href="/wiki/Congenital_distal_spinal_muscular_atrophy" title="Congenital distal spinal muscular atrophy">Congenital DSMA</a></li>
<li>Spinal muscular atrophy with lower extremity predominance (SMALED)
<ul><li><a href="/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_1" title="Spinal muscular atrophy with lower extremity predominance 1">SMALED1</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_2A" title="Spinal muscular atrophy with lower extremity predominance 2A">SMALED2A</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_2B" title="Spinal muscular atrophy with lower extremity predominance 2B">SMALED2B</a></li></ul></li>
<li><a href="/wiki/Pontocerebellar_hypoplasia" title="Pontocerebellar hypoplasia">SMA-PCH</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_progressive_myoclonic_epilepsy" title="Spinal muscular atrophy with progressive myoclonic epilepsy">SMA-PME</a></li></ul></li>
<li><a href="/wiki/Progressive_muscular_atrophy" title="Progressive muscular atrophy">Progressive muscular atrophy</a></li>
<li><a href="/wiki/Progressive_bulbar_palsy" title="Progressive bulbar palsy">Progressive bulbar palsy</a>
<ul><li><a href="/wiki/Fazio%E2%80%93Londe_disease" title="Fazio–Londe disease">Fazio–Londe</a></li>
<li><a href="/wiki/Infantile_progressive_bulbar_palsy" title="Infantile progressive bulbar palsy">Infantile progressive bulbar palsy</a></li></ul></li></ul></li></ul>
<ul><li><i>both:</i>
<ul><li><a class="mw-selflink selflink">Amyotrophic lateral sclerosis</a></li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Amyotrophic_lateral_sclerosis" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r992953826"/><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Amyotrophic_lateral_sclerosis" title="Template:Amyotrophic lateral sclerosis"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Amyotrophic_lateral_sclerosis" title="Template talk:Amyotrophic lateral sclerosis"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Amyotrophic_lateral_sclerosis&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Amyotrophic_lateral_sclerosis" style="font-size:114%;margin:0 4em"><a class="mw-selflink selflink">Amyotrophic lateral sclerosis</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">General</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Genetics_of_amyotrophic_lateral_sclerosis" title="Genetics of amyotrophic lateral sclerosis">Genetics of ALS</a></li>
<li><a href="/wiki/Amyotrophic_lateral_sclerosis_research" title="Amyotrophic lateral sclerosis research">ALS research</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Organizations in the United States</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/ALS_Association" title="ALS Association">ALS Association</a></li>
<li><a href="/wiki/ALS_Therapy_Development_Institute" title="ALS Therapy Development Institute">ALS Therapy Development Institute</a></li>
<li><a href="/wiki/Les_Turner_ALS_Foundation" title="Les Turner ALS Foundation">Les Turner ALS Foundation</a></li>
<li><a href="/wiki/Muscular_Dystrophy_Association" title="Muscular Dystrophy Association">Muscular Dystrophy Association</a></li>
<li><a href="/wiki/Project_ALS" title="Project ALS">Project ALS</a></li>
<li><a href="/wiki/Prize4Life" title="Prize4Life">Prize4Life</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">International organizations</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/ALS_Society_of_Canada" title="ALS Society of Canada">ALS Society of Canada</a></li>
<li><a href="/wiki/Motor_Neurone_Disease_Association" title="Motor Neurone Disease Association">Motor Neurone Disease Association</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Events</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/ALS_Awareness_Month" title="ALS Awareness Month">ALS Awareness Month</a></li>
<li><a href="/wiki/Ice_Bucket_Challenge" title="Ice Bucket Challenge">Ice Bucket Challenge</a></li>
<li><a href="/wiki/Annual_ALS_Awareness_Game" class="mw-redirect" title="Annual ALS Awareness Game">Annual ALS Awareness Game</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">People</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/O.J._Brigance" class="mw-redirect" title="O.J. Brigance">O.J. Brigance</a></li>
<li><a href="/wiki/Paul_Cellucci" title="Paul Cellucci">Paul Cellucci</a></li>
<li><a href="/wiki/Dwight_Clark" title="Dwight Clark">Dwight Clark</a></li>
<li><a href="/wiki/Jay_S._Fishman" title="Jay S. Fishman">Jay Fishman</a></li>
<li><a href="/wiki/Pete_Frates" class="mw-redirect" title="Pete Frates">Pete Frates</a></li>
<li><a href="/wiki/Lou_Gehrig" title="Lou Gehrig">Lou Gehrig</a></li>
<li><a href="/wiki/Richard_Glatzer" title="Richard Glatzer">Richard Glatzer</a></li>
<li><a href="/wiki/Steve_Gleason" title="Steve Gleason">Steve Gleason</a></li>
<li><a href="/wiki/Stephen_Hawking" title="Stephen Hawking">Stephen Hawking</a></li>
<li><a href="/wiki/Stephen_Heywood" title="Stephen Heywood">Stephen Heywood</a></li>
<li><a href="/wiki/Stephen_Hillenburg" title="Stephen Hillenburg">Stephen Hillenburg</a></li>
<li><a href="/wiki/Jacob_Javits" title="Jacob Javits">Jacob Javits</a></li>
<li><a href="/wiki/Jason_Becker" title="Jason Becker">Jason Becker</a></li>
<li><a href="/wiki/Augie_Nieto" title="Augie Nieto">Augie Nieto</a></li>
<li><a href="/wiki/Jon_Stone" title="Jon Stone">Jon Stone</a></li>
<li><a href="/wiki/Kevin_Turner_(running_back)" title="Kevin Turner (running back)">Kevin Turner</a></li>
<li><a href="/wiki/Henry_A._Wallace" title="Henry A. Wallace">Henry Wallace</a></li>
<li><a href="/wiki/Mickey_Marvin" title="Mickey Marvin">Mickey Marvin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Related</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/List_of_people_with_amyotrophic_lateral_sclerosis" title="List of people with amyotrophic lateral sclerosis">List of people with ALS</a></li>
<li><a href="/wiki/Lou_Gehrig_Memorial_Award" title="Lou Gehrig Memorial Award">Lou Gehrig Memorial Award</a></li>
<li><i><a href="/wiki/Ice_Bucket_Challenge:_Pete_Frates_and_the_Fight_Against_ALS" title="Ice Bucket Challenge: Pete Frates and the Fight Against ALS">Ice Bucket Challenge: Pete Frates and the Fight Against ALS</a></i></li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox authority-control" aria-labelledby="Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q206901#identifiers&amp;#124;Edit_this_at_Wikidata" style="padding:3px"><table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th id="Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q206901#identifiers&amp;#124;Edit_this_at_Wikidata" scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control</a> <a href="https://www.wikidata.org/wiki/Q206901#identifiers" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="nowrap"><a href="/wiki/BNF_(identifier)" class="mw-redirect" title="BNF (identifier)">BNF</a>: <span class="uid"><a rel="nofollow" class="external text" href="https://catalogue.bnf.fr/ark:/12148/cb12110754p">cb12110754p</a> <a rel="nofollow" class="external text" href="https://data.bnf.fr/ark:/12148/cb12110754p">(data)</a></span></span></li>
<li><span class="nowrap"><a href="/wiki/LCCN_(identifier)" class="mw-redirect" title="LCCN (identifier)">LCCN</a>: <span class="uid"><a rel="nofollow" class="external text" href="https://id.loc.gov/authorities/subjects/sh85004728">sh85004728</a></span></span></li>
<li><span class="nowrap"><a href="/wiki/LNB_(identifier)" class="mw-redirect" title="LNB (identifier)">LNB</a>: <span class="uid"><a rel="nofollow" class="external text" href="https://kopkatalogs.lv/F?func=direct&amp;local_base=lnc10&amp;doc_number=000125199&amp;P_CON_LNG=ENG">000125199</a></span></span></li>
<li><span class="nowrap"><a href="/wiki/NDL_(identifier)" class="mw-redirect" title="NDL (identifier)">NDL</a>: <span class="uid"><a rel="nofollow" class="external text" href="https://id.ndl.go.jp/auth/ndlna/01127913">01127913</a></span></span></li></ul>
</div></td></tr></tbody></table></div>
<!-- 
NewPP limit report
Parsed by mw1371
Cached time: 20210410213243
Cache expiry: 2592000
Dynamic content: false
Complications: [vary‐revision‐sha1]
CPU time usage: 2.363 seconds
Real time usage: 2.659 seconds
Preprocessor visited node count: 11499/1000000
Post‐expand include size: 513606/2097152 bytes
Template argument size: 9019/2097152 bytes
Highest expansion depth: 13/40
Expensive parser function count: 11/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 643049/5000000 bytes
Lua time usage: 1.115/10.000 seconds
Lua memory usage: 8933356/52428800 bytes
Lua Profile:
    ?                                                                340 ms       27.4%
    Scribunto_LuaSandboxCallback::match                              140 ms       11.3%
    Scribunto_LuaSandboxCallback::gsub                               100 ms        8.1%
    dataWrapper <mw.lua:668>                                         100 ms        8.1%
    Scribunto_LuaSandboxCallback::callParserFunction                 100 ms        8.1%
    Scribunto_LuaSandboxCallback::getEntityStatements                 60 ms        4.8%
    recursiveClone <mwInit.lua:41>                                    40 ms        3.2%
    Scribunto_LuaSandboxCallback::getAllExpandedArguments             40 ms        3.2%
    tostring                                                          40 ms        3.2%
    Scribunto_LuaSandboxCallback::getEntity                           40 ms        3.2%
    [others]                                                         240 ms       19.4%
Number of Wikibase entities loaded: 1/400
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 2184.024      1 -total
 35.27%  770.264    131 Template:Cite_journal
  6.83%  149.170      2 Template:Infobox
  4.48%   97.867      8 Template:Navbox
  4.27%   93.260      1 Template:Authority_control
  4.13%   90.112      1 Template:Infobox_medical_condition_(new)
  4.04%   88.177      1 Template:CNS_diseases_of_the_nervous_system
  3.95%   86.348      1 Template:Medical_resources
  3.85%   84.188      1 Template:Commons_category
  3.65%   79.706      1 Template:Sister_project
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:19375577-0!canonical and timestamp 20210410213240 and revision id 1016485537. Serialized with JSON.
 -->
</div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript>
<div class="printfooter">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;oldid=1016485537">https://en.wikipedia.org/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;oldid=1016485537</a>"</div></div>
		<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Amyotrophic_lateral_sclerosis" title="Category:Amyotrophic lateral sclerosis">Amyotrophic lateral sclerosis</a></li><li><a href="/wiki/Category:Motor_neuron_diseases" title="Category:Motor neuron diseases">Motor neuron diseases</a></li><li><a href="/wiki/Category:Rare_diseases" title="Category:Rare diseases">Rare diseases</a></li><li><a href="/wiki/Category:Unsolved_problems_in_neuroscience" title="Category:Unsolved problems in neuroscience">Unsolved problems in neuroscience</a></li><li><a href="/wiki/Category:Systemic_atrophies_primarily_affecting_the_central_nervous_system" title="Category:Systemic atrophies primarily affecting the central nervous system">Systemic atrophies primarily affecting the central nervous system</a></li><li><a href="/wiki/Category:Cytoskeletal_defects" title="Category:Cytoskeletal defects">Cytoskeletal defects</a></li><li><a href="/wiki/Category:Neuromuscular_disorders" title="Category:Neuromuscular disorders">Neuromuscular disorders</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1:_long_volume_value" title="Category:CS1: long volume value">CS1: long volume value</a></li><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_is_different_from_Wikidata" title="Category:Short description is different from Wikidata">Short description is different from Wikidata</a></li><li><a href="/wiki/Category:Use_dmy_dates_from_September_2020" title="Category:Use dmy dates from September 2020">Use dmy dates from September 2020</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2016" title="Category:Articles containing potentially dated statements from 2016">Articles containing potentially dated statements from 2016</a></li><li><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_October_2020" title="Category:Articles with unsourced statements from October 2020">Articles with unsourced statements from October 2020</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2017" title="Category:Articles containing potentially dated statements from 2017">Articles containing potentially dated statements from 2017</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_July_2015" title="Category:Articles containing potentially dated statements from July 2015">Articles containing potentially dated statements from July 2015</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2013" title="Category:Articles containing potentially dated statements from 2013">Articles containing potentially dated statements from 2013</a></li><li><a href="/wiki/Category:Commons_category_link_is_on_Wikidata" title="Category:Commons category link is on Wikidata">Commons category link is on Wikidata</a></li><li><a href="/wiki/Category:Articles_with_Curlie_links" title="Category:Articles with Curlie links">Articles with Curlie links</a></li><li><a href="/wiki/Category:Wikipedia_articles_with_BNF_identifiers" title="Category:Wikipedia articles with BNF identifiers">Wikipedia articles with BNF identifiers</a></li><li><a href="/wiki/Category:Wikipedia_articles_with_LCCN_identifiers" title="Category:Wikipedia articles with LCCN identifiers">Wikipedia articles with LCCN identifiers</a></li><li><a href="/wiki/Category:Wikipedia_articles_with_LNB_identifiers" title="Category:Wikipedia articles with LNB identifiers">Wikipedia articles with LNB identifiers</a></li><li><a href="/wiki/Category:Wikipedia_articles_with_NDL_identifiers" title="Category:Wikipedia articles with NDL identifiers">Wikipedia articles with NDL identifiers</a></li><li><a href="/wiki/Category:Wikipedia_medicine_articles_ready_to_translate" title="Category:Wikipedia medicine articles ready to translate">Wikipedia medicine articles ready to translate</a></li><li><a href="/wiki/Category:RTTNEURO" title="Category:RTTNEURO">RTTNEURO</a></li></ul></div></div>
	</div>
</div>
<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

<div id="mw-navigation">
	<h2>Navigation menu</h2>
	<div id="mw-head">
		<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-personal" class="mw-portlet mw-portlet-personal vector-menu" aria-labelledby="p-personal-label" role="navigation" 
	 >
	<h3 id="p-personal-label" class="vector-menu-heading">
		<span>Personal tools</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="pt-anonuserpage">Not logged in</li><li id="pt-anontalk"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n">Talk</a></li><li id="pt-anoncontribs"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y">Contributions</a></li><li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Amyotrophic+lateral+sclerosis" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Amyotrophic+lateral+sclerosis" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o">Log in</a></li></ul>
		
	</div>
</nav>

		<div id="left-navigation">
			<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-namespaces" class="mw-portlet mw-portlet-namespaces vector-menu vector-menu-tabs" aria-labelledby="p-namespaces-label" role="navigation" 
	 >
	<h3 id="p-namespaces-label" class="vector-menu-heading">
		<span>Namespaces</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="ca-nstab-main" class="selected"><a href="/wiki/Amyotrophic_lateral_sclerosis" title="View the content page [c]" accesskey="c">Article</a></li><li id="ca-talk"><a href="/wiki/Talk:Amyotrophic_lateral_sclerosis" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t">Talk</a></li></ul>
		
	</div>
</nav>

			<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-variants" class="mw-portlet mw-portlet-variants emptyPortlet vector-menu vector-menu-dropdown" aria-labelledby="p-variants-label" role="navigation" 
	 >
	<input type="checkbox" class="vector-menu-checkbox" aria-labelledby="p-variants-label" />
	<h3 id="p-variants-label" class="vector-menu-heading">
		<span>Variants</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"></ul>
		
	</div>
</nav>

		</div>
		<div id="right-navigation">
			<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-views" class="mw-portlet mw-portlet-views vector-menu vector-menu-tabs" aria-labelledby="p-views-label" role="navigation" 
	 >
	<h3 id="p-views-label" class="vector-menu-heading">
		<span>Views</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="ca-view" class="selected"><a href="/wiki/Amyotrophic_lateral_sclerosis">Read</a></li><li id="ca-edit"><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=edit" title="Edit this page [e]" accesskey="e">Edit</a></li><li id="ca-history"><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=history" title="Past revisions of this page [h]" accesskey="h">View history</a></li></ul>
		
	</div>
</nav>

			<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-cactions" class="mw-portlet mw-portlet-cactions emptyPortlet vector-menu vector-menu-dropdown" aria-labelledby="p-cactions-label" role="navigation" 
	 >
	<input type="checkbox" class="vector-menu-checkbox" aria-labelledby="p-cactions-label" />
	<h3 id="p-cactions-label" class="vector-menu-heading">
		<span>More</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"></ul>
		
	</div>
</nav>

			<div id="p-search" role="search" >
	<h3 >
		<label for="searchInput">Search</label>
	</h3>
	<form action="/w/index.php" id="searchform">
		<div id="simpleSearch" data-search-loc="header-navigation">
			<input type="search" name="search" placeholder="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput"/>
			<input type="hidden" name="title" value="Special:Search"/>
			<input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton"/>
			<input type="submit" name="go" value="Go" title="Go to a page with this exact name if it exists" id="searchButton" class="searchButton"/>
		</div>
	</form>
</div>

		</div>
	</div>
	
<div id="mw-panel">
	<div id="p-logo" role="banner">
		<a class="mw-wiki-logo" href="/wiki/Main_Page"
			title="Visit the main page"></a>
	</div>
	<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-navigation" class="mw-portlet mw-portlet-navigation vector-menu vector-menu-portal portal" aria-labelledby="p-navigation-label" role="navigation" 
	 >
	<h3 id="p-navigation-label" class="vector-menu-heading">
		<span>Navigation</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Articles related to current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x">Random article</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works">About Wikipedia</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact us</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us by donating to the Wikimedia Foundation">Donate</a></li></ul>
		
	</div>
</nav>

	<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-interaction" class="mw-portlet mw-portlet-interaction vector-menu vector-menu-portal portal" aria-labelledby="p-interaction-label" role="navigation" 
	 >
	<h3 id="p-interaction-label" class="vector-menu-heading">
		<span>Contribute</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-introduction"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia">Learn to edit</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r">Recent changes</a></li><li id="n-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Add images or other media for use on Wikipedia">Upload file</a></li></ul>
		
	</div>
</nav>
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-tb" class="mw-portlet mw-portlet-tb vector-menu vector-menu-portal portal" aria-labelledby="p-tb-label" role="navigation" 
	 >
	<h3 id="p-tb-label" class="vector-menu-heading">
		<span>Tools</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Amyotrophic_lateral_sclerosis" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Amyotrophic_lateral_sclerosis" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;oldid=1016485537" title="Permanent link to this revision of this page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;action=info" title="More information about this page">Page information</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Amyotrophic_lateral_sclerosis&amp;id=1016485537&amp;wpFormIdentifier=titleform" title="Information on how to cite this page">Cite this page</a></li><li id="t-wikibase"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q206901" title="Structured data on this page hosted by Wikidata [g]" accesskey="g">Wikidata item</a></li></ul>
		
	</div>
</nav>
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-coll-print_export" class="mw-portlet mw-portlet-coll-print_export vector-menu vector-menu-portal portal" aria-labelledby="p-coll-print_export-label" role="navigation" 
	 >
	<h3 id="p-coll-print_export-label" class="vector-menu-heading">
		<span>Print/export</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="coll-download-as-rl"><a href="/w/index.php?title=Special:DownloadAsPdf&amp;page=Amyotrophic_lateral_sclerosis&amp;action=show-download-screen" title="Download this page as a PDF file">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li></ul>
		
	</div>
</nav>
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-wikibase-otherprojects" class="mw-portlet mw-portlet-wikibase-otherprojects vector-menu vector-menu-portal portal" aria-labelledby="p-wikibase-otherprojects-label" role="navigation" 
	 >
	<h3 id="p-wikibase-otherprojects-label" class="vector-menu-heading">
		<span>In other projects</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li class="wb-otherproject-link wb-otherproject-commons"><a href="https://commons.wikimedia.org/wiki/Category:Amyotrophic_lateral_sclerosis" hreflang="en">Wikimedia Commons</a></li></ul>
		
	</div>
</nav>

	<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-lang" class="mw-portlet mw-portlet-lang vector-menu vector-menu-portal portal" aria-labelledby="p-lang-label" role="navigation" 
	 >
	<h3 id="p-lang-label" class="vector-menu-heading">
		<span>Languages</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li class="interlanguage-link interwiki-af"><a href="https://af.wikipedia.org/wiki/Motorneuronsiekte" title="Motorneuronsiekte – Afrikaans" lang="af" hreflang="af" class="interlanguage-link-target">Afrikaans</a></li><li class="interlanguage-link interwiki-ar"><a href="https://ar.wikipedia.org/wiki/%D8%AA%D8%B5%D9%84%D8%A8_%D8%AC%D8%A7%D9%86%D8%A8%D9%8A_%D8%B6%D9%85%D9%88%D8%B1%D9%8A" title="تصلب جانبي ضموري – Arabic" lang="ar" hreflang="ar" class="interlanguage-link-target">العربية</a></li><li class="interlanguage-link interwiki-ast"><a href="https://ast.wikipedia.org/wiki/Esclerosis_llateral_amiotr%C3%B3fica" title="Esclerosis llateral amiotrófica – Asturian" lang="ast" hreflang="ast" class="interlanguage-link-target">Asturianu</a></li><li class="interlanguage-link interwiki-az"><a href="https://az.wikipedia.org/wiki/Yan_amiotrofik_skleroz" title="Yan amiotrofik skleroz – Azerbaijani" lang="az" hreflang="az" class="interlanguage-link-target">Azərbaycanca</a></li><li class="interlanguage-link interwiki-bg"><a href="https://bg.wikipedia.org/wiki/%D0%90%D0%BC%D0%B8%D0%BE%D1%82%D1%80%D0%BE%D1%84%D0%B8%D1%87%D0%BD%D0%B0_%D0%BB%D0%B0%D1%82%D0%B5%D1%80%D0%B0%D0%BB%D0%BD%D0%B0_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7%D0%B0" title="Амиотрофична латерална склероза – Bulgarian" lang="bg" hreflang="bg" class="interlanguage-link-target">Български</a></li><li class="interlanguage-link interwiki-ca"><a href="https://ca.wikipedia.org/wiki/Esclerosi_lateral_amiotr%C3%B2fica" title="Esclerosi lateral amiotròfica – Catalan" lang="ca" hreflang="ca" class="interlanguage-link-target">Català</a></li><li class="interlanguage-link interwiki-cs"><a href="https://cs.wikipedia.org/wiki/Amyotrofick%C3%A1_later%C3%A1ln%C3%AD_skler%C3%B3za" title="Amyotrofická laterální skleróza – Czech" lang="cs" hreflang="cs" class="interlanguage-link-target">Čeština</a></li><li class="interlanguage-link interwiki-da"><a href="https://da.wikipedia.org/wiki/Amyotrofisk_lateral_sklerose" title="Amyotrofisk lateral sklerose – Danish" lang="da" hreflang="da" class="interlanguage-link-target">Dansk</a></li><li class="interlanguage-link interwiki-de"><a href="https://de.wikipedia.org/wiki/Amyotrophe_Lateralsklerose" title="Amyotrophe Lateralsklerose – German" lang="de" hreflang="de" class="interlanguage-link-target">Deutsch</a></li><li class="interlanguage-link interwiki-et"><a href="https://et.wikipedia.org/wiki/Am%C3%BCotroofne_lateraalskleroos" title="Amüotroofne lateraalskleroos – Estonian" lang="et" hreflang="et" class="interlanguage-link-target">Eesti</a></li><li class="interlanguage-link interwiki-el"><a href="https://el.wikipedia.org/wiki/%CE%91%CE%BC%CF%85%CE%BF%CF%84%CF%81%CE%BF%CF%86%CE%B9%CE%BA%CE%AE_%CF%80%CE%BB%CE%B5%CF%85%CF%81%CE%B9%CE%BA%CE%AE_%CF%83%CE%BA%CE%BB%CE%AE%CF%81%CF%85%CE%BD%CF%83%CE%B7" title="Αμυοτροφική πλευρική σκλήρυνση – Greek" lang="el" hreflang="el" class="interlanguage-link-target">Ελληνικά</a></li><li class="interlanguage-link interwiki-es"><a href="https://es.wikipedia.org/wiki/Esclerosis_lateral_amiotr%C3%B3fica" title="Esclerosis lateral amiotrófica – Spanish" lang="es" hreflang="es" class="interlanguage-link-target">Español</a></li><li class="interlanguage-link interwiki-eo"><a href="https://eo.wikipedia.org/wiki/Amiotrofa_lateralsklerozo" title="Amiotrofa lateralsklerozo – Esperanto" lang="eo" hreflang="eo" class="interlanguage-link-target">Esperanto</a></li><li class="interlanguage-link interwiki-eu"><a href="https://eu.wikipedia.org/wiki/Alboko_esklerosi_amiotrofiko" title="Alboko esklerosi amiotrofiko – Basque" lang="eu" hreflang="eu" class="interlanguage-link-target">Euskara</a></li><li class="interlanguage-link interwiki-fa"><a href="https://fa.wikipedia.org/wiki/%D8%A7%D8%B3%DA%A9%D9%84%D8%B1%D9%88%D8%B2_%D8%AC%D8%A7%D9%86%D8%A8%DB%8C_%D8%A2%D9%85%DB%8C%D9%88%D8%AA%D8%B1%D9%88%D9%81%DB%8C%DA%A9" title="اسکلروز جانبی آمیوتروفیک – Persian" lang="fa" hreflang="fa" class="interlanguage-link-target">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="https://fr.wikipedia.org/wiki/Scl%C3%A9rose_lat%C3%A9rale_amyotrophique" title="Sclérose latérale amyotrophique – French" lang="fr" hreflang="fr" class="interlanguage-link-target">Français</a></li><li class="interlanguage-link interwiki-gl"><a href="https://gl.wikipedia.org/wiki/Esclerose_lateral_amiotr%C3%B3fica" title="Esclerose lateral amiotrófica – Galician" lang="gl" hreflang="gl" class="interlanguage-link-target">Galego</a></li><li class="interlanguage-link interwiki-ko"><a href="https://ko.wikipedia.org/wiki/%EA%B7%BC%EC%9C%84%EC%B6%95%EC%84%B1_%EC%B8%A1%EC%82%AD%EA%B2%BD%ED%99%94%EC%A6%9D" title="근위축성 측삭경화증 – Korean" lang="ko" hreflang="ko" class="interlanguage-link-target">한국어</a></li><li class="interlanguage-link interwiki-hy"><a href="https://hy.wikipedia.org/wiki/%D4%BF%D5%B8%D5%B2%D5%B4%D5%B6%D5%A1%D5%B5%D5%AB%D5%B6_%D5%A1%D5%B4%D5%AB%D5%B8%D5%BF%D6%80%D5%B8%D6%86%D5%AB%D5%AF_%D5%BD%D5%AF%D5%AC%D5%A5%D6%80%D5%B8%D5%A6" title="Կողմնային ամիոտրոֆիկ սկլերոզ – Armenian" lang="hy" hreflang="hy" class="interlanguage-link-target">Հայերեն</a></li><li class="interlanguage-link interwiki-hi"><a href="https://hi.wikipedia.org/wiki/%E0%A4%AA%E0%A5%87%E0%A4%B6%E0%A5%80%E0%A4%B6%E0%A5%8B%E0%A4%B7%E0%A5%80_%E0%A4%AA%E0%A4%BE%E0%A4%B0%E0%A5%8D%E0%A4%B6%E0%A5%8D%E0%A4%B5_%E0%A4%95%E0%A4%BE%E0%A4%A0%E0%A4%BF%E0%A4%A8%E0%A5%8D%E0%A4%AF_(%E0%A4%8F%E0%A4%AE%E0%A4%BF%E0%A4%AF%E0%A5%8B%E0%A4%9F%E0%A5%8D%E0%A4%B0%E0%A5%89%E0%A4%AB%E0%A4%BC%E0%A4%BF%E0%A4%95_%E0%A4%B2%E0%A5%88%E0%A4%9F%E0%A4%B0%E0%A4%B2_%E0%A4%B8%E0%A5%8D%E0%A4%95%E0%A4%B2%E0%A4%BF%E0%A4%B0%E0%A5%89%E0%A4%B8%E0%A4%BF%E0%A4%B8)" title="पेशीशोषी पार्श्व काठिन्य (एमियोट्रॉफ़िक लैटरल स्कलिरॉसिस) – Hindi" lang="hi" hreflang="hi" class="interlanguage-link-target">हिन्दी</a></li><li class="interlanguage-link interwiki-hr"><a href="https://hr.wikipedia.org/wiki/Amiotrofi%C4%8Dna_lateralna_skleroza" title="Amiotrofična lateralna skleroza – Croatian" lang="hr" hreflang="hr" class="interlanguage-link-target">Hrvatski</a></li><li class="interlanguage-link interwiki-id"><a href="https://id.wikipedia.org/wiki/Sklerosis_lateral_amiotrofik" title="Sklerosis lateral amiotrofik – Indonesian" lang="id" hreflang="id" class="interlanguage-link-target">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-is"><a href="https://is.wikipedia.org/wiki/Lou_Gehrig-sj%C3%BAkd%C3%B3mur" title="Lou Gehrig-sjúkdómur – Icelandic" lang="is" hreflang="is" class="interlanguage-link-target">Íslenska</a></li><li class="interlanguage-link interwiki-it"><a href="https://it.wikipedia.org/wiki/Sclerosi_laterale_amiotrofica" title="Sclerosi laterale amiotrofica – Italian" lang="it" hreflang="it" class="interlanguage-link-target">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="https://he.wikipedia.org/wiki/%D7%98%D7%A8%D7%A9%D7%AA_%D7%90%D7%9E%D7%99%D7%95%D7%98%D7%A8%D7%95%D7%A4%D7%99%D7%AA_%D7%A6%D7%99%D7%93%D7%99%D7%AA" title="טרשת אמיוטרופית צידית – Hebrew" lang="he" hreflang="he" class="interlanguage-link-target">עברית</a></li><li class="interlanguage-link interwiki-ka"><a href="https://ka.wikipedia.org/wiki/%E1%83%90%E1%83%9B%E1%83%98%E1%83%9D%E1%83%A2%E1%83%A0%E1%83%9D%E1%83%A4%E1%83%A3%E1%83%9A%E1%83%98_%E1%83%92%E1%83%95%E1%83%94%E1%83%A0%E1%83%93%E1%83%98%E1%83%97%E1%83%98_%E1%83%A1%E1%83%99%E1%83%9A%E1%83%94%E1%83%A0%E1%83%9D%E1%83%96%E1%83%98" title="ამიოტროფული გვერდითი სკლეროზი – Georgian" lang="ka" hreflang="ka" class="interlanguage-link-target">ქართული</a></li><li class="interlanguage-link interwiki-sw"><a href="https://sw.wikipedia.org/wiki/Sklerosisi_ya_kimiotrofia_ya_pembezoni" title="Sklerosisi ya kimiotrofia ya pembezoni – Swahili" lang="sw" hreflang="sw" class="interlanguage-link-target">Kiswahili</a></li><li class="interlanguage-link interwiki-la"><a href="https://la.wikipedia.org/wiki/Sclerosis_lateralis_amyotrophica" title="Sclerosis lateralis amyotrophica – Latin" lang="la" hreflang="la" class="interlanguage-link-target">Latina</a></li><li class="interlanguage-link interwiki-lv"><a href="https://lv.wikipedia.org/wiki/Amiotrof%C4%81_later%C4%81l%C4%81_skleroze" title="Amiotrofā laterālā skleroze – Latvian" lang="lv" hreflang="lv" class="interlanguage-link-target">Latviešu</a></li><li class="interlanguage-link interwiki-li"><a href="https://li.wikipedia.org/wiki/ALS" title="ALS – Limburgish" lang="li" hreflang="li" class="interlanguage-link-target">Limburgs</a></li><li class="interlanguage-link interwiki-hu"><a href="https://hu.wikipedia.org/wiki/Amiotr%C3%B3fi%C3%A1s_later%C3%A1lszkler%C3%B3zis" title="Amiotrófiás laterálszklerózis – Hungarian" lang="hu" hreflang="hu" class="interlanguage-link-target">Magyar</a></li><li class="interlanguage-link interwiki-mk"><a href="https://mk.wikipedia.org/wiki/%D0%90%D0%BC%D0%B8%D0%BE%D1%82%D1%80%D0%BE%D1%84%D0%B8%D1%87%D0%BD%D0%B0_%D0%BB%D0%B0%D1%82%D0%B5%D1%80%D0%B0%D0%BB%D0%BD%D0%B0_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7%D0%B0" title="Амиотрофична латерална склероза – Macedonian" lang="mk" hreflang="mk" class="interlanguage-link-target">Македонски</a></li><li class="interlanguage-link interwiki-ml"><a href="https://ml.wikipedia.org/wiki/%E0%B4%85%E0%B4%AE%E0%B4%BF%E0%B4%9F%E0%B5%8D%E0%B4%B0%E0%B5%8B%E0%B4%AB%E0%B4%BF%E0%B4%95%E0%B5%8D_%E0%B4%B2%E0%B4%BE%E0%B4%B1%E0%B5%8D%E0%B4%B1%E0%B4%B1%E0%B5%BD_%E0%B4%B8%E0%B5%8D%E2%80%8C%E0%B4%95%E0%B5%8D%E0%B4%B2%E0%B5%80%E0%B4%B1%E0%B5%8B%E0%B4%B8%E0%B4%BF%E0%B4%B8%E0%B5%8D" title="അമിട്രോഫിക് ലാറ്ററൽ സ്‌ക്ലീറോസിസ് – Malayalam" lang="ml" hreflang="ml" class="interlanguage-link-target">മലയാളം</a></li><li class="interlanguage-link interwiki-xmf"><a href="https://xmf.wikipedia.org/wiki/%E1%83%90%E1%83%9B%E1%83%98%E1%83%9D%E1%83%A2%E1%83%A0%E1%83%9D%E1%83%A4%E1%83%A3%E1%83%9A%E1%83%98_%E1%83%A1%E1%83%99%E1%83%9A%E1%83%94%E1%83%A0%E1%83%9D%E1%83%96%E1%83%98" title="ამიოტროფული სკლეროზი – Mingrelian" lang="xmf" hreflang="xmf" class="interlanguage-link-target">მარგალური</a></li><li class="interlanguage-link interwiki-ms"><a href="https://ms.wikipedia.org/wiki/Sklerosis_lateral_amiotrofik" title="Sklerosis lateral amiotrofik – Malay" lang="ms" hreflang="ms" class="interlanguage-link-target">Bahasa Melayu</a></li><li class="interlanguage-link interwiki-nl"><a href="https://nl.wikipedia.org/wiki/Amyotrofe_laterale_sclerose" title="Amyotrofe laterale sclerose – Dutch" lang="nl" hreflang="nl" class="interlanguage-link-target">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="https://ja.wikipedia.org/wiki/%E7%AD%8B%E8%90%8E%E7%B8%AE%E6%80%A7%E5%81%B4%E7%B4%A2%E7%A1%AC%E5%8C%96%E7%97%87" title="筋萎縮性側索硬化症 – Japanese" lang="ja" hreflang="ja" class="interlanguage-link-target">日本語</a></li><li class="interlanguage-link interwiki-no"><a href="https://no.wikipedia.org/wiki/Amyotrofisk_lateralsklerose" title="Amyotrofisk lateralsklerose – Norwegian Bokmål" lang="nb" hreflang="nb" class="interlanguage-link-target">Norsk bokmål</a></li><li class="interlanguage-link interwiki-or"><a href="https://or.wikipedia.org/wiki/%E0%AC%86%E0%AC%AE%E0%AC%BE%E0%AD%9F%E0%AD%8B%E0%AC%9F%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%AB%E0%AC%BF%E0%AC%95%E0%AD%8D_%E0%AC%B2%E0%AC%BE%E0%AC%9F%E0%AD%87%E0%AC%B0%E0%AC%BE%E0%AC%B2_%E0%AC%B8%E0%AD%8D%E0%AC%95%E0%AD%8D%E0%AC%B2%E0%AD%87%E0%AC%B0%E0%AD%8B%E0%AC%B8%E0%AC%BF%E0%AC%B8%E0%AD%8D" title="ଆମାୟୋଟ୍ରୋଫିକ୍ ଲାଟେରାଲ ସ୍କ୍ଲେରୋସିସ୍ – Odia" lang="or" hreflang="or" class="interlanguage-link-target">ଓଡ଼ିଆ</a></li><li class="interlanguage-link interwiki-pl"><a href="https://pl.wikipedia.org/wiki/Stwardnienie_zanikowe_boczne" title="Stwardnienie zanikowe boczne – Polish" lang="pl" hreflang="pl" class="interlanguage-link-target">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="https://pt.wikipedia.org/wiki/Esclerose_lateral_amiotr%C3%B3fica" title="Esclerose lateral amiotrófica – Portuguese" lang="pt" hreflang="pt" class="interlanguage-link-target">Português</a></li><li class="interlanguage-link interwiki-ro"><a href="https://ro.wikipedia.org/wiki/Scleroz%C4%83_lateral%C4%83_amiotrofic%C4%83" title="Scleroză laterală amiotrofică – Romanian" lang="ro" hreflang="ro" class="interlanguage-link-target">Română</a></li><li class="interlanguage-link interwiki-ru"><a href="https://ru.wikipedia.org/wiki/%D0%91%D0%BE%D0%BA%D0%BE%D0%B2%D0%BE%D0%B9_%D0%B0%D0%BC%D0%B8%D0%BE%D1%82%D1%80%D0%BE%D1%84%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7" title="Боковой амиотрофический склероз – Russian" lang="ru" hreflang="ru" class="interlanguage-link-target">Русский</a></li><li class="interlanguage-link interwiki-si"><a href="https://si.wikipedia.org/wiki/%E0%B6%B4%E0%B7%9A%E0%B7%82%E0%B7%93%E0%B6%B4%E0%B7%9D%E0%B7%82%E0%B6%AB_%E0%B6%B4%E0%B7%8F%E0%B6%BB%E0%B7%8A%E0%B7%81%E0%B7%8A%E0%B7%80%E0%B7%93%E0%B6%BA_%E0%B6%A2%E0%B7%8F%E0%B6%BB%E0%B6%A8%E0%B7%8A%E2%80%8D%E0%B6%BA%E0%B6%BA" title="පේෂීපෝෂණ පාර්ශ්වීය ජාරඨ්‍යය – Sinhala" lang="si" hreflang="si" class="interlanguage-link-target">සිංහල</a></li><li class="interlanguage-link interwiki-simple"><a href="https://simple.wikipedia.org/wiki/Motor_neurone_disease" title="Motor neurone disease – Simple English" lang="en-simple" hreflang="en-simple" class="interlanguage-link-target">Simple English</a></li><li class="interlanguage-link interwiki-sk"><a href="https://sk.wikipedia.org/wiki/Amyotrofick%C3%A1_later%C3%A1lna_skler%C3%B3za" title="Amyotrofická laterálna skleróza – Slovak" lang="sk" hreflang="sk" class="interlanguage-link-target">Slovenčina</a></li><li class="interlanguage-link interwiki-sl"><a href="https://sl.wikipedia.org/wiki/Amiotrofi%C4%8Dna_lateralna_skleroza" title="Amiotrofična lateralna skleroza – Slovenian" lang="sl" hreflang="sl" class="interlanguage-link-target">Slovenščina</a></li><li class="interlanguage-link interwiki-ckb"><a href="https://ckb.wikipedia.org/wiki/%D8%A6%D8%A7%D9%85%DB%8C%DB%86%D8%AA%D8%B1%DB%86%D9%81%DB%8C%DA%A9_%D9%84%D8%A7%D8%AA%DB%8E%D8%B1%D8%A7%D9%84_%D8%B3%DA%A9%D9%84%DB%8E%D8%B1%DB%86%D8%B2%DB%8C%D8%B3" title="ئامیۆترۆفیک لاتێرال سکلێرۆزیس – Central Kurdish" lang="ckb" hreflang="ckb" class="interlanguage-link-target">کوردی</a></li><li class="interlanguage-link interwiki-sr"><a href="https://sr.wikipedia.org/wiki/Amiotrofi%C4%8Dna_lateralna_skleroza" title="Amiotrofična lateralna skleroza – Serbian" lang="sr" hreflang="sr" class="interlanguage-link-target">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh"><a href="https://sh.wikipedia.org/wiki/Amiotrofi%C4%8Dna_lateralna_skleroza" title="Amiotrofična lateralna skleroza – Serbo-Croatian" lang="sh" hreflang="sh" class="interlanguage-link-target">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi"><a href="https://fi.wikipedia.org/wiki/ALS-tauti" title="ALS-tauti – Finnish" lang="fi" hreflang="fi" class="interlanguage-link-target">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="https://sv.wikipedia.org/wiki/Amyotrofisk_lateralskleros" title="Amyotrofisk lateralskleros – Swedish" lang="sv" hreflang="sv" class="interlanguage-link-target">Svenska</a></li><li class="interlanguage-link interwiki-tl"><a href="https://tl.wikipedia.org/wiki/Amyotrophic_lateral_sclerosis" title="Amyotrophic lateral sclerosis – Tagalog" lang="tl" hreflang="tl" class="interlanguage-link-target">Tagalog</a></li><li class="interlanguage-link interwiki-ta"><a href="https://ta.wikipedia.org/wiki/%E0%AE%A4%E0%AE%9A%E0%AF%88%E0%AE%AF%E0%AF%82%E0%AE%9F%E0%AF%8D%E0%AE%9F%E0%AE%AE%E0%AE%B1%E0%AF%8D%E0%AE%B1_%E0%AE%AA%E0%AE%95%E0%AF%8D%E0%AE%95_%E0%AE%AE%E0%AE%B0%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%81_%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8D" title="தசையூட்டமற்ற பக்க மரப்பு நோய் – Tamil" lang="ta" hreflang="ta" class="interlanguage-link-target">தமிழ்</a></li><li class="interlanguage-link interwiki-th"><a href="https://th.wikipedia.org/wiki/%E0%B8%AD%E0%B8%B0%E0%B9%84%E0%B8%A1%E0%B9%82%E0%B8%AD%E0%B9%82%E0%B8%97%E0%B8%A3%E0%B8%9F%E0%B8%B4%E0%B8%81_%E0%B9%81%E0%B8%A5%E0%B9%80%E0%B8%97%E0%B8%AD%E0%B8%A3%E0%B8%B1%E0%B8%A5_%E0%B8%AA%E0%B9%80%E0%B8%81%E0%B8%A5%E0%B8%AD%E0%B9%82%E0%B8%A3%E0%B8%8B%E0%B8%B4%E0%B8%AA" title="อะไมโอโทรฟิก แลเทอรัล สเกลอโรซิส – Thai" lang="th" hreflang="th" class="interlanguage-link-target">ไทย</a></li><li class="interlanguage-link interwiki-tr"><a href="https://tr.wikipedia.org/wiki/Amyotrofik_lateral_skleroz" title="Amyotrofik lateral skleroz – Turkish" lang="tr" hreflang="tr" class="interlanguage-link-target">Türkçe</a></li><li class="interlanguage-link interwiki-uk"><a href="https://uk.wikipedia.org/wiki/%D0%91%D1%96%D1%87%D0%BD%D0%B8%D0%B9_%D0%B0%D0%BC%D1%96%D0%BE%D1%82%D1%80%D0%BE%D1%84%D1%96%D1%87%D0%BD%D0%B8%D0%B9_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B7" title="Бічний аміотрофічний склероз – Ukrainian" lang="uk" hreflang="uk" class="interlanguage-link-target">Українська</a></li><li class="interlanguage-link interwiki-vi"><a href="https://vi.wikipedia.org/wiki/X%C6%A1_c%E1%BB%A9ng_teo_c%C6%A1_m%E1%BB%99t_b%C3%AAn" title="Xơ cứng teo cơ một bên – Vietnamese" lang="vi" hreflang="vi" class="interlanguage-link-target">Tiếng Việt</a></li><li class="interlanguage-link interwiki-wuu"><a href="https://wuu.wikipedia.org/wiki/%E8%82%8C%E8%90%8E%E7%BC%A9%E6%80%A7%E8%84%8A%E9%AB%93%E4%BE%A7%E7%B4%A2%E7%A1%AC%E5%8C%96%E7%97%87" title="肌萎缩性脊髓侧索硬化症 – Wu Chinese" lang="wuu" hreflang="wuu" class="interlanguage-link-target">吴语</a></li><li class="interlanguage-link interwiki-yi"><a href="https://yi.wikipedia.org/wiki/ALS" title="ALS – Yiddish" lang="yi" hreflang="yi" class="interlanguage-link-target">ייִדיש</a></li><li class="interlanguage-link interwiki-zh-yue"><a href="https://zh-yue.wikipedia.org/wiki/%E8%82%8C%E8%82%89%E8%90%8E%E7%B8%AE%E6%80%A7%E8%84%8A%E9%AB%93%E5%81%B4%E7%B4%A2%E7%A1%AC%E5%8C%96%E7%97%87" title="肌肉萎縮性脊髓側索硬化症 – Cantonese" lang="yue" hreflang="yue" class="interlanguage-link-target">粵語</a></li><li class="interlanguage-link interwiki-zh"><a href="https://zh.wikipedia.org/wiki/%E8%82%8C%E8%90%8E%E7%BC%A9%E6%80%A7%E8%84%8A%E9%AB%93%E4%BE%A7%E7%B4%A2%E7%A1%AC%E5%8C%96%E7%97%87" title="肌萎缩性脊髓侧索硬化症 – Chinese" lang="zh" hreflang="zh" class="interlanguage-link-target">中文</a></li></ul>
		<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q206901#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>
	</div>
</nav>

</div>

</div>
<footer id="footer" class="mw-footer" role="contentinfo" >
	<ul id="footer-info" >
	<li id="footer-info-lastmod"> This page was last edited on 7 April 2021, at 12:40<span class="anonymous-show">&#160;(UTC)</span>.</li>
	<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//foundation.wikimedia.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//foundation.wikimedia.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>

	<ul id="footer-places" >
	<li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy policy</a></li>
	<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
	<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
	<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
	<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Amyotrophic_lateral_sclerosis&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
	<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
	<li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li>
	<li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Cookie_statement">Cookie statement</a></li>
</ul>

	<ul id="footer-icons" class="noprint">
	<li id="footer-copyrightico"><a href="https://wikimediafoundation.org/"><img src="/static/images/footer/wikimedia-button.png" srcset="/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation" loading="lazy" /></a></li>
	<li id="footer-poweredbyico"><a href="https://www.mediawiki.org/"><img src="/static/images/footer/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></li>
</ul>

</footer>


<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"2.363","walltime":"2.659","ppvisitednodes":{"value":11499,"limit":1000000},"postexpandincludesize":{"value":513606,"limit":2097152},"templateargumentsize":{"value":9019,"limit":2097152},"expansiondepth":{"value":13,"limit":40},"expensivefunctioncount":{"value":11,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":643049,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00% 2184.024      1 -total"," 35.27%  770.264    131 Template:Cite_journal","  6.83%  149.170      2 Template:Infobox","  4.48%   97.867      8 Template:Navbox","  4.27%   93.260      1 Template:Authority_control","  4.13%   90.112      1 Template:Infobox_medical_condition_(new)","  4.04%   88.177      1 Template:CNS_diseases_of_the_nervous_system","  3.95%   86.348      1 Template:Medical_resources","  3.85%   84.188      1 Template:Commons_category","  3.65%   79.706      1 Template:Sister_project"]},"scribunto":{"limitreport-timeusage":{"value":"1.115","limit":"10.000"},"limitreport-memusage":{"value":8933356,"limit":52428800},"limitreport-profile":[["?","340","27.4"],["Scribunto_LuaSandboxCallback::match","140","11.3"],["Scribunto_LuaSandboxCallback::gsub","100","8.1"],["dataWrapper \u003Cmw.lua:668\u003E","100","8.1"],["Scribunto_LuaSandboxCallback::callParserFunction","100","8.1"],["Scribunto_LuaSandboxCallback::getEntityStatements","60","4.8"],["recursiveClone \u003CmwInit.lua:41\u003E","40","3.2"],["Scribunto_LuaSandboxCallback::getAllExpandedArguments","40","3.2"],["tostring","40","3.2"],["Scribunto_LuaSandboxCallback::getEntity","40","3.2"],["[others]","240","19.4"]]},"cachereport":{"origin":"mw1371","timestamp":"20210410213243","ttl":2592000,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Amyotrophic lateral sclerosis","url":"https:\/\/en.wikipedia.org\/wiki\/Amyotrophic_lateral_sclerosis","sameAs":"http:\/\/www.wikidata.org\/entity\/Q206901","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q206901","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2003-01-28T09:18:07Z","dateModified":"2021-04-07T12:40:52Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/7\/75\/ALS_Coronal.jpg","headline":"neurodegenerative disease characterized by progressive muscular paralysis"}</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":195,"wgHostname":"mw1275"});});</script>
</body></html>